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The group I introns from Tetrahymena thermophila, Tth.L1925, and Physarum
polycephalum, Ppo.L1925, are closely related, sharing 70% sequence identity in their
ribozyme regions. However, Ppo.L1925 also contains an open reading frame (ORF)
encoding the homing endonuclease I-PpoI, which is separated from the ribozyme by a
53 nucleotide 3’UTR region; Tth.L1925 lacks both the ORF and 3’UTR regions.
Previous studies of Ppo.L1925 have shown that the I-PpoI protein is translated
from the RNA Pol I-derived spliced intron RNA.  In order to better understand
Ppo.L1925-encoded ORF translation, I created several chimeric ORF-containing
Tth.L1925 introns and integrated them into the rDNA of Saccharomyces cerevisiae.
Previous attempts to exchange the I-PpoI ORF found that small (~300 bp) ORFs can
be integrated whereas larger ORFs disrupt intron splicing.  I found that Tth.L1925-
based introns could accommodate and express both small and larger ORFs;  these
introns produce protein at levels similar to proteins produced from wild-type
Ppo.L1925 (~ 0.01% of total yeast protein).
To better understand the effect of intron sequence on protein expression, I
added Ppo.L1925 sequences to chimeric Tth.L1925 introns.  Some 3’UTR sequences
had previously been shown to increase expression from Ppo.L1925 nearly 20-fold;
however, all of the 3’UTR sequences tested in chimeric Tth.L1925 introns lowered
expression.  Replacing the Tth.L1925 5’end sequence with that of Ppo.L1925, though,
increased expression nearly 10-fold.  To further study the effect of the intron 5’ end
sequence on expression, I created an intron pool with random 5’ end sequences.
About 25% of these introns had increased expression up to 20-fold, while about 50%
had their expression lowered to undetectable levels.  I examined two models for
expression of chimeric intron-encoded ORFs that explain how 5’ end sequence
changes could affect translation: interaction with the invasive growth IRES system and
translation through formation of intron RNA circles.  Addition of an invasive growth
IRES sequence did not increase expression from a Tth.L1925-based intron, while RT-
PCR amplification of intron RNA circle junctions demonstrated no relationship
between the circle species formed and expression level.  These results suggest that the
intron-encoded ORF is not being translated through either of these two models.
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1CHAPTER I
The Biology of Mobile Nuclear Group I Introns
Group I introns
The discovery of group I introns radically changed the role that RNA was
thought to play in a cell.  Until the early 1980’s, RNA was thought to be an
intermediary between DNA and protein.  mRNA is transcribed from DNA in the
nucleus, transported to the cytoplasm, where the ribosome, which was thought to be
composed of catalytic protein and structural rRNA, and aminoacyl-tRNAs translate
the message into protein.  This view was changed in 1982 by the discovery of an RNA
that could catalyze chemical reactions. Cech and his coworkers discovered that an
intron in the immature ribosomal RNA (pre-rRNA) of Tetrahymena thermophila,
currently known as Tth.L1925, could self-splice without protein factors (Kruger,
Grabowski et al. 1982).  This discovery was followed in 1993 by the Altman group’s
discovery that the RNA component of Ribonuclease P (RNase P) was responsible for
RNA cleavage (Guerrier-Takada, Gardiner et al. 1983).  These discoveries earned
Cech and Altman the 1989 Nobel Prize in chemistry and started the search for other
catalytic RNAs.  Discovered ribozymes include group I introns, a family of
Tetrahymena-like self-splicing introns.  Other ribozymes include group II introns, a
family of self-splicing introns unrelated to group I introns, and the RNA-cleaving
hammerhead and hairpin ribozymes.  In vitro selection of ribozymes has evolved
ribozymes capable of catalyzing many reactions, such as aminoacylation of tRNA,
RNA-dependent RNA polymerization, and acyl-transferase of amino-acids (Green and
Szostak 1992; Lohse and Szostak 1996; Lee, Bessho et al. 2000).  Proteins themselves
are even the product of RNA catalysis, as the RNA in the ribosome has been shown to
2be responsible for catalyzing peptide bond synthesis (Khaitovich, Mankin et al. 1999;
Khaitovich, Tenson et al. 1999; Cech 2000; Nissen, Hansen et al. 2000).
Since their discovery of the Tetrahymena intron, group I introns have grown
into a family with over 2,700 identified members (listed at
http://www.rna.ccbb.utexas.edu/) (Cannone, Subramanian et al. 2002).  This family is
defined by a limited amount of shared primary sequence and by the ability of the
intron RNA to fold into a common secondary structural motif.  It is this structure that
allows the intron RNA to catalyze its own removal from the surrounding RNA,
preventing the intron sequence from disrupting the function of the host sequence
(Cech 1988; Michel and Westhof 1990).
Group I introns share many features with Group II introns, a separate family of
catalytic RNAs, and inteins, protein domains that splice themselves out of their host
protein after translation.  All three of these groups share similar evolutionary niches
and are found interrupting transcribed DNA.  They are able to post-transcriptionally
(group I and group II introns) or post-translationally (inteins) catalyze their own
removal from their host sequence, which allows the host gene to function despite the
presence of the parasitic element.  All three sequences have undergone horizontal
transfer between relatively unrelated organisms.  Lastly, there are many examples of
these elements gaining additional sequences in the form of open reading frames
(ORFs) (group I and group II introns) or separate protein domains (inteins) during the
course of their evolution.  These ORFs and protein domains either aid in the splicing
of the element or allow it to horizontally transfer more efficiently (Perler, Olsen et al.
1997).   Because of the similarities, it is illuminating to discuss group II introns and
inteins alongside group I introns.
The most striking ability of group I introns, group II introns and inteins is their
ability to self-splice.   Each of these groups uses a distinct pathway to ensure that their
3host gene functions normally.  The splicing reactions are catalyzed by the insertional
elements themselves, but sometimes require additional cofactors, such as an
exogenous guanosine (Group I introns), Mg2+, splicing factors and maturases (see
intron-encoded proteins, below).
Group I Intron Splicing
In vitro, the self-splicing reaction of the many group I intron requires only
Mg2+ and an exogenous guanosine cofactor (Termed the exoG, which can be a GTP,
GDP, GMP, or unphosphorylated guanosine).  The splicing reaction initiates with the
non-covalent interaction of the exoG and the G-binding site in the P7 stem (Figure
1.1A).  The 3’-OH of the exoG attacks at the 5’ splice site, binding to the 5’ end of the
intron RNA and displacing the 3’ end of the 5’ exon RNA.  The 3’ -OH of the 5’ exon
RNA then attacks between the 3’ end of the intron RNA and the 5’ end of the 3’ exon,
which liberates the intron RNA and joins the exons together.
In vivo the rate of the splicing reaction is dependent on several factors.
Neighboring exon RNA sequence can slow the rate of intron splicing by interfering
with the folding of the ribozyme (Woodson and Cech 1991).  In other cases,
neighboring intron sequences can aid in folding, increasing the rate of splicing
(Rocheleau and Woodson 1995; Koduvayur and Woodson 2004).  Protein factors also
aid group I intron slicing, increasing the rate of splicing by facilitating the folding of
the ribozyme RNA (see Maturases and Splicing Factors, below).
4Figure 1.1:  Group I intron, group II intron, and intein splicing.
A.  The group I intron splicing reaction, with the exons in red and the intron in
black.  1.  The intron-containing gene (DNA) is transcribed to RNA.  2.  An
exogenous GTP, GDP, GMP or guanosine (green) binds to the intron.  3.  The 3’
OH of the G residue attacks at the 5’ splice site, liberating the 5’ exon RNA and
covalently binding to the 5’ end of the intron.  4.  The 3’ OH of the 5’ exon attacks
at the 5’ end of the 3’ exon.  5.  This attack liberates the intron and joins the 5’ and
3’ exons.
B.  The group II intron splicing reaction with the exons in red and the intron in
black.  1. The intron-containing gene (DNA) is transcribed to RNA. 2.  The 2’ OH
of an internal A attacks at the 3’ end of the 5’ splice site.  3. This liberates the 5’
exon and forms a RNA lariat at the 5’ end of the intron. 4.  The 3’ OH of the 5’
exon attacks at the 5’ end of the 3’ exon.  5.  This attack liberates the intron and
joins the 5’ and 3’ exons.
C.  The intein splicing reaction.  The exteins are in red and the intein in black. 1.
The intein-containing gene (DNA) is transcribed to RNA. 2.  The intein-containing
RNA is translated to protein.  3. If the initial intein residue is a cysteine, the N-
extein is transferred to the side chain of the first residue at the N-terminal end of the
intein through an N-S acyl rearrangement.  If the initial residue of the intein is a
serine then the N-extein is transferred through an N-O rearrangement.  4. The N-
terminal extein is transferred to the side chain of the C-terminal residue of the
intein, which can be either serine, threonine, or cysteine, through a trans-
esterification reaction.  5.  The side chain of the C-terminal intein asparagine
cyclize with the intein C-terminus, releasing the exteins.  6.  A peptide bond is
formed between the N-terminal and C-terminal exteins through a spontaneous O-N
(or S-N) acyl rearrangement.
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6Group II intron and intein splicing
The splicing of group II introns also involves two transesterification reactions
(Figure 1.1B).  Unlike group I introns, which use an exogenous cofactor to initiate
splicing, the group II introns use the 2’ OH of an internal A residue as the first
attacking group of the splicing reaction. The 2’-OH of the A residue attacks at the 5’
splice site, binding to the 5’ end of the intron RNA and forming a “lariat” structure.
This attack also displaces the 3’ end of the 5’ exon RNA.  The 3’ -OH of the 5’ exon
RNA then attacks between the 3’ end of the intron RNA and the 5’ end of the 3’ exon,
which liberates the intron RNA lariat and joins the exons together.
Initial observations of the splicing mechanism of group II introns and
spliceosomal introns found that they were similar, leading to the suggestion that group
II introns may be the forbearers of the spliceosomal complex (Sharp 1985; Cech 1986;
Sharp 1991).  Further mechanistic investigations of the catalysis of both of the splicing
reactions have found them to be indistinguishable (Moore and Sharp 1993; Padgett,
Podar et al. 1994).  Furthermore, regions of group II intron sequence can complement
the loss of spliceosomal RNAs and vice-versa (Hetzer, Wurzer et al. 1997; Shukla and
Padgett 2002).  Taken together, these facts are highly suggestive that the spliceosomal
complex is another example of a protein-RNA complex taking over the role previously
played purely by RNA.
Inteins, being made of protein, splice in a completely different manner, and are
unrelated to both group I and group II introns (Figure 1.1C).  They are translated into a
protein domain that splices itself out of the host protein, or extein.  The initial step of
intein splicing is either an N-S acyl rearrangement if the initial intein residue is a
cysteine or a N-O rearrangement if the initial residue is a serine.  This results in the
movement of the N-extein to the side chain of the first residue at the N-terminal end of
the intein.  A transesterification reaction with the first residue of the C-terminal extein,
7which can be either serine, threonine, or cysteine, moves the N-extein to the side chain
of the first residue in the C-extein.  Cyclization of the intein C-terminal asparagine
side chain excises the intein from the exteins.  Lastly, a spontaneous O-N (or S-N)
acyl rearrangement forms a peptide bond between the exteins (Liu 2000).
Group I intron nomenclature
There are two nomenclature schemes describing group I introns inserted in
ribosomal RNA genes.  The original nomenclature scheme names introns by taking the
first two letters based on the organism of origin, one for genus and two for species,
and follows them by three letters abbreviating the gene within which they are inserted
and a number indicating the order in which the intron was discovered.  For example,
the group I intron from the large ribosomal subunit of Physarum polycephalum would
be named PpLSU3:  “Pp” for the first letters of Physarum polycephalum, “LSU” for
the large ribosomal subunit, and “3” as it was the third intron found in this gene and
organism (Dujon, Belfort et al. 1989; Michel and Westhof 1990).
More recently, nomenclature has been proposed for introns inserted in genes
encoding ribosomal RNA (rDNA).  The newer nomenclature takes into account the
position of insertion based on the numbering of the E. coli sequence.  The Physarum
intron would be named Ppo.L1925:  “Ppo” for Physarum polycephalum, “L” for large
ribosomal subunit, and “1925” as it is inserted between 1925 and 1926 in reference to
the E. coli LSU sequence.  An additional letter is added before the subunit letter to
denote location in mitochondrial  (an “m”) or chloroplast (a “c”) genome, as in the
mitochondrial intron Sce.mL2449 (Johansen and Haugen 2001).  Unfortunately, this
nomenclature has not been widely accepted.  In order to avoid confusion, this thesis
uses the common names of each intron and the above nomenclature for the
Tetrahymena intron (Tth.L1925) and Physarum intron (Ppo.L1925).
8Group I intron structure
Group I introns are able to fold into a very similar secondary structure even
though there is often less than ten percent sequence identity between many of them
(Davies, Waring et al. 1982; Michel, Jacquier et al. 1982; Cech, Damberger et al.
1994).  This structure has been confirmed though chemical and enzymatic probing
(Been and Cech 1987; Burke 1988; Couture, Ellington et al. 1990) and later through
crystal structures  of introns from Tetrahymena, Azoarcus, and bacteriophage Twort.
(Golden, Gooding et al. 1998; Adams, Stahley et al. 2004; Adams, Stahley et al. 2004;
Guo, Gooding et al. 2004; Golden, Kim et al. 2005).
The secondary structure of a group I ribozyme (Figure 1.2A) consists of
regions of paired RNA sequence, denoted by “P” followed by a number indicating the
order of the stem, 5’ to 3’.  The core ribozyme region, which is defined as being both
the conserved sequences among group I introns and the sequences necessary for
ribozyme activity, consists of P1, P3, P4, P5, P6, P7, P8, and P9 regions.  Other
regions, such as P5abc (Figure 1.2B), P2-P2.1 and P9.1-P9.2 in the case of the
Tth.L1925 pictured, are not present in all cases (Michel and Westhof 1990).  Based on
the presence or lack of these optional regions, group I introns have been classified into
five major classes, A through E.  These are divided into smaller subgroups based on
variations within the group (Michel and Westhof 1990).
Crystal structures show that the core region of the ribozyme is arranged into
two long helical domains consisting of the P5-P4-P6 and P8-P3-P7-P9 stem loops.
The P1 region, which contains of the 3’ end of the 5’ exon and the 5’ splice site, forms
a third helix that interacts with the interface of the two larger stem loops.  The intron
sequence that pairs with this region, known as the internal guide sequence (IGS), is
responsible for determining the location of the 5’ end of the intron.  Changes to the
IGS can either change the location of the 5’ splice site or abrogate splicing entirely.
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Figure 1.2:  Group I intron structure.
A.  The core structure of a group I intron.  The intron is in black, while the exon
sequences are in red.
B.  The extend P5abc loop found in some group I introns.  The P5abc loop
stabilizes the three-dimensional structure of the intron.
C.  Some group I introns contain ORF sequences in loops.  The group I intron
Ppo.L1925 contains an ORF in the P1 loop as shown here.
D.  Some group I introns have an ORF and a second group I ribozyme inserted into
the P2 loop.
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The G binding site is located in the P7 stem, while the P9 and P10 regions play a role
in determining the location of the 3’ splice site (Golden, Gooding et al. 1998).
Mg2+ is necessary for group I intron activity in vitro, both by playing roles in
stabilizing the RNA structure and in the chemistry of the splicing reaction (Pyle 1993;
Hanna and Doudna 2000).  Three Mg2+ ions are proposed to play a role in the
ribozyme catalysis, two of which coordinate the nucleophile in both steps of the
splicing reaction, while the third stabilizes the leaving group (Weinstein, Jones et al.
1997).  Candidates for the former two Mg2+ ions are observed in the Azoarcus intron
structure.  These two ions interact with all three helical domains and bring the 5’ and
3’ splice sites into the catalytic core (Adams, Stahley et al. 2004).
Group I introns often contain peripheral sequences in addition to the core
ribozyme.  These sequences include RNA that folds to support the intron structure,
ORFs that are inserted within loop regions of the introns, or even a sequence that
forms a second ribozyme structure.  Many introns contain extended RNA sequence in
the P5 loop, the P5abc structure (Figure 1.2B), which helps to stabilize the intron
structure (see Maturases, below). Inserted ORFs have been found in both sense and
anti-sense orientation and usually code for maturases or homing endonucleases,
proteins that give the intron an advantage either by aiding in intron splicing or in the
transfer of the intron (Figure 1.2C).  Two introns, Nja.S516,  and Dir.S956-1, have a
twin-ribozyme organization (Figure 1.2D) (Johansen and Vogt 1994; Decatur, Einvik
et al. 1995).  Cleavage by the second ribozyme plays a role in expression of the intron-
encoded ORF (See Expression of Nuclear Group I Intron Encoded Genes, below).
Post-splicing reactions
Group I intron RNAs also undergo a number of post-splicing reactions, some
of which seem to have additional biological significance.  One of these reactions is a
reverse of the splicing reaction, where the intron splices into another RNA (Figure
11
1.3A).  Initiation of reverse splicing is primarily mediated by IGS binding.  The intron
RNA can splice into both the exon RNA and other RNA molecules with sequence
complementary to the IGS.  As group I intron splicing is essentially a two-step
chemical reaction, consisting of two transesterifications catalyzed by a ribozyme with
no net energy change, the splicing reaction is fully reversible.  Spliced full-length
intron will cleave a target RNA and insert itself into RNA at sites homologous the site
of intron insertion.  The new insertion site does not necessarily have to be the original
site of intron insertion; it merely has to have homology to the original site for IGS
binding.  Weaker IGS binding results in a slower reaction.  A sequence neighboring
the insertion site can also interfere with reverse splicing if it forms secondary
structures that block IGS binding.  Reverse splicing has been demonstrated both in
vitro (Woodson and Cech 1989) and in vivo (Thompson and Herrin 1994; Roman and
Woodson 1995; Birgisdottir and Johansen 2005) and may play a role in the horizontal
transfer of group I introns lacking homing endonucleases (see Horizontal Transfer of
Group I Introns).
Some group I intron ribozymes catalyze cleavage of the spliced intron RNA
(Figure 1.3B).  These processing cleavages are mediated by a G addition in a similar
manner to the first step of splicing.  The 3-OH of the exoG attacks at the cleavage
point, cleaving the intron into a 5’ piece and a 3’ piece with an additional 5’ G.  This
processing has been shown to reduce protein production from Ppo.L1925 in yeast and
may serve to reduce the levels of potentially toxic homing endonuclease produced
from the intron (Ruoff, Johansen et al. 1992; Lin and Vogt 1998; Decatur, Johansen et
al. 2000; Haugen, De Jonckheere et al. 2002).
Group I introns also form circular RNA after splicing (Figure 1.3D and 1.3E).
The circularization reaction can be thought of as a reverse of the last step of the
splicing reaction, wherein the 3’ -OH of the intron attacks the 5’ end of the intron.
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Figure 1.3:  Post-splicing reactions.
A.  Reverse splicing:  1.  The IGS of the fully-spliced intron (black) binds to a free
target RNA (red).  2.  The 3’ OH of the intron attacks the bound RNA downstream
of the IGS binding site.  3.  The 3’ OH of the 5’ target RNA attacks between the
exogenous G (green) added in the splicing reaction and the first nucleotide of the
intron.  4.  This frees the exogenous G and inserts the intron into the target RNA.
B.  Processing.  1.  A second exogenous G (purple) binds to the spliced intron RNA
(black).  The 3’ OH of this G attacks in the intron sequence.  2.  This results in the
cleavage of the intron and the second exogenous G covalently bound to the 5’ end
of the 3’ intron piece.
C.  Formation of full-length intron circles pre-splicing.  1.  The terminal G of the
intron attacks at the 5’ splice site.  2.  This results in the formation of a full-length
intron circle and does not ligate the 5’ and 3’ exons (red lines).
D.  Formation of full-length intron circles post-splicing.  1.  The 3’ OH of at the 3’
end off the spliced intron (black) attacks between the exogenous G (green) added in
the splicing reaction and the first nucleotide of the intron.  2.  This frees the
exogenous G and circularizes the intron RNA.
E.  Formation of truncated intron circles.  The 3’ OH of at the 3’ end off the spliced
intron (black) attacks in the intron sequence.  2.  This frees the 5’ end of the intron
sequence and circularizes the 3’ intron RNA.
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There appear to be two general types of circles formed, full-length circles where the 3’
end of the intron attacks between the exogenous G and the first nucleotide of the
intron, and truncated circles, where the 3’ end of the intron attacks in or near the IGS
of the intron.  Tth.L1925 primarily forms IGS circles at the +15 and +19 positions
both in vitro and in vivo, although full-length circles have been seen as a minor species
in vitro (Been and Cech 1986; Inoue, Sullivan et al. 1986; Been and Cech 1987).
The group I intron Dir.S956-1 forms full-length circles through an alternate
pathway, which occurs before the intron splices itself out of its host RNA (Figure
1.3C).  The bond between the 3’-most nucleotide of the intron, a G (referred to as the
ΩG), and the 5’ end of the 3’ exon is hydrolyzed.  The 3’ OH of the ΩG attacks at the
5’ splice site, resulting in a circular intron.  Evidence for the formation of full-length
pathways has been seen for most nuclear group I introns in vitro, including Tth.L1925.
However, this pathway seems to be inhibited in Tth.L1925 in vivo.  Interestingly, this
pathway is detrimental to the intron’s host, as circle formation by this pathway
produces nonfunctional rRNA (Nielsen, Fiskaa et al. 2003).
Intron encoded and associated proteins
The majority of intron-encoded proteins serve one of two functions.  They
either are homing endonucleases, which allow the intron to enter into intron-lacking
alleles, or are maturases, proteins that aid in the intron splicing reaction.  There are
exceptions, though, such as the Neurospora mitochondrial large rRNA intron, which
encodes the essential ribosomal S-5 protein (Burke and RajBhandary 1982).
Homing endonuclease genes (HEG) have been found in group I introns, group
II introns, inteins, and in inter-genic regions (Belfort and Roberts 1997).  HEGs allow
their parent insertional element to transfer, or home (as DNA), into element-lacking
alleles through a double-strand break repair (DSBR) mechanism (see Horizontal
transfer of group I introns, below).  The endonucleases these genes produce are similar
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to restriction enzymes in that they recognize a specific DNA target site and make a
double stranded break at that site, although homing endonuclease recognition sites are
much larger, ranging from12 to 40 bp.  Homing endonucleases do not necessarily
recognize the strict palindromic sequences that are characteristic of restriction enzyme
target sites and they tolerate sequence degeneracy in their target site, which is
uncommon in restriction enzymes.  Intron-encoded homing endonucleases also tend to
be smaller than restriction enzymes, and it is possible that their size is constrained by
requirements for intron splicing. There are four families of homing endonucleases
based on active site sequence motifs: His-Cys box, LAGLIDADG, H-N-H, and GIY-
YIG.(Lambowitz and Belfort 1993; Mueller 1993; Roberts 1993; Roberts and Macelis
1997).
Homing endonucleases are named in a fashion similar to restriction enzymes
with the addition of a prefix to indicate the location of the endonuclease ORF.  Intron-
encoded endonucleases are indicated with an “I” prefix, intein-encoded endonucleases
with a "PI", and freestanding ORF's are indicated by an "F" prefix.  The endonuclease
encoded by the Physarum intron Ppo.L1925 is named I-Ppo I, “I” as it is intron-
encoded, “Ppo” for Physarum polycephalum, and “I” as it is the first discovered
homing endonuclease encoded by an intron in this organism (Roberts, Belfort et al.
2003).
The reaction rate of self-splicing introns in vitro is often much slower than the
intron splices in vivo.  In vivo, proteins can bind to the intron and increase the intron’s
reaction rate.   When these proteins are intron-encoded, they are called maturases,
while proteins encoded elsewhere in the genome are termed splicing factors.
Group I intron maturases appear to have evolved from LAGLIDADG motif
homing endonucleases (Belfort and Roberts 1997).  Many group I intron encoded
proteins possess both maturase and endonuclease activity, while a few amino acid
15
substitutions can activate endonuclease activity in the I-Cre I maturase (Dalgaard,
Klar et al. 1997).  Crystal structures of the I-AniI, a bi-functional homing
endonuclease/maturase from the Aspergillus nidulans mitochondrial COB intron
(AnCOB), show that the maturase and endonuclease activity are the result of distinct
domains.  It is possible that maturase activity developed in regions of the protein not
important in endonuclease function after the HEG sequence entered into the intron
sequence (Lambowitz 1989; Bolduc, Spiegel et al. 2003; Chatterjee, Brady et al.
2003).
Splicing factors are host-encoded proteins that aid in intron splicing.  There are
two well-characterized group I intron splicing factors, Neurospora crassa
mitochondrial tyrosyl-tRNA synthetase Cyt-18 and the yeast cytochrome B processing
protein Cbp2.  Other known splicing factors include two proteins from yeast, Mrs2
and leucyl-tRNA synthetase NAM2 and two E. coli proteins, StpA and ribosomal
protein S12.
Cyt-18 is a mitochondrial tyrosyl-tRNA synthetase in Neurospora crassa.  It
can also act as a splicing factor for three mitochondrial group I introns, the
mitochondrial large ribosomal RNA intron, cytrochrome oxidase intron cob-I2, and
NADH dehyrdogenase intron ND1 (Akins and Lambowitz 1987; Wallweber, Mohr et
al. 1997).  CYT-18 has also been shown to suppress splicing mutations in the T4 td
intron core that abrogate splicing (Mohr, Zhang et al. 1992) and can facilitate the
splicing of the yeast bI5 intron (Webb, Rose et al. 2001).  All of the previously
mentioned introns lack an extension of the P5 stem, the P5abc region which is present
in other group I introns, such as the Tetrahymena intron, Tth.L1925.  The P5abc
region enhances intron folding, and therefore enhances splicing, by stabilizing the P4-
P6 stem.  A crystal structure of CYT-18 bound to the Twort ribozyme shows that the
protein serves in a similar capacity in P5abc-lacking introns by binding to the P4-P6
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region of the ribozyme (Paukstelis, Chen et al. 2008).  CYT-18 does not stimulate the
splicing of P5abc-containing Tth.L1925 in vitro but does rescue splicing in a mutant
Tth.L1925 lacking the P5abc region (Mohr, Caprara et al. 1994; Wallweber, Mohr et
al. 1997).
The yeast CBP2 is a nuclear gene that plays the role of splicing factor with
several yeast introns.  Unlike CYT-18, CBP2 does not appear to have a function in
addition to that of a splicing factor.  CBP2 was first isolated in a screen for respiratory
mutants in Saccharomyces cerevisiae, and was later found to act as a splicing factor
for the last intron in the mitochondrial cytorchrome oxidase b, bI5 (McGraw and
Tzagoloff 1983; Hill, McGraw et al. 1985; Gampel, Nishikimi et al. 1989).  The lack
of phenotype in yeast that lack both CBP2 and bI5 led to a search for another function
for the protein.   Saccharomyces douglasii was found to encode a CBP2-like protein,
but lacks the bI5 intron, suggesting that CBP2 had an additional activity, which
resulted in its conservation in S. douglasii.  Investigation showed, though, that CBP2
was acting as a splicing factor in S. douglasii, with it being required for the splicing of
a group I intron in the mitochondrial large ribosomal subunit gene (Tian, Li et al.
1998). CBP2 stimulates the splicing of a similar S. cerevisiae intron, Sce.mL2449 in
vitro, but is not essential for splicing of this intron in vitro or in vivo.  Unlike CYT-18,
CBP2 does not accelerate splicing in either the AnCOB intron or the td intron (Shaw
and Lewin 1997).
Studies using bI5 intron as a model show that CBP2 facilitates splicing of
introns in a different fashion than CYT-18.  These proteins interact with different
areas of the intron; CYT-18 interacts primarily with the P5-P4-P6 domain, while
CBP2 interacts with the P1-P2 and P3-P7.1-P8 regions of the intron (Hill, McGraw et
al. 1985; Weeks and Cech 1995; Caprara, Lehnert et al. 1996; Buchmueller, Webb et
al. 2000; Webb, Rose et al. 2001).  CYT-18 binds when the intron RNA is in a
17
collapsed but unfolded state.  The initial state does not involve specific RNA-CYT-18
or RNA-RNA interactions.  The unstructured ribozyme starts to fold, initially at the
P5-P4-P6 domain, with which CYT-18 interacts.  The remaining RNA regions then
slowly fold around the P5-P4-P6 region to form the active CYT-18-bI5 complex
(Webb, Rose et al. 2001).  CBP2, on the other hand, does not interact the bI5 RNA
until after the RNA has moved from the unstructured collapsed state to a state where
the bI5 core is nearly formed, (Weeks and Cech 1996; Buchmueller, Webb et al.
2000).  After CBP2 binding, the intron RNA folds rapidly, and in a single step, to an
active state (Webb and Weeks 2001).
Mrs1 and Nam2 act as splicing factors for the third and fourth cytochrome
oxidase introns, bI3 and bI4 respectively, in yeast.  These proteins act in conjunction
with intron-encoded maturases to facilitate splicing.  In the case of the bI3 intron, both
the splicing factor and maturase appear to be proteins that have been co-opted by the
intron to aid in splicing and have lost their original functions.  Mrs1 is a nuclear
protein which shares homology with the Holiday Junction protein Cce1, but is inactive
as a nuclease, while the bI3-encoded maturase contains a the LAGLIDADG motif, but
is inactive as an endonuclease (Kreike, Schulze et al. 1986; Kreike, Schulze et al.
1987; Dalgaard, Klar et al. 1997; Wardleworth, Kvaratskhelia et al. 2000).  Mrs1
binds the bI3 intron RNA as a tetramer, along with a single copy of bI3 maturase, to
form a large RNS-protein complex that is competent for splicing (Bassi, de Oliveira et
al. 2002).
Nam2 is a yeast mitochondrial leucyl-tRNA synthetase that is involved in
splicing two yeast mitochondrial introns, bI4 and cytrochome oxidase a intron, aI4
(Labouesse, Herbert et al. 1987; Herbert, Labouesse et al. 1988).  Both of these introns
encode maturases, but mutations in the bI4 maturase that disrupt its maturase activity
block the splicing of both bI4 and aI4 introns.  Mutations in Nam2 can restore splicing
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activity to both introns.  Interestingly, splicing of these introns in the mutant Nam2
strains is now dependent on aI4 maturase, as disruption of the aI4 maturase ORF
disrupts the splicing activity of both introns.  Although the mechanism that the aI4
maturase uses to compensate for the loss of bI4 is currently unclear, three-hybrid
analysis of Nam2, bI4 maturase and bI4 intron has shed light on how the three interact
with each other.  This analysis indicated that Nam2 and the maturase are not directly
interacting with each other.  Instead, the intron RNA bridges between the two proteins
(Rho and Martinis 2000).
Two E. coli proteins have been found to act as splicing factors for the T4
phage td intron.  StpA, a transcriptional repressor, was isolated because it rescued a
splicing defective td intron and stimulates td splicing in vitro (Zhang, Derbyshire et al.
1995). E. coli ribosomal protein S12 has also been shown to facilitate splicing of td
intron in vitro and in vivo (Coetzee, Herschlag et al. 1994; Semrad and Schroeder
1998).  Unlike the previously mentioned splicing factors, which recognize and bind
specific RNA structures in the intron, StepA and S12 both bind RNA non-specifically.
These proteins act as RNA chaperones and prevent misfolding of the intron RNA or
aid in melting misfolded RNAs (Herschlag 1995; Clodi, Semrad et al. 1999).
Horizontal transfer of group I introns
Group I introns are found in a variety of genes in bacteria, chloroplasts,
mitochondria, viruses, and the nuclei of fungi and algae (Lambowitz and Belfort
1993).   Bacterial, viral, chloroplast, and mitochondrial group I introns occupy
positions within genes that encode proteins, rRNA or tRNA.  Nuclear group I introns,
though, are invariably found within genes encoding ribosomal RNA.  The reason for
this localization is not well understood, but suggests that group I introns depend on
one or more of the special properties of rDNA, either during the horizontal transfer
event, or later, to aid in intron splicing.  These nucleolus-specific properties include
19
the many protein and RNA factors that localize to the nucleolus, the high sequence
conservation of rDNA between organisms (the sites of intron insertion tend to be in
the most conserved regions.  See (Johansen, Haugen et al. 2007) for a summary of
known nuclear group I introns insertion sites.), or the arrangement of rRNA genes in a
large number of tandem repeats (usually over 100 copies).
Group I introns occupy these diverse positions because they are mobile
elements, able to move to intron-lacking loci in different species.  Evolutionary trees
based on intron sequence vary widely from those constructed using the surrounding
exon sequence.  For example, a comparison of the intron and rDNA sequences of
several species of Tetrahymena found that the intron Tth.L1925 was independently
acquired on multiple occasions (Nielsen and Engberg 1985; Sogin, Ingold et al. 1986).
In addition, Tth.L1925 shares a very strong sequence similarity with other group I
introns.  It shares 70% identity with its closest known relative, the ribozyme of
Ppo.L1925 (Ruoff, Johansen et al. 1992).  This implies that group I introns have
transferred horizontally between relatively different organisms.  Similar results have
been found with introns in fungi (Holst-Jensen, Vaage et al. 1999), red and brown
algal ribosomal RNA (Bhattacarya, Cannone et al. 2001) and introns in the cox1 gene
of plant mitochondria (Cho, Qiu et al. 1998).
Mobility is commonly conferred to group I introns through intron-encoded
endonucleases.  These endonucleases allow the intron to enter into intron-lacking
alleles through a process called homing (Figure 1.4).  Homing endonucleases
recognize a relatively large sequence (~12-40 nucleotides) around the site of intron
insertion in intron-lacking alleles.  They catalyze a double-stranded break at the site of
intron insertion.  Repair of the break through the DSBR pathway, using the intron-
containing allele as a template, results in the intron being copied into both alleles.  Due
to the use of the DSBR pathway, intron homing also results in a variable extent of co-
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Figure 1.4:  Intron homing.  1.  Homing endonuclease (purple circle) is produced
from the intron-containing allele.  2.  The homing endonuclease makes a double-
stranded break in the intron-lacking allele.  3.  The intron-containing allele is used
as a template for repair of the intron-lacking allele through double-stranded break
repair.  4.  This results into the intron being copied into the intron lacking allele,
and some amount of co-conversion of the 5’ and 3’ exon sequence.
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conversion of flanking sequences around the site of intron insertion.  The insertion of
the intron interrupts the homing endonuclease target site, making the repaired allele
resistant to further cleavage (Belfort and Perlman 1995).
Homing was first studied in Sce.mL2449, also known as Ω, an intron in yeast
mitochondrial LSU RNA .  To date, homing is the only demonstrated mechanism of
horizontal transfer of group I introns (Colleaux, d'Auriol et al. 1986; Colleaux,
D'Auriol et al. 1988). Ppo.L1925 was the first nuclear group I intron to be
demonstrated to be mobile.  Ppo.L1925 homing has been demonstrated both in strains
of Physarum, where it is found naturally, and in S. cerevisiae, where it can be induced
artifically.  In yeast, the intron is able to home both from a plasmid encoded-sequence
into the chromosomal XII rDNA loci and from intron-containing chromosomal loci to
intron lacking chromosomal loci (Muscarella and Vogt 1989; Muscarella and Vogt
1993).
The fact that the majority of group I introns lack encoded homing
endonucleases raises the question of how these introns entered into their respective
alleles.  There are two possibilities to explain their distribution.  Either these introns
once possessed homing endonucleases that were later lost, or they were able to enter
into their current position through a different mechanism.  One model is transfer
through a retrotransposition mechanism.  In this model, the intron reverse splices into
a new site in an RNA, followed by the conversion of the RNA to DNA by an
endogenous reverse transcriptase, and reinsertion of the DNA into a chromosome by
homologous recombination (Belfort and Perlman 1995; Holst-Jensen, Vaage et al.
1999; Birgisdottir and Johansen 2005).
The transposition model of horizontal transfer has not been demonstrated at the
present, although it is similar to the retrohoming and retrotransposition of group II
introns, wherein an intron-encoded protein plays the role of reverse transcriptase (see
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below) (Eskes, Yang et al. 1997; Cousineau, Smith et al. 1998; Eskes, Liu et al. 2000).
Evidence pointing to group I intron transposition includes partial and full reverse
splicing into new target sites in vivo (Woodson and Cech 1989; Thompson and Herrin
1994; Roman and Woodson 1995; Birgisdottir and Johansen 2005).  No group I
introns encode their own reverse transcriptase, so it must come from another source,
possibly a retrovirus or retrotransposon.  It is also unclear how the reverse transcribed
RNA would make its way into the nucleus to undergo recombination.  Nevertheless,
the idea of group I introns horizontally transferring through reverse transcriptase-
mediated process is appealing, as not only does it explain how the introns can transfer
from the same gene between species, but it also how they can enter into new sites.
The larger question is the identity of the vector that allows transfer between
organisms.  It is difficult to imagine how an intron is transferred from the chloroplast
genome of one angiosperm to one in a distantly related angiosperm.  At the moment,
there is no evidence to explain this transfer, although it has been suggested that
transfer could occur through feeding of one organism on another or through the
intermediate of a pathogenic fungus or a double stranded RNA virus (Holst-Jensen,
Vaage et al. 1999).
Group II Intron Retrohoming and Retrotransposition.
Unlike ORF-encoding group I introns, group II introns enter into new sites
through a RNA-mediated process called retrohoming (Figure 1.5).  Although there are
several variant strategies for group II intron retrohoming, all of them utilize intron-
encoded multifunctional proteins that have maturase, endonuclease and reverse
transcriptase activity.  For example, horizontal transfer of the yeast COXI intron, aI2,
is initiated by the binding of the intron-encoded protein to the spliced intron lariat to
form a ribonucleoprotein (RNP) complex.  The RNP complex makes a nick in the
intron-lacking DNA by intron-catalyzed partial reverse splicing of the intron RNA
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Figure 1.5:  Reverse splicing.  1.  The intron-encoded protein (three circles,
contains reverse transcriptase (RT-green), maturase (M-orange) and endonuclease
(E-blue) activities) causes a single stranded break in the antisense strand of DNA
(black lines).  2-4.  The intron RNA (red) binds to the IGS at the cut site and
through reverse splicing, inserts itself into the sense strand.  5.  The intron RNA is
then converted to DNA in the antisense strand by the RT activity of the intron
encoded protein.  6.  This results in the permanent integration of the intron into the
new locus.
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onto the 5’ end of the DNA that codes for the 3’ exon.  The second strand of the target
DNA is then cleaved by the exonuclease domain of the RNP.  The reverse
transcriptase domain of the RNP fills in the break, priming at the 5’ end of the second
nick and using an unspliced pre-mRNA as a template.  Use of the pre-mRNA template
results in co-conversion of sequence 5’ of the intron, but minimal to no co-conversion
of sequence 3’ of the intron (Moran, Zimmerly et al. 1995; Zimmerly, Guo et al. 1995;
Zimmerly, Guo et al. 1995).
The retrohoming of the yeast COXI intron aI1 follows the initial steps as the
neighboring aI2 intron, except that the intron RNA attached to the target DNA is used
as a template for reverse transcription.  This RNA can be used either as a template for
full repair, which results in no co-conversion of upstream or downstream sequences,
or the intron RNA can be partially copied and the rest of the gap is filled in using the
DNA-mediated DSBR pathway, resulting in co-conversion of 5’ sequences but not 3’
sequences.  Interestingly, a small percentage (20%) of aI1 intron horizontal transfers
appear to be RT-independent homing events similar to group I intron homing.  As with
group I intron homing, these events result in co-conversion of both upstream and
downstream sequences (Eskes, Liu et al. 2000).
The aI1 intron has been shown to be able retrotranspose into ectopic sites in
the COX1 gene that share sequence homology with the original insertion site of the
intron position.  The mechanism of intron transposition is similar to retrohoming, with
the RNP nicking the ectopic site.  The intron RNA reverse-splices fully into the
ectopic DNA site, which is then repaired by the intron-encoded RT.  As only the
reverse spliced intron serves as the template for the RT, there is no co-conversion of
the upstream or downstream sequence at the ectopic site with sequence from the donor
site (Dickson, Huang et al. 2001).
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Horizontal transfer of homing endonuclease genes
Homing endonucleases confer mobility upon the elements that they are
inserted in, but they also appear to be mobile elements in and of themselves. The
evidence for this mobility includes the sporadic distribution of endonucleases, with
similar ORFs being found in group I introns, group II introns, and inteins.
Endonuclease ORFs are also often optional a particular intron, with some strains of
host organism having ORF-less introns, while other strains have introns that encode
endonucleases.   There are several examples of homing endonucleases colonizing new
sequences, some of which are discussed below (Mota and Collins 1988; Shub, Gott et
al. 1988; Bell-Pedersen, Quirk et al. 1990; Haugen, Wikmark et al. 2005).
Two examples occur in introns from the fungus Podospora.  The first involves
a group I intron in the mitochondrial nad1-I4 gene, which is found in one of three
states, without an ORF, with a single endonuclease ORF, or with two endonuclease
ORFs.  The second ORF, a homing endonuclease, is able to move into one-ORF
introns when protoplasts from two different strains were fused.  Analysis of single
nucleotide differences between the two introns shows that, while the sequence near the
site of the second ORF's insertion is converted from that of the one-ORF intron to that
of the two-ORF intron, the sequence farther away remains that of the one-ORF intron.
Thus, the transfer only involves the ORF and does not involve replacement of the
entire one-ORF intron with a two-ORF intron (Sellem and Belcour 1997).
The second Podospora example involves a mitochondrial group I intron from
Podospora curvicolla which can encode two endonuclease ORFs, one ORF which is
present in all copies of the intron, and a second, optional ORF.  Heteroplasmon
formation experiments between the two strains resulted in the second ORF sequence
being transferred to the allele that lacked it.  The second endonuclease cleaves at or
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near the ORF insertion point in the target intron, and appears to be transferred to the
single-ORF sequence through a homing process (Saguez, Lecellier et al. 2000).
Another fascinating example of HEG mobility is the case of Didymium iridis
introns Dir.S956-1 and Dir.S956-2.  Even though both of these introns are inserted at
the same small ribosomal subunit gene in two closely related strains of D. iridis, the
Dir.S956-1 and Dir.S956-2 splicing ribozymes are only very distantly related.
Dir.S956-1 has a twin ribozyme structure and is a group IC ribozyme, while Dir.S956-
2 has only a single ribozyme, which belongs to group IE.  The I-DirI ORF is inserted
between the two ribozymes in Dir.S956-1 and contains a 51 nucleotide spliceosomal
intron, while the I-DirII ORF is inserted in the anti-sense direction related to Dir.S956-
2, and contains a 50 nucleotide spliceosomal intron.  The I-DirI and I-DirII genes
themselves are very closely related.  The intron sequence flanking the I-DirII ORF and
the exon sequence flanking Dir.S956-2 are identical in 14 out of 17 positions.  This
implies that the ancestral Dir.S956-2 sequence would have been recognized by I-DirII
and suggests that the I-DirII ORF was acquired through a homing mechanism
(Haugen, Wikmark et al. 2005).
Expression of nuclear group I intron encoded genes
To date, all nuclear, ORF-containing group I introns found have been inserted
in genes that code for ribosomal RNA, or rDNA.  This poses a potential paradox, as
rRNA is transcribed by RNA polymerase I (RNA Pol I), while eukaryotic proteins are
translated from RNAs that are transcribed by RNA polymerase II (RNA Pol II).  RNA
polymerase II transcripts have distinctive features that distinguish them from the
normally untranslated RNA Pol I and III transcripts (Figure 1.6).  These features
includes a 7-methyl G cap on the 5’ end of the RNA and 3’ poly-(A) tail. Capped and
polyadenylated RNAs are translated much more efficiently than corresponding RNAs
lacking either a cap or tail (Gallie 1991).
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Figure 1.6:  Expression of a generic RNA Polymerase II-transcribed gene.  A.
A typical RNA polymerase II gene.  B.  Expression of a typical RNA Polymerase
II-transcribed gene.  1.  The DNA (thin lines) is transcribed by RNA Polymerase II
into RNA (thick lines).  A 5’methyl-G cap is added co-transcriptionally.  2-3.  The
spliceosomal complex catalyzes the splicing of the intron out of the upstream and
downstream RNA.  A Poly-a tail is added to the 3’ end of the RNA.  4.  The RNA
is translated into protein.
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In translation initiation, the cap is specifically bound by eukaryotic initiation
factor 4E (eIF4E), which interacts with eIF4G.  eIF4G recruits eIF3 and the 40S
ribosomal subunit (Altmann, Sonenberg et al. 1989; Morino, Hazama et al. 1996;
Tarun and Sachs 1997; Tarun, Wells et al. 1997; Sachs and Varani 2000).  The poly-
(A) tail contributes to this interaction as well.  It is bound by the poly (A)-binding
protein (Pab1p) (Sachs, Davis et al. 1987).  Pab1p also helps to recruit the ribosome
by interacting with eIF4G (Imataka, Gradi et al. 1998; Kessler and Sachs 1998).
Endonuclease expression from six nuclear group I introns has been examined
in detail, revealing several different strategies for protein production.  Ppo.L1925 has
been studied primarily in S. cerevisiae, since S. cerevisiae is a more tractable organism
that P. Polycephalum.  The intron can be artificially trans-integrated into the yeast
genome by transforming two plasmids into the yeast, one encoding Ppo.L1925 and the
other encoding the I-Ppo I ORF under GAL promoter control (Figure 1.7).
Inductionof the homing endonuclease leads to double stranded breaks in all the rDNA
copies in the yeast genome.  This kills the majority of the yeast cells.  The cells can
survive in two different ways.  Some yeast cells encode mutations in their rDNA that
cause them to be resistant to cleavage by the I-PpoI endonuclease.  These mutations
rapidly spread to the other ~120 copies of rDNA after I-PpoI induction.  Other cells
survive, in a manner similar to intron homing, by using the plasmid-encoded intron as
a template for repair.  This results in the insertion of the intron into all of the rDNA
copies.  In order for the yeast cells with inserted introns to survive, the transcribed
intron RNA must be functional enough to able to be splice itself out of the pre-rRNA.
Yeast with integrated non-functional introns will be unable to make ribosomes and
will die.  It is assumed that when introns are unable to be integrated, this implies that
that intron is not capable of efficiently splicing in vivo (Muscarella and Vogt 1993).
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Figure 1.7:  Trans-integration.  A plasmid containing the intron of interest,
flanked by ribosomal RNA sequence, and a plasmid with a homing endonuclease
ORF under Gal promoter control are transformed into S. cerevisiae.  1.  Production
of the endonuclease is induced and it makes double stranded cuts in the rRNA on
chromosome 12.  The double stranded cuts are:  A.  Not repaired, leading to the
death of the host yeast cell.  B.  Repaired using the intron as a template, which
results in the intron being spread into all the rDNA copies in the yeast.  Or C.
Repaired using a rDNA copy containing an endonuclease-resistant mutation, which
results in the mutation being spread into all the rDNA copies of the yeast.
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The Ppo.L1925 ORF is located in the P1 stem of the intron, and is followed by
a 53 nucleotide region termed the 3’UTR, which lies between the ORF and the
resumption of ribozyme sequence (Figure 1.8).  In S. cerevisiae Ppo.L1925 undergoes
post splicing at two points, Internal Processing Site 1 (IPS1) which is 53 nt from the
end of the I-Ppo I ORF and Internal Processing Site 2 (IPS2), which is 15 nt
downstream from IPS1.  The IPS1 cleavage occurs both in P. Polycephalum and in S.
cerevisiae, and defines the end of the 3’ UTR.  Cleavage at IPS2 occurs at the base of
the P1 stem and only occurs in S. cerevisiae.  Additionally, Ppo.L1925 has been
shown to form full length intron circles in vitro, although whether these are formed in
vivo and if they are biologically significant is unknown (Haugen, De Jonckheere et al.
2002) (Figure 1.9).
While Pol I-transcribed intron RNA was an obvious source of RNA for
translation of I-Ppo I, there was also the distinct possibility that the I-Ppo I message
was produced from a cryptic RNA Pol II promoter.  An elegant experiment showed
that I-Ppo I is translated from a Pol I-derived RNA (Figure 1.10).  Ppo.L1925 was
trans-integrated into a yeast strain with a ts RNA Pol I.  This strain does not normally
grow at restrictive temperatures, due the lack of ribosomal RNA, but a plasmid
encoding the 35S rRNA under GAL7 promoter control can provide enough rRNA to
compensate for the lack of Pol I.  If the I-Ppo I message was translated from a Pol II
message, the protein should still be produced when the yeast was shifted to the
restrictive temperature.  The strain produced no I-Ppo I at the restrictive temperature,
and thus the I-Ppo I message must be transcribed by RNA Pol I or somehow otherwise
be dependent of RNA Pol I translation of the rDNA locus (Lin and Vogt 1998).
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Figure 1.8:  Ppo.L1925.  A.  Representation of important Ppo.L1925 regions.
Note that there is a small region (11 nucleotides) of ribozyme RNA 5’ of the I-PpoI
start site.  B.  Diagram of the Ppo.L1925 P1 stem-loop.  The P1 stem-loops consists
of the 5’ exon sequence (black), Ppo.L1925 ribozyme sequence (green), the I-PpoI
ORF (purple box) and the 3’UTR (pink).  IPS1 defines the end of the 3’UTR.  IPS2
cleavage only occurs at in S. cerevisiae.
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Figure 1.9:  The splicing and post-splicing processing of Ppo.L1925.  1.
Ppo.L1925 is transcribed by RNA Polymerase I as part of the pre-rRNA.  2.  The
intron splices itself out of the pre-rRNA.  3.  The full-length intron is processed at
either IPS1 or IPS2.  4.  The intron circularizes to form either a full-length or
internal circle.  The circularization reaction is reversible, and full-length circles can
open up to return to linear, full-length RNA.
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Figure 1.10:  I-PpoI is translated from a RNA Pol I-transcribed RNA.
Ppo.L1925 is integrated into the chromosomal rDNA of a yeast strain with a
temperature sensitive RNA Polymerase I.  This yeast is transformed with a plasmid
encoding ribosomal RNA under RNA Polymerase II control.  When the yeast is
shifted to the non-permissive temperature, the TS Pol I is not functional and the Pol
II plasmid provides all of the rRNA of the yeast cell.  A.  If I-PpoI is translated
from a Pol I-transcribed RNA, no I-PpoI should be produced at the restrictive
temperature.  This is the result seen.  B.  If I-PpoI were translated from an RNA
transcribed from a cryptic Pol II promoter, I-Ppo I should still be produced at the
restrictive temperature.
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The function of the Ppo.L1925 3’UTR sequence is mysterious.  Initially it was
thought that post-splicing cleavage at IPS 1 was important in translation of the intron-
encoded ORF, as that cleavage removes the ribozyme region from the ORF.  This is
not the case, as mutation of IPS1, which abolishes processing and which should also
reduce or prevent expression of the intron-encoded ORF if the processed RNA served
as the message, actually increased translation of the intron-encoded ORF.  This
suggests that the full-length intron RNA actually serves as the I-Ppo I message.  The
role of the processing is unknown, but could be a way to reduce the expression of the
homing endonuclease, which, at high levels, could potentially cut chromosomal DNA
at degenerate sites, to levels that are more manageable for the cell (Lin and Vogt
1998).
The nucleotides at the 3’ end of the 3’ UTR play an important role in both
splicing and translation.  The importance of the nucleotides on the 3’ end of the 3’
UTR in splicing was demonstrated by a series of mutant Ppo.L1925 introns deleting
the 3’ UTR in 10 nucleotide segments (Figure 1.11A) (Lin and Vogt 2000).  Deleting
nucleotides 1-10, 11-20, 21-30, or 31-40 appeared to have not effect on integration of
Ppo.L1925 in S. cerevisiae.  Deleting nucleotides 41-50 prevented the mutant
Ppo.L1925 from integrating, suggesting that those nucleotides are important for
splicing.
The construction of Ppo-α, a chimeric Ppo.L1925, provided more data on
expression from the intron and the function of the 3’ UTR (Lin and Vogt 2000).  The
Ppo-α was constructed by replacing the I-Ppo I ORF with the sequence for the β-
galactosidase α fragment.  When the β-galactosidase α fragment forms a complex
with the larger Ω fragment, it serves as a reporter protein when both are expressed in
trans.  When normalized for the relative levels of transcript, the β-galactosidase
36
Figure 1.11:  Role of the Ppo.L1925 3’UTR in splicing and intron-encoded
protein production.  A.  Role of 3’ UTR in Ppo.L1925.  Deletion of nucleotides 1-
10, 11-20, 21-30, and 31-40 (black bar) does not prevent the intron from integrating
into the yeast genome.  Deletion of nucleotides 41-50 prevents the intron from
integrating.  B. Role of the 3’ UTR in Ppo-α.  Integration Ppo-α lacking
nucleotides 41-50 results with either yeast containing both intron-integrated and I-
PpoI resistant rDNA or yeast containing only I-PpoI resistant rDNA.
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 message of the intron-containing yeast was found to be translated at roughly 3% of
the rate of the β-galactosidase α fragment translated from an RNA Pol II promoter.
Through the ease of assays of β-galactosidase activity, this chimeric intron
allowed for larger scale testing of expression from the intron (Figure 1.11B).  Deletion
of nucleotides 41-50 of the 3’ UTR of Ppo-α also reduces the ability of the intron to
integrate into the yeast genome.  The intron is able to integrate into some, but not all,
of the ~120 copies of the rDNA with 3’ UTR nucleotides 41-50 deleted.  Presumably,
the remaining copies of rDNA contain I-PpoI resistance mutations that are able to
supply enough rRNA to the yeast to live.
The effect of 3’ UTR nucleotides 41-53 on splicing and translation was tested
through the creation of two pools of mutant Ppo-α introns.  One pool, Ppo-α ran1,
contained introns with 3’ UTR nucleotides 48-53 randomized, while the other pool,
Ppo-αran2, contained introns with randomized bases at positions 41-47 of the 3’UTR.
If the primary sequence in this region is important for splicing, very few of the
randomized introns should have been able to integrate into the yeast genome.  This
was not the case, as the majority of the randomized introns were able to integrate.
Additionally, while yeast with integrated introns from Ppo-α ran2 exhibited β-
galactosidase activity similar to that of Ppo-α, the majority of yeast with integrated
Ppo-αran1 introns exhibited higher levels of β-galactosidase.  Surprisingly, a few Ppo-
α introns had over 40 fold more activity than the wild type Ppo-α.  There is no
obvious consensus sequence shared by these high expressor, or HE, 3’ UTR
sequences.  Although how the 3’UTR is affecting translation is still mysterious, this
data suggests that, like the IPS1 cleavage, one of the roles of the 3’ UTR is to down-
regulate translation of the homing endonuclease (Lin and Vogt 2000).
Attempts to make other chimeric Ppo.L1925 introns by replacing the I-PpoI
ORF with other ORFs have been largely unsuccessful (Figure 1.12).  There are
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Figure 1.12:  Chimeric Ppo.L1925 introns.  ORFs were inserted into Ppo-ClaI, a
version of Ppo.L1925 with the majority of the I-PpoI ORF deleted and replaced
with a ClaI site. Fifteen I-PpoI ORF nucleotides were retained 5’ and 3’ of the ClaI.
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exceptions, an intron containing the 225 nt SOM1 ORF, which encodes a
mitochondrial protease (Esser, Pratje et al. 1996), was able to be integrated into the
yeast genome (Nam 1999).  However, chimeric introns containing the HIS3, URA3,
TRP1, or Neo ORFs were unable to integrate into the yeast genome.  This is most
likely due the size of the ORFs, with the larger ORFS interfering with the ribozyme-
mediated splicing of the intron.
In summary, the I-PpoI message is inferred to be translated from the spliced,
full-length intron RNA, while post-splicing processing reduces the available I-PpoI
message (Figure 1.13).
Two introns from Naegleria, Nae.L1926 and Nmo.L2563, are very similar to
Ppo.L1925 (Figure 1.14).  They both undergo processing at sites very similar to those
of Ppo.L1925 and form full-length intron circles in vitro.  Nae.L1926 and Nmo.L2563
have 13 nt 3' UTRs, which is much smaller than 53 nt Ppo.L1925 3' UTR. Both
Nae.L1926 and Nmo.L2563 3' UTRs encode polyadenylation signals which are absent
in the Ppo.L1925 3' UTR. This implies that in this case processing of the intron is
important for endonuclease expression (Haugen, De Jonckheere et al. 2002).
Dir.S956-1, found in the small ribosomal subunit of Didymium iridis strain
Pan2, is a mobile group I intron with a twin-ribozyme organization (Figure 1.15)
(Johansen and Vogt 1994; Decatur, Einvik et al. 1995; Johansen, Elde et al. 1997).
The intron is organized with the I-DirI ORF sandwiched between the two ribozymes,
GIR1 and GIR2.  GIR2 is responsible for catalyzing intron excision, exon ligation, and
circularization of the spliced intron. GIR1 is a group I branching ribozyme that
catalyzes the formation of a 5’-2’ lariat at the 5’ end of the I-DirI ORF. This branching
reaction results in a cleavage between the GIR1 sequence and the ORF.  (Decatur,
Einvik et al. 1995; Einvik, Decatur et al. 1997; Nielsen, Westhof et al. 2005).
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Figure 1.13  Expression of I-PpoI from Ppo.L1925.  A.  A schematic
representation of Ppo.L1925.  B. Expression of I-PpoI from Ppo.L1925.  1.  The
DNA is transcribed by RNA Polymerase I into RNA.  2.  The Ppo.L1925 ribozyme
catalyzes the splicing of the intron out of the upstream and downstream RNA. 3.
Some of the introns are processed, removing them from the pool of potential I-PpoI
message.  4.  I-PpoI is translated from the full-length intron.
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Figure 1.14 Expression of I-NaeI from Nae.L1926.  A.  A schematic
representation of Nae.L1926 (Nmo.L2563 is similar).  B. Expression of I-NaeI
from Nae.L1926 (or I-NmoI from Nmo.L2563).  1.  The DNA is transcribed by
RNA Polymerase I into RNA.  2.  The intron ribozyme catalyzes the splicing of the
intron out of the upstream and downstream RNA. 3.  The intron RNA molecule is
processed.  4. Processing of the intron reveals a polyadenylation site, which results
in the polyadenylation of the intron RNA.  5.   I-NaeI is translated from the
processed RNA.
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Figure 1.15:  Expression of I-DirI from Dir.S956-1.  A.  A schematic
representation of Dir.S956-1.  B  Expression of I-DirI from Dir.S956-1.  1.  The
DNA(thin lines) is transcribed by RNA Polymerase I into RNA (thick lines). 2.
The GIR2 ribozyme splices the intron RNA out of the exon RNA.  3.  The GIR1
ribozyme catalyzes the formation of a 2’-5’ lariat at the 5’ end of the I-DirI ORF,
which separates GIR1 from the rest of the intron.  4-5.  The GIR2 ribozyme region
is removed, and then most likely the cellular poly-adenylation machinery adds a
poly-A tail to the 3’ end of the I-DirI ORF.  A 51-nt spliceosomal intron (yellow) is
removed by the spliceosomal complex.  6.  The processed I-DirI RNA is translated
into the I-DirI protein.
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The homing endonuclease ORF, I-DirI, contains a 51 nucleotide spliceosomal
intron (I51).  I-DirI appears to be translated from a RNA Pol I transcript which is then
processed to mimic a RNA Pol II transcript.  After Dir.S956-1 is spliced from the
ribosomal small subunit pre-RNA, it undergoes processing to form the 2’-5’ lariat,
which caps the 5’ end and removes the GIR1 sequence, and one cleavage at the 3’ end,
which removes the majority of the GIR2 sequence from the I-Dir I ORF.  The 3’
processing cleavage exposes a polyadenylation signal on the 3’ end of the I-Dir ORF,
which results in the addition of a poly-A tail to the processed ORF.  The spliceosomal
complex removes the I51 intron, and the processed I-Dir I ORF is exported from the
nucleus, where I-DirI is translated (Vader, Nielsen et al. 1999).
Work with the closely related twin-ribozyme group I intron, Nja.S516,
demonstrates the importance of the GIR1 cleavage in translation from these introns.
After several unsuccessful attempts to trans-integrate the intron into the S. cerevisiae
genome the intron was transcribed from a plasmid. Nja.S516 is most likely unable to
trans-integrate due to either slow splicing of the ribozyme or cleavage of the I-NjaI
endonuclease at degenerate sites.  Translated from a plasmid in yeast, Nja.S516 splices
itself from the exon RNA and produces I-NjaI protein.  The spliced intron produces
processing products that are similar in size to those produced by Dir.S956-1.  It is
likely that the Nja.S516 GIR1 catalyzes a 2’-5’ lariat similar to that of Dir.S956-1 but
this has not been demonstrated.  Mutation of the G binding site in GIR1 prevents
processing at IPS1 and IPS2, illustrating that GIR1 is responsible for these cleavages.
Additionally, mutant GIR1 introns do not produce any detectable I-Nja I activity
(Decatur, Johansen et al. 2000).
The intron Dir.S956-2 is found in Didymium iridis strain CR8-1, inserted at the
same site as Dir.S956-1 (Figure 1.16).  Dir.S956-2 encodes a homing endonuclease,
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Figure 1.16: Expression of I-DirII from Dir.S956-2.  A.  A schematic
representation of Dir.S956-2.  Note that the I-DirII ORF (light blue) is oriented in
the antisense direction in relation to Dir.S956-2.  B.  Expression of I-DirII from
Dir.S956-2.  1.  The I-DirII gene DNA (thin lines) is transcribed by RNA
Polymerase II into RNA (thick lines), independently of the transcription of the SSU
and Dir.S956-2.  2.  A 50-nt intron is removed by the spliceosomal complex, and a
5’ cap and poly-A tail are added to the I-DirII RNA.  3.  The processed I-Dir-II
RNA is translated into the I-DirII protein.
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I-DirII, in its P8 loop.  The open reading frame for the I-DirII endonuclease is oriented
in the anti-sense direction with respect to Dir.S956-2 and the rest of the small
ribosomal subunit gene.  The I-Dir II message is transcribed by a Pol II like promoter
and is polyadenylated at the 3’ end.  The  I-Dir II ORF is also interrupted by a 50
nucleotide spliceosomal intron, which was found to be spliced out of the
predominance of the polyadenylated ORF RNA (Johansen, Vader et al. 2006).
In summary, very divergent mechanisms for translation of ORFs from nuclear
group I introns inserted in rDNA.  Although some of these mechanisms have been
characterized, many of them are poorly understood.
The role of intron circles
Full-length spliced intron circles have been found in several of the above
nuclear group I introns.  The roles these structures play, if any, is currently unknown.
It is easy to imagine that circular RNA would be more stable than linear RNA, and
that the added stability plays a role in the horizontal transfer of the intron (Decatur,
Johansen et al. 2000).  They could also play a role in translation of intron-encoded
proteins, by stabilizing intron RNA or perhaps by mimicking the circles formed by
eIFs and poly-A binding protein in mRNA translation initiation (Haugen, De
Jonckheere et al. 2002).
Noncanonical translation
There are several examples of translation from non-canonical mRNA. The
simplest of these are attempts to express proteins from genes under the control of Pol I
and Pol III promoters.  These experiments generally have found that proteins can be
produced from such transcripts, but at much lower levels than from a Pol II transcript
(Fleischer and Grummt 1983; Grummt and Skinner 1985; Smale and Tjian 1985;
Lopata, Cleveland et al. 1986; Gunnery and Mathews 1995).
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Experiments in S. cerevisiae have shown that protein can be translated from an
RNA Pol I transcript.  The HIS4 gene was placed under the control of a Pol I promoter
and replaced the normal HIS4 gene on chromosome III.  This gene produced RNA that
was not capped, but was poly-adenylated, implying that poly-adenylation is not tightly
linked to Pol II transcription in yeast.  The Pol I derived RNA was transcribed at
higher levels than the Pol II transcript, but was also less stable, most likely due to its
cap-less state, resulting in the accumulation of similar amounts of the RNA.  The Pol I
derived RNA was translated inefficiently, at roughly 3% of the level the Pol II derived
RNA (Lo, Huang et al. 1998).
Internal ribosome entry sites (IRES) are RNA elements that allow cap-
independent translation initiation to occur.  These elements allow ribosomes to enter
an mRNA internally and allow translation initiation of ORFs downstream of a 5' ORF.
The primary assay for these elements is to place a sequence between two reporter
genes on a bi-cistronic mRNA.  Activity of the second reporter gene indicate IRES
activity in the putative IRES sequence.  While viral IRES elements have not been
shown to function in S. cerevisiae without disrupting other players in translation
(Thompson, Gulyas et al. 2001), there are currently two  characterized examples of
naturally occurring IRES elements in the yeast genome, the invasive growth and the
URE2 IRES elements.  IRES activity has also been demonstrated for yeast genes
HAP4, YAP1, TAF145, and TIF4631 in vivo, but neither the IRES elements, nor the
proteins involved in the internal initiation, have been defined for these genes (Zhou,
Edelman et al. 2001; Seino, Yanagida et al. 2005; Raychaudhuri, Fontanes et al.
2006).
As its name implies, the invasive growth IRES is involved in the conversion
from non-invasive growth to invasive growth in yeast.  This conversion is triggered
through glucose starvation (Cullen and Sprague 2000).  During the conversion,
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translational initiation is inhibited for nearly all genes (Ashe, De Long et al. 2000)
except those genes required for invasive growth.  All of the invasive growth genes
share a short poly-A stretch in their 5’ leader sequence.  These sequences appear to be
responsible for the continued translation of the invasive growth genes.  They can
confer IRES activity on reporter RNAs electroporated into yeast cells, and deletion of
the leader sequences from invasive growth genes prevents their translation during
glucose starvation. Chemical probing of the minimal IRES element RNA indicates
that the region is unstructured.  Translation from this IRES is inhibited by the addition
of competing poly-A RNA in yeast translation extracts, and is rescued by the addition
of extra Pab1 protein. Thus, it is likely that this IRES functions through interactions
with the yeast poly-A binding protein, Pab1, which then allows the recruitment of
other translation machinery (Gilbert, Zhou et al. 2007).
There are two forms of the Ure2p naturally found in yeast, both of which are
translated from the same mRNA (Komar, Lesnik et al. 2003).  The larger of the two
proteins is translated from the first AUG on the URE2 mRNA, while the shorter form
of the protein is the result of an initiation at an internal AUG.   Analysis of URE2
truncations placed between a stable stem loop, which inhibits cap-dependent initiation,
and a lacZ reporter gene localized the IRES activity to nucleotides 205 to 309 of the
URE2 gene.  Structural probing of the region found that the region forms a 25
nucleotide long stem with a 24 nucleotide loop.  Interestingly, the first two nucleotides
of the IRES-derived Ure2p start codon, nucleotides 279-281, are base paired in this
structure.  Because of this, the structure must unwind during translation initiation.
How this is accomplished, and what factors are involved in initiation at this IRES, are
currently unclear (Reineke, Komar et al. 2008).
It is unclear if any of these noncanonical translation pathways is involved in
the translation of Ppo.l1925-encoded ORFs in yeast cells.  Proteins are translated from
49
Ppo.L1925 and Ppo-α at levels similar to that of the RNA Pol I-transcribed HIS4 (Lo,
Huang et al. 1998; Lin and Vogt 2000).  It could be that the intron RNA is translated
in a similar fashion.  However, this observation does not explain the increases in
expression seen in some of the Ppo-α ran1 mutants.  The increased level of expression
is not caused by an increase in the production or stability of the intron RNA, as the
levels of full-length or IPS1- and IPS2-processed intron RNAs are not significantly
different between the wild type and high expressing (HEUTR) mutant introns.  These
mutations could promote interactions between other noncanonical translation
pathways, such as the invasive growth IRES pathway, which would increase
expression of the intron-encoded ORF.  Alternatively, these mutations could promote
the formation of a relatively rare intron RNA species, such as a circular intron RNA,
which acts as the mRNA for the intron-encoded ORF.  This species could have been
hidden from detection due to the large amount of full-length and IPS-processed intron
RNAs.
Thesis outline
The close relationship of group I introns Ppo.L1925 and Tth.L1925 provides a
unique opportunity to study I-PpoI’s novel expression from a RNA Pol I transcript.
The ribozyme regions of these two introns are very closely related, even though
Tth.L1925 lacks a sequence corresponding to the I-PpoI ORF and 3’UTR regions of
the Ppo.L1925. Since it does not contain an ORF to be expressed, Tth.L1925 presents
itself as a test-bed for understanding how Ppo.L1925 expresses I-PpoI and how
Ppo.L1925 sequences affect that expression.
Chapter II:  Materials and Methods
The second chapter of this thesis describes the materials and methods used in
chapters III-V.
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Chapter III: Chimeric ORF-Containing Tetrahymena Introns can Trans-Integrate and
Produce Protein in S. cerevisiae.
It is likely that group I introns have gained homing endonuclease ORFs over
the history of their evolution.  Since Tth.L1925 and Ppo.L1925 are so similar, can
Tth.L1925 introns with ORFs inserted at a site homologous to that of I-PpoI in
Ppo.L1925 be trans-integrated into the S. cerevisiae genome?  Previous work found
that larger ORFs, such as Neo and HIS3, disrupted the splicing of chimeric Ppo.L1925
introns.  Since Tth.L1925 splices more rapidly than Ppo.L1925, will chimeric
Tth.L1925 introns with large ORFs, which disrupted the splicing of Ppo.L1925, be
able to integrate?  If the chimeric Tth.L1925 introns are able to integrate, will their
ORFs be expressed and, if they are expressed, at what levels?
In chapter III, I find that chimeric Tth.L1925 introns containing the β-
galactosidase α fragment, Neo, or HIS3 ORFs are able to trans-integrate into the S.
cerevisiae genome.  The proteins encoded by all three of the ORFs are expressed from
the chimeric introns. The chimeric Tth.L1925 introns expressed at levels similar to
that of the chimeric Ppo.L1925 introns in yeast.  Surprisingly, a chimeric Tth.L1925
containing the I-PpoI ORF were unable to integrate into S. cerevisiae, possibly due to
the lack of the Ppo.L1925 3’UTR sequence.
Chapter IV: The Role of Intron Sequence Elements on expression from Chimeric
Tetrahymena Introns.
Even though there is over 70% identity in the ribozyme regions of Ppo.L1925
and Tth.L1925, there are regions of the introns that differ.  The Ppo.L1925 3’ UTR
sequence has been shown to have a large effect on both intron splicing and expression
levels of intron encoded ORFs.  Deletion of the 3’ UTR prevents the Ppo.L1925 intron
for integrating into S. cerevisiae and changing the sequence of the last seven
nucleotides can decrease or vastly increase protein expression from the intron.  How
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would adding the 3’UTR to chimeric Tth.L1925 affect expression?  Would the HE 3’
URT sequences that increase expression in Ppo.L1925 have the same effect on
expression from Tth.L1925?  The 5’ ends of the two introns are also very different.
The 5’ end of the intron RNA could play a role in translation initiation.  How would
the replacing the 5’ end of Tth.L1925 with that of Ppo.L1925 affect expression?
In chapter IV, I investigate how the Ppo.L1925 3’ UTR and 5’ end affect
translation from chimeric Tth.L1925 introns.  I used the chimeric Tth.L1925 intron
containing the α fragment of β-galactosidase ORF, Tth-α, for these experiments, since
expression levels are easily measured through β-galactosidase activity.  Addition of
the Ppo.L1925 3’ UTR to Tth-α slightly decreased β-galactosidase activity from the
intron.  Mutation of the last seven nucleotides of the 3’ UTR to the Ppo.L1925 HE
sequences did not increase expression from Tth-α.  Mutating the 5’ end of Tth-α to
that of Ppo.L1925, to create the intron Tth-α-5’P, increased β-galactosidase activity
ten fold.  Adding the Ppo.L1925 3’UTR to Tth-α-5’P affected expression from the
intron in a similar fashion to the how they affected expression from Tth-α.  Both the
wild type and HE 3’UTRs reduced expression when added to Tth-α-5’P suggesting
that the HE 3’UTRs are not interacting with the 5’ end of Ppo.L1925.
In order to gain a better understanding of the role of the intron’s 5’ end, I
created two pools of introns with randomized sequence at the 5’ end of the intron.  The
first pool randomized four nucleotides in the 5’ end of Tth-α.  Many of these introns
were able to integrate into the yeast genome, but none of them exhibited a significant
increase in β-galactosidase over Tth-α.  The second pool contained randomized
nucleotides at eight positions in the longer 5’ end of Tth-α-5’P.  As with the previous
pool, a large percentage of the introns from this pool were able to integrate.  Roughly
half of the introns tested have similar activity to Tth-α-5’P, one quarter had activity
similar to Tth-α, and one quarter had little to no activity.  There does not seem to be a
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consensus sequence that increased expression in the intron.  These results indicate
that, while changes in the sequence identity of the intron 5’ end has little to no effect
on intron splicing, it does have a large effect on expression of the intron encoded ORF.
Chapter V: Investigation of the Mechanism of Translation of Chimeric Tetrahymena
Intron-Encoded ORFs
There are currently two examples of cap-independent translation in wild type
S. cerevisiae, the glucose-starvation IRES sequences and the URE2 IRES.  The URE2
IRES is unlikely to be involved in expression from Ppo.L1925 and the chimeric
Tth.L1925 introns, since it is so large.  The glucose-starvation IRES, on the other
hand, is a small sequence and it seemed possible that the chimeric-intron encoded
proteins are expressed through this pathway.  Alternatively, the intron RNA circles
could be acting as the message for translation of the intron-encoded ORFs.  Could
either of these be factors in intron encoded ORF translation?
In chapter V, I investigate the affect of the glucose starvation IRES sequence
on expression from chimeric Tth.L1925.  The adition of a glucose starvation IRES
sequence to a chimeric intron did not signifigantly increase the amount of expression
from the intron.  This leads to the conclusion that the Tth.L1925 encoded ORFs are
not expressed through the glucose starvation ORF pathway.  I also examined the role
of intron RNA circles in expression.  I examined chimeric Tth.L1925 and Ppo.L1925
introns for the formation of intron RNA circles.  All of the introns tested formed either
full-length or smaller circles.  However, there is no apparent correlation between the
junction of the circular RNAs and the expression level of the intron encoded ORF,
which suggests that the circular introns are not acting as the message.
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Chapter VI:  Perspectives on Future Research.
In chapter VI, I discuss other models for the expression of ORFs encoded by
chimeric group I introns and how understanding how these ORFs are expressed could
provide us with a novel tool to produce large amounts of protein in vivo.
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Chapter II
Materials and Methods
Plasmid Construction
Plasmids used are listed in Table 2.1.  Plasmids were constructed by standard
cloning methods (Sambrook, Fritsch et al. 1989).  Mutations were introduced by
multiple-step PCR with mutations included in the primers (see Table 2.2 for primer
sequences) as described (Vallett, Merge et al. 1988).  Two external primers with the
appropriate restriction enzyme sites and complementary internal primers containing
the desired mutations were used in this process.  Two parallel PCR reactions, each
using one external primer and one mutagenic primer, were performed.  The products
from the first step were gel-purified with the QIAEXII kit (Qiagen, Catalog number
20051).  The purified PCR products were then combined and used as templates with
the two external primers to create the final PCR product.  The PCR product was
purified using the High Pure PCR Purification Kit (Roche, Catalog number
11732668001).  It was then cloned into the desired vector using standard methods
(Sambrook, Fritsch et al. 1989).
pJLTth-ClaI was made by amplifying the 5’ end of the Tth.L1925 intron and
upstream yeast rDNA with JL9 and JL165 and the 3’ half of the Tth.L1925 with
JL164 and JL85.  The resulting two products were combined and amplified using JL9
and JL85 to make the full-length Tth-ClaI intron flanked by rDNA sequence.  This
product was cloned into EcoRI-SalI digested pRS423 (Christianson, Sikorski et al.
1992).
Table 2.1:  Plasmids used.
Plasmid Name Backbone Additional sequence Other Names References
pRS423 n.a. Christianson, Sikorski et al., 1992
pCpIPpo pYES Gal 1,10 driven I-PpoI ORF Lin and Vogt, 1998
pRSTth-ClaI pRS423 Intron Tth-ClaI This work
pRSTth-α pRS423 Intron Tth-α pRSTtLSU1-α This work
pRSTth-Neo pRS423 Intron Tth-Neo pRSTtLSU1-Neo This work
pRSTth-His3HA pRS423 Intron Tth-His3HA This work
pRSTth-IPpoHA pRS423 Intron Tth-IPpoHA This work
pRSPpo-αHEUTR A pRS423 Intron Ppo-αHEUTR A pRSI3αran1 9-7 This work
pRSPpo-αHEUTR B pRS423 Intron Ppo-αHEUTR B pRSI3αran1 13-47 This work
pRSPpo-αHEUTR C pRS423 Intron Ppo-αHEUTR C pRSI3αran1 10-2 This work
pRSPpo-αHEUTR D pRS423 Intron Ppo-αHEUTR D pRSI3αran1 2-26 This work
pRSPpo-αHEUTR E pRS423 Intron Ppo-αHEUTR E pRSI3αran1 10-11 This work
pRSPpo-αHEUTR F pRS423 Intron Ppo-αHEUTR F pRSI3αran1 12-9 This work
pRSTth-αUTR pRS423 Intron Tth-αUTR pRSTtLSU1-αUTR This work
pRSTth-αHEUTR A pRS423 Intron Tth-αHEUTR A pRSTtLSU-αHEUTR A This work
pRSTth-αHEUTR B pRS423 Intron Tth-αHEUTR B pRSTtLSU1-αHEUTR B This work
pRSTth-αHEUTR C pRS423 Intron Tth-αHEUTR C pRSTtLSU1-αHEUTR C This work
pRSTth-5’P-α pRS423 Intron Tth-5’P-α pRSTtLSU1P-α 5'P This work
pRSTth-5’P-αUTR pRS423 Intron Tth-5’P-αUTR pRSTtLSU1-αUTR 5'P This work
pRSTth-5’P-αHEUTR A pRS423 Intron Tth-5’P-αHEUTR A pRSTtLSU1-αHEUTR A 5’P This work
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 Table 2.1 (Continued)
Plasmid Name Backbone Additional sequence Other Names References
pRSTth-5’P-αHEUTR B pRS423 Intron Tth-5’P-αHEUTR B pRSTtLSU1-αHEUTR B 5’P This work
pRSTth-5’P-αHEUTR C pRS423 Intron Tth-5’P-αHEUTR C pRSTth-αHEUTR C 5'P This work
pRSTth-5’P-His3HA pRS423 Intron Tth-5’P-His3HA This work
pRSTth-αHA pRS423 Intron Tth-αHA This work
pRSTth-IRESαHA pRS423 Intron Tth-IRESαHA This work
pRSTth-RCIRESαHA pRS423 Intron Tth-RCIRESαHA This work
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Table 2.2:  Primer sequences.
Name Primer Sequence (5’ to 3’)
JL8 TATATCGATTCTGCCAAGCCCGT
JL9 CGTGAATTCAACTTAGAACTGGTAC
JL83 TCACCCCGGAATTGGTTTATCC
JL84 CGAATGGGACCTTGAATGC
JL85 ACAGGTCGACAAGGTAGTGGTATTTCACTGG
JL164 CTAAATAGCATCGATTACCTTTGGAGGGAAAAG
JL165 CCAAAGGTAATCGATGCTATTTAGAGAGTC
PrRS31 ATCATCGATATGATTGAACAAGATGGATTGC
PrRS32 ATCATCGATTCAGAAGAACTCGTCAAGAAGG
PrRS35 ATCATCGATCGGTCAGCGTTTTGCCCGTGGCGCTGACCCACCCGAT
CTAGTAACCTC
PrRS36 ATCATCGATCCTATTGCGTTTTGCCCGTGGCGCTGACCCACCCGAT
CTAGTAACCTC
PrRS39 ATCATCGATATGGCGCTCACCAATCGCTTAATTACGG
PrRS40 ATCATCGATTTATACCACAAAGTGACTAATTGATAAGACG
PrRS41 CCCGATCTAGTAACCTCAGACCTTATACCACAAAGTGACTAA
PrRS42 GGATCCGATATCCCCGGGCTGCAGGAATTCAAC
PrRS43 TGGGATCCGGGCCCCCCCTCGAGGTCG
PrRS44 GTAATCGATGCTATTTAGAGAGTCATAGTTACTCCCGCCGTTTACT
CGCGCTTG
PrRS49 TAATACGACTCACTATAGGGCGAGTACTCCAAAAC
PrRS53 ATCGATTACCGTAGGAGAGAAAAG
PrRS54 CTTTTCTCTCCTACGGTAATCG
PrRS60 GACGGTCTTGCCTTTTAAACCG
PrRS61 ATCTCTAGAATGGCGCTCACCAATCGCTTAATTACGG
PrRS62 ATCGTCGACTTATACCACAAAGTGACTAATTG
PrRS65 CCCTCACTAAAGGGAACAAAAGCTGG
PrRS66 CGACTCACTATAGGGCGAATTGGG
PrRS71 GCTGCAAGGCGATTAAGTTGGG
PrRS72 CCCTTAATGGGGACCTGGAGAAG
PrRS73 GCGCGAGTAAACGGCGGGAGTAACTATGACTCTCTCACCCCCTTA
AATCGATATGGCGCTCACCAATCGC
PrRS74 AGAGAGTCATAGTTACTCCCGCCGTTTACTC
PrRS79 TAATACGACTCACTATAGGGCGCTGATTCCAAACTCGGGTGC
PrRS80 ACCAAGTAGGAGAGAAAAGTCAC
PrRS81 TAATACGACTCACTATAGGGTTATACCACAAAGTGACTAATCG
PrRS82 CACCTGGTAGCTAGTCTTTAAACC
PrRS83 TAATACGACTCACTATAGGGATGGCGCTCACCAATCG
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Table 2.2 (Continued)
Name Primer Sequence (5’ to 3’)
PrRS85 CGAGTACTCCAAAAC
PrRS86 CGACGGCCAGTGAATCCGTAATTAAGCGATTGGTGAGCGCCAT
PrRS87 CGAGTACTCCAAAACTAATCAATATACTTTCGCATACAAATTAG
PrRS88 ATCTTCGAATTATACCACAAAGTGACTAATTGATAAGACG
PrRS89 GATATCATCGATNNNNNNNNGTGAGAGAGTCATAGTTACTCCCGC
PrRS90 ATCGAATTCTTCCATAGGCTTCCGCCCCCCTGACGAGCATC
PrRS91 CGGGCTTCCCATACAATCTGTAGATTGTCGCACCTGATTGCCC
PrRS92 GGGCAATCAGGTGCGACAATCTACAGATTGTATGGGAAGCCCG
PrRS93 GATATCATCGATTTAGAAAAACTCATCGAGCATCAAATGAAAC
PrRS97 GGGTCAGCGCCACGGGCAAAACGCGTTTAAATCGATTACC
PrRS98 GGGTCAGCGCCACGGGCAAAACGCCCTCGAATCGATTACC
PrRS101 GATATCATCGATNNNNTTTAGAGAGTCATAGTTACTCCCGC
PrRS103 AGTGATGCAACACTGGAGCCGCTGGG
PrRS104 TCACCCCGGAATTGGTTTATCCGGAG
PrRS105 CGAATGGGACCTTGAATGCTAGAACG
PrRS109 TAATACGACTCACTATAGGGCGAAAAAATCGGACCGGCCAACC
PrRS110 CGAAAAAATCGGACCGGCCAACC
PrRS111 TCGATTCCGGAGAGGGAGC
PrRS112 ATCATCGATATGACAGAGCAGAAAGCCC
PrRS113 ATCATCGATCTACATAAGAACACCTTTGGTGG
PrRS114 ATCATCGATATGGCGCTCACCAATGCTC
PrRS115 ATCATCGATTTATACCACAAAGTGACTGCCC
PrRS119 ATCATCGATTATGCATAGTCCGGGACGTCATAGGGATAGCCCGCA
TAGTCAGGAACATCGTATGGGTA
PrRS120 GGAACATCGTATGGGTATACCACAAAGTGACTGCCC
PrRS123 GGAACATCGTATGGGTATACCACAAAGTGACTAATTGATAAGACG
PrRS127 ATCATCGATAACAAAAAAAAAATGGCGCTCACCAATCGCTTAATT
ACGG
PrRS128 ATCATCGATTTTTTTTTTGTTATGGCGCTCACCAATCGCTTAATTAC
GG
PrRS157 CCCTTTCCCGCAATTTGACGGTC
PrRS158 CCAGGTGCCTACCTGTGAC
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pRSTth-ClaI was made to correct a C to T mutation in at the -2 position in
pJLTth-ClaI.  A fragment was amplified using PrRS42 and PrRS44.  This fragment
was then cloned into the BamHI and ClaI sites in pJLTth-ClaI.  PrRS42 adds an
EcoRV site to the 5' MCS that was not in pJLTth-ClaI.
pRSTth-α was made by amplifying the α fragment from pJLI3α with prRS39
and prRS40 which was then cloned into the ClaI site in pRSTth-ClaI.
pRSTth-Neo was made by amplifying the Neo fragment from pET28-b+ with
PrRS31 and prRS32 which was then cloned into the ClaI site in pRSTth-ClaI.
pRSTth-His3HA was made by amplifying the HIS3 gene from plasmid
pRS423 with primers PrRS112 and PrRS113.  The resulting PCR product was
amplified using PrRS112 and PrRS119 to added the HA tag to the 3’ end.  The
product of the second amplification was cloned into Tth-ClaI
pRSTth-IPpoHA was made by amplifying the I-PpoI gene from plasmid pJLI3
with primers PrRS114 and PrRS115.  The resulting PCR product was amplified using
PrRS114 and PrRS119 to added the HA tag to the 3’ end.  The product of the second
amplification was cloned into Tth-ClaI
pRSPpo-αHETUR A through F were made by amplifying the appropriate
intron from yeast total genomic DNA using primers JL9 and JL85 and cloning the
amplified product into EcoRI-SalI cut pRS423.
pRSTth-αUTR was made by amplifying the α fragment from pRSTth-α with
PrRS39 and prRS41 and then re-amplifying with PrRS39 and prRS35 to add the 3’
end of the UTR and the ClaI site.  The second round PCR product was then cloned
into the ClaI site in pRSTth-ClaI.
pRSTth-αHEUTR A was made by amplifying the α fragment from pRSTth-α
with PrRS39 and PrRS41 and then re-amplifying with PrRS39 and PrRS36 to add the
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3’ end of the UTR and the ClaI site.  The second round PCR product was then cloned
into the ClaI site in pRSTth-ClaI.
pRSTth-αHEUTR B was made by amplifying the α fragment from pRSTth-α
with PrRS39 and PrRS41 and then re-amplifying with PrRS39 and PrRS97 to add the
3’ end of the UTR and the ClaI site.  The second round PCR product was then cloned
into the ClaI site in pRSTth-ClaI.
pRSTth-αHEUTRC was made by amplifying the α fragment from pRSTth-α
with PrRS39 and PrRS41 and then re-amplifying with PrRS39 and PrRS98 to add the
3’ end of the UTR and the ClaI site.  The second round PCR product was then cloned
into the ClaI site in pRSTth-ClaI.
pRSTth-5’P-ClaI was made through a three step process.  The 5’ insert piece
was made by amplifying the region between the EcoRI site and ClaI site of pRSTth-
ClaI with PrRS65 and PrRS74.  The middle insert piece was made by amplifying the
region between the ClaI site and the pRSTth-ClaI P1’ region with primers PrRS73 and
PrRS54.  The 3’ insert piece was made by amplifying the region between the P1’
region and the XhoI site of pRSTth-ClaI with PrRS53 and PrRS66.  A fragment fusing
the 5’ piece and middle piece was made by combining the 5’ and middle insert pieces
and amplifying using PrRS65 and PrRS54.  The 5’-middle piece was then fused to the
3’ piece by combining them and amplifying with PrRS65 and PrRS66.  This 5’-
middle-3’ fusion piece was then cloned between the EcoRI and SphI sites in pRSTth-
ClaI to make pRSTth-5’P-ClaI.
pRSTth-5’P-α was made by inserting the α fragment from ClaI-digested
pRSTth-α into the ClaI site of pRSTth-5'P-ClaI.
pRSTth-5’P-αUTR was made by amplifying the α-UTR fragment from
pRSTth-αUTR with primers PrRS39 and PrRS35 and cloning it into the ClaI site of
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pRSTth-ClaI. This amplification was necessary since the ClaI site 3’ of the αUTR
fragment of pRSTth-αUTR is methylated by Dam methylase.
pRSTth-5’P-αHEUTR A was made by amplifying the α-UTR fragment from
pRSTth-αHEUTR A with primers PrRS39 and PrRS36 and cloning it into the ClaI site
of pRSTth-ClaI. (This amplification was necessary since the ClaI site 3’ of the αUTR
fragment of pRSTth-αUTR is methylated by Dam methylase.)
pRSTth-5’P-αHEUTR was made by amplifying the α-UTR fragment from
pRSTth-αHEUTR B with primers PrRS39 and PrRS97 and cloning it into the ClaI site
of pRSTth-ClaI.
pRSTth-5’P-αHEUTR C was made by amplifying the α-UTR fragment from
pRSTth-αHEUTR B with primers PrRS39 and PrRS98 and cloning it into the ClaI site
of pRSTth-ClaI.
pRSTth-5’P-His3HA was made by cloning the HIS3-HA fragment from
pRSTth-His3HA into the ClaI site of pRSTth-5’P-ClaI.
pRSTth-αHA was made by amplifying the α fragment from pRSTth-α with
primers PrRS39 and PrRS123.  The product of this amplification was re-amplified
using PrRS39 and PrRS119 to add the duel HA tags to the sequence.  The αHA
fragment was then cloned into the ClaI site of pRSTth-ClaI.
pRSTth-IRES-αHA was made by amplifying the αfragment from pRSTth-α
with primers PrRS127 and PrRS123.  The product of this amplification was re-
amplified using PrRS127 and PrRS119 to add the duel HA tags to the sequence.  The
αHA fragment was then cloned into the ClaI site of pRSTth-ClaI.
pRSTth-RCIRES-αHA was made by amplifying the α fragment from pRSTth-
α with primers PrRS128 and PrRS123.  The product of this amplification was re-
amplified using PrRS127 and PrRS119 to add the duel HA tags to the sequence.  The
αHA fragment was then cloned into the ClaI site of pRSTth-ClaI.
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Randomization
To make the vector for the 5’ end randomization in the context of the Tth-5’P-
α intron (a.k.a. the Tth-5’P-α-ran pool), pRSTth-5’P-α-BST-KAN (Figure 2.1), the α
fragment was amplified from pRSTth-α using primers PrRS39 and PrRS88.  This
replaced the 3’ ClaI site with a BstBI site.  This amplified fragment was cloned into
the ClaI site of Tth-5’P-ClaI.  The resulting plasmid, pRSTth-5’P-α-BST, has a ClaI
site 5’ of the α gene and a hybrid ClaI/BstBI site 3’ of the α gene.  To remove the
internal ClaI site from the KAN gene, it was amplified in two stages.  The first half of
the KAN gene was amplified from plasmid pET28-b+ using primers PrRS90 and
PrRS91.  The second half of the KAN gene was amplified using and PrRS93.  The two
KAN halves were then combined and amplified using PrRS90 and PrRS93 to make a
full-length KAN fragment.  The resulting KAN fragment was cloned between the
EcoRI and ClaI sites of pRSTth-5’P-α-BST to make pRSTth-5’P-α-BST-KAN.  The
gel-purified EcoRI-ClaI-cut pRSTth-5’P-α-BST-KAN backbone was then gel purified
To make the randomized pool, the region between the EcoRI site and ClaI site
of pRSTth-5’P-α was amplified using primers PrRS65 and PrRS89.  PrRS89 contains
equal concentrations of A, C, G, and T at the N positions.  This pool was digested with
EcoRI and ClaI and gel purified.  To make the plasmid pool, 300 ng of digested vector
was combined with 250 ng of digested insert and ligated at 16˚C overnight.  The
ligation mixture was ethanol precipitated, washed twice with 1 ml of cold 70%
ethanol, and transformed by electroporaton (BioRad GenePulser II, 2.0 kV, 200 W,
25 µF, 0.1 cm electroporation cuvette) into ElectroMAX DH5a-E cells (Invitrogen
Catalog number 11319019).  To estimate the number of transformants, 1%,
0.1%, and 0.01% of the transformed E. coli were plated on 2YT, 2YT + Amp
(to estimate pool size) and 2YT + Amp +Kan plates (to estimate the amount of
uncut plasmid).  The remainder of the transformation was added to 200 ml of
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Figure 2.1:  Construction of pRSTth-5’P-α-BST-KAN.  1.  A PCR product
consisting of the 5’ LSU sequence, 5’ intron sequence, and alpha ORF with the 3’
ClaI site replaced with a BstBI site is cloned into EcoRI and ClaI digested pRSTth-
5’P-α.  2.  The ClaI/BstBI hybrid site disrupts the 3’ ClaI site.  3-4. The resulting
plasmid is again digested with EcoRI and ClaI, and a Kan stuffer fragment is
cloned into it.  5.  The Kan stuffer fragment is removed by digesting with EcoRI
and ClaI and a replaced with a fragment from a pool with randomized nucleotides
at the intron 5’ end.
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liquid 2YT + Amp and incubated at 37˜C for 16 hours to increase the amount of
DNA in the pool.  The plasmid DNA was harvested from the amplified pool
using a Qiagen Midi Kit (Catalog number 12143) and co-transformed into yeast
strain NOY505GalΩT with plasmid pCPIPpo.  To estimate transformation
efficiency, 1% of the transformed yeast was plated on SD plates.  The
remainder of the transformation mixture was plated on SD–Ura-His plates.
Yeast transformants were washed off of the plates and combined.  A fraction of
the pool (5%) was grown in 100 ml of SD-Ura-His over night.  Cells were
collected, washed twice with SG-Ura-His media, and then plated on SG-Ura-
His plates.  Individual colonies were selected from the SG-Ura-His plates and
patched on to SG+XGal plates to screen for β-galactosidase activity.
The vector for the Tth-α-context 5’ end randomization (the Tth-α-ran pool),
pRSTth-α-BST-KAN, was made as above, except that pRSTth-α was used as a
starting point instead of pRSTth-5’P-α.  Primers PrRS65 and PrRS101 were used to
make the randomized pool.  PrRS101 contains equal concentrations of A, C, G, and T
at the N positions.
Yeast strains and media
Yeast strains used are listed in Table 2.3.  Yeast were grown according to
procedures in (Sherman, Fink et al. 1986).  Yeast cultures were grown in YEPD (1%
yeast extract, 2% Bacto-peptone, 2% dextrose) or, when induction of Gal-promoter
genes was necessary, YEPG (1% yeast extract, 2% Bacto-peptone, 2% galactose).
When selection was needed, yeast cells were grown in synthetic minimal medium (S
medium) (0.17% yeast nitrogen base (without amino acids or ammonium sulfate),
0.5% ammonium sulfate) supplemented with amino acids as needed (30 mg/ml of L-
histidine, 40 mg/ml of L-leucine, 30 mg/ml of L-Lysine, and 30 mg/ml of L-
Tryptophan).
Table 2.3:  Yeast strains used.
Strain Genotype Integrated Intron Notes Source
INVSc2
MATΑ his3-D200
ura3-167
None Invitrogen, Inc.
INVSc2/Tth-ClaI similar to INVSc2 Tth-ClaI This work
INVSc2/Tth-Neo similar to INVSc2 Tth-Neo This work
Noy505GalΩT MATa ade2 ura3
leu2 trp1 his3 can1
None
β-gal Ω under
gal 1,10 promoter
control
in trp1 locus
Lin and Vogt, 2000
Noy505GalΩT/Tth-ClaI similar to Noy505GalΩT Tth-ClaI This work
Noy505GalΩT/Tth-α similar to Noy505GalΩT Tth-Α This work
Noy505GalΩT/Tth-His3HA similar to Noy505GalΩT Tth-His3HA This work
Noy505GalΩT/Ppo-αHEUTR A similar to Noy505GalΩT Ppo-αHEUTR A This work
Noy505GalWT/Ppo-αHEUTR B similar to Noy505GalΩT Ppo-αHEUTR B This work
Noy505GalWT/Ppo-αHEUTR C similar to Noy505GalΩT Ppo-αHEUTR C This work
Noy505GalWT/Ppo-αHEUTR D similar to Noy505GalΩT Ppo-αHEUTR D This work
Noy505GalWT/Ppo-αHEUTR E similar to Noy505GalΩT Ppo-αHEUTR E This work
Noy505GalWT/Ppo-αHEUTR F similar to Noy505GalΩT Ppo-αHEUTR F This work
Noy505GalΩT/Tth-αUTR similar to Noy505GalΩT Tth-αUTR This work
Noy505GalΩT/Tth-αHEUTR A similar to Noy505GalΩT Tth-αHEUTR A This work
Noy505GalΩT/Tth-αHEUTR B similar to Noy505GalΩT Tth-αHEUTR B This work
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Table 2.3 (Continued)
Strain Genotype Integrated Intron Notes Source
Noy505GalΩT/Tth-αHEUTR C similar to Noy505GalΩT Tth-αHEUTR C This work
Noy505GalΩT/Tth-5’P-α similar to Noy505GalΩT TtLSU1-5’P-α This work
Noy505GalΩT/Tth-5’P-αUTR similar to Noy505GalΩT Tth-5’P-αUTR This work
Noy505GalΩT/Tth-5’P-αHEUTR A similar to Noy505GalΩT Tth-5’P-αHEUTR A This work
Noy505GalΩT/Tth-5’P-ΑHEUTR B similar to Noy505GalΩT Tth-5’P-αHEUTR B This work
Noy505GalΩT/Tth-5’P-αHEUTR C similar to Noy505GalΩT Tth-5’P-αHEUTR C This work
Noy505GalΩT/Tth-5’P-α-ran (1-18) similar to Noy505GalΩT Tth-5’P-α-ran (1-18)* 18 different strains
see Figure 4.15 This work
Noy505GalΩT/Tth-α-ran (1-24) similar to Noy505GalΩT Tth-α-ran (1-24)* 24 different strains
see Figure 4.18
This work
Noy505GalΩT/Tth-ΑHA similar to Noy505GalΩT Tth-αHA This work
Noy505GalΩT/Tth-IRESαHA similar to Noy505GalΩT Tth-IRESαHA This work
Noy505GalΩT/Tth-5’RCIRESαHA similar to Noy505GalΩT Tth-5’RCIRESαHA This work
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Trans-integration
Two plasmids, pCPIPpo and a plasmid (Table 2.1) encoding the intron of interest
(Table 2.4), were co-transformed into the yeast strain INVSc2 (Invitrogen
Corporation) or NOY505GalΩT (Lin and Vogt 2000) either by the lithium acetate
method (Ausubel, Brent et al. 1990) or using the Frozen-EZ Yeast Transformation II
(Zymo Research, Catalog number T2001).  To select for yeast that had taken up both
plasmids, transformations were plated on SD-Ura-His plates.  Transformants were
streaked on SGal-Ura-His plates to induce the expression of I-PpoI from pCPIPpo.
Single colonies on SGal-Ura-His plates were grown in SGal-Ura-His liquid medium.
Genomic DNA was prepared from the above culture and PCR was performed to
screen for intron-integrated colonies.  Primer pair JL83  and JL84 or PrRS104 and
PrRS105, both spanning the Ppo.L1925 and Tth.L1925 insertion site, were used for
this PCR analysis.  The cells were cured of plasmids by growing them in liquid YEPD
for approximately 10 generations and plating on YEPD plates.  The loss of the
plasmids was checked by replicating colonies from YEPD plates onto SD-Ura and
SD-His plates.
Yeast genomic DNA preparation
Yeast cultures were grown to an OD600 of 1-3 in YEPD or YEPG media.  Cells
from 3 ml of culture were pelleted by centrifugation and then resuspended in 200 ml
of breaking buffer (2% Triton X-100, 1% SDS, 100mM NaCl, 10mM Tris HCl [pH
8.0], 1mM EDTA [pH 8.0]).  Approximately 200 µl of sterile glass beads (425-600
micron, Sigma) and 200 ml phenol/chloroform (equilibrated with TE) was added to
the cell suspension.  The mixture was then vortexed at highest speed for 3 min to
break the yeast cells.  Two hundred µl of TE (pH 8.0) was added and the cells were
spun at maximum speed in a tabletop centrifuge for 5 min at room temperature.  The
aqueous layer was transferred to a fresh tube and the DNA was precipitated by adding
 Table 2.4: Introns used.
*See figure 4.14 and 4.18 for Tth-5’P-Α-ran and Tth-α-ran 5’ end sequences.
Intron Name Ribozyme ORF Other Sequence Other Names
Ppo.L1925 Ppo.L1925 I-PpoI 3’UTR PpLSU3, I3
Ppo-α Ppo.L1925 α 3’UTR JLI3-α
Ppo-αHEUTR A Ppo.L1925 α I3αran1 9-7 9-45, 10-12
Ppo-αHEUTR B Ppo.L1925 α I3αran1 13-47
Ppo-αHEUTR C Ppo.L1925 α I3αran1 10-2
Ppo-αHEUTR D Ppo.L1925 α I3αran1 2-26 9-18
Ppo-αHEUTR E Ppo.L1925 α I3αran1 10-11
Ppo-αHEUTR F Ppo.L1925 α I3αran1 12-9
Tth.L1925 Tth.L1925 n/a n/a TtLSU1
Tth-ClaI Tth.L1925 n/a ClaI in P1 TtLSU1-ClaI
Tth-α Tth.L1925 α n/a TtLSU1-α
Tth-Neo Tth.L1925 Neo n/a TtLSU1-Neo
Tth-His3HA Tth.L1925 His3HA n/a n/a
Tth-IPpoHA Tth.L1925 I-PpoIHA n/a n/a
Tth-αUTR Tth.L1925 α 3’UTR TtLSU1-αWTUTR
Tth-αHEUTR A Tth.L1925 α 3’HEUTR 9-7 TtLSU1-αHEUTRA
Tth-αHEUTRB Tth.L1925 α 3’HEUTR 13-47 TtLSU1-αHEUTRB
Tth-αHEUTRC Tth.L1925 α 3’HEUTR 10-2 TtLSU1-αHEUTRC
Tth-5’P-α Tth.L1925 α Ppo.l1925 5’ end TtLSU1-α5’P
Tth-5’P-His3HA Tth.L1925 His3HA Ppo.l1925 5’ end n/a
Tth-5’P-αUTR Tth.L1925 α Ppo.l1925 5’ end, 3’UTR TtLSU1-α5’PWTUTR
Tth-5’P-αHEUTR A Tth.L1925 α Ppo.l1925 5’ end, HEUTR 9-7 TtLSU1-Α5’PHEUTRA
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Table 2.4 (Continued)
Intron Name Ribozyme ORF Other Sequence Other Names
Tth-5’P-αHEUTR B Tth.L1925 α Ppo.l1925 5’ end, HEUTR 13-47 TtLSU1-α5’PHEUTRB
Tth-5’P-αHEUTR C Tth.L1925 α Ppo.l1925 5’ end, HEUTR 10-2 TtLSU1-α5’PHEUTRC
Tth-αHA Tth.L1925 αHA n/a n/a
Tth-IRESαHA Tth.L1925 αHA YMR181c IRES n/a
Tth-RCIRESαHA Tth.L1925 αHA Reverse complement of YMR181c IRES n/a
Tth-5’α-ran 1 Tth.L1925 α Ppo.l1925 5’ end, 8 nt randomized* ran89 D3, D4, D5, D8
Tth-5’α-ran 2 Tth.L1925 α Ppo.l1925 5’ end, 8 nt randomized* ran89 D11
Tth-5’α-ran 3 Tth.L1925 α Ppo.l1925 5’ end, 8 nt randomized* ran89 D7
Tth-5’α-ran 4 Tth.L1925 α Ppo.l1925 5’ end, 8 nt randomized* ran89 D1
Tth-5’α-ran 5 Tth.L1925 α Ppo.l1925 5’ end, 8 nt randomized* ran89 L7
Tth-5’α-ran 6 Tth.L1925 α Ppo.l1925 5’ end, 8 nt randomized* ran89 L11
Tth-5’α-ran 7 Tth.L1925 α Ppo.l1925 5’ end, 8 nt randomized* ran89 D2
Tth-5’α-ran 8 Tth.L1925 α Ppo.l1925 5’ end, 8 nt randomized* ran89 D12
Tth-5’α-ran 9 Tth.L1925 α Ppo.l1925 5’ end, 8 nt randomized* ran89 D9
Tth-5’α-ran 10 Tth.L1925 α Ppo.l1925 5’ end, 8 nt randomized* ran89 D6
Tth-5’α-ran 11 Tth.L1925 α Ppo.l1925 5’ end, 8 nt randomized* ran89 L5
Tth-5’α-ran 12 Tth.L1925 α Ppo.l1925 5’ end, 8 nt randomized* ran89 L8
Tth-5’α-ran 13 Tth.L1925 α Ppo.l1925 5’ end, 8 nt randomized* ran89 L10
Tth-5’α-ran 14 Tth.L1925 α Ppo.l1925 5’ end, 8 nt randomized* ran89 L2
Tth-5’α-ran 15 Tth.L1925 α Ppo.l1925 5’ end, 8 nt randomized* ran89 L3
Tth-5’α-ran 16 Tth.L1925 α Ppo.l1925 5’ end, 8 nt randomized* ran89 L4
Tth-5’α-ran 17 Tth.L1925 α Ppo.l1925 5’ end, 8 nt randomized* ran89 L9
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Table 2.4 (Continued)
Intron Name Ribozyme ORF Other Sequence Other Names
Tth-5’α-ran 18 Tth.L1925 α Ppo.l1925 5’ end, 8 nt randomized* ran89 L6
Tth-α-ran 1 Tth.L1925 α Tth.L1925 5' end, 4 nt randomized* ran101 D2
Tth-α-ran 2 Tth.L1925 α Tth.L1925 5' end, 4 nt randomized* ran101 D3
Tth-α-ran 3 Tth.L1925 α Tth.L1925 5' end, 4 nt randomized* ran101 D5
Tth-α-ran 4 Tth.L1925 α Tth.L1925 5' end, 4 nt randomized* ran101 D8
Tth-α-ran 5 Tth.L1925 α Tth.L1925 5' end, 4 nt randomized* ran101 D11
Tth-α-ran 6 Tth.L1925 α Tth.L1925 5' end, 4 nt randomized* ran101 L1
Tth-α-ran 7 Tth.L1925 α Tth.L1925 5' end, 4 nt randomized* ran101 L2
Tth-α-ran 8 Tth.L1925 α Tth.L1925 5' end, 4 nt randomized* ran101 L5
Tth-α-ran 9 Tth.L1925 α Tth.L1925 5' end, 4 nt randomized* ran101 D1
Tth-α-ran 10 Tth.L1925 α Tth.L1925 5' end, 4 nt randomized* ran101 D4
Tth-α-ran 11 Tth.L1925 α Tth.L1925 5' end, 4 nt randomized* ran101 D6
Tth-α-ran 12 Tth.L1925 α Tth.L1925 5' end, 4 nt randomized* ran101 D7
Tth-α-ran 13 Tth.L1925 α Tth.L1925 5' end, 4 nt randomized* ran101 D9
Tth-α-ran 14 Tth.L1925 α Tth.L1925 5' end, 4 nt randomized* ran101 D10
Tth-α-ran 15 Tth.L1925 α Tth.L1925 5' end, 4 nt randomized* ran101 D12
Tth-α-ran 16 Tth.L1925 α Tth.L1925 5' end, 4 nt randomized* ran101 L3
Tth-α-ran 17 Tth.L1925 α Tth.L1925 5' end, 4 nt randomized* ran101 L4
Tth-α-ran 18 Tth.L1925 α Tth.L1925 5' end, 4 nt randomized* ran101 L6
Tth-α-ran 19 Tth.L1925 α Tth.L1925 5' end, 4 nt randomized* ran101 L7
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Table 2.4 (Continued)
Intron Name Ribozyme ORF Other Sequence Other Names
Tth-α-ran 20 Tth.L1925 α Tth.L1925 5' end, 4 nt randomized* ran101 L8
Tth-α-ran 21 Tth.L1925 α Tth.L1925 5' end, 4 nt randomized* ran101 L9
Tth-α-ran 22 Tth.L1925 α Tth.L1925 5' end, 4 nt randomized* ran101 L10
Tth-α-ran 23 Tth.L1925 α Tth.L1925 5' end, 4 nt randomized* ran101 L11
Tth-α-ran 24 Tth.L1925 α Tth.L1925 5' end, 4 nt randomized* ran101 L12
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1 ml of 100% ethanol.  DNA was spun down at room temperature for 3 minutes and
resuspended in 400 ml of TE.  To remove they yeast RNA, 6 µl of 10 mg/ml RNase A
was added and the DNA was incubated at 37°C for 5 minutes.  DNA was precipitated
by adding 10 ml of 5M NH4OAC and 1 ml of 100% ethanol and resuspended in 50 ml
TE (pH8.0).  Two µl of DNA was used for a 50 ml PCR reaction.
RNA preparation
RNA was prepared as in (Schmitt, Brown et al. 1990).  Yeast cultures were
grown to an OD600 of 1.0-1.5.  Cells from a 10 ml culture were collected by
centrifugation and resuspended in 400 ml AE buffer (50 mM NaOAc (pH 5.3), 10 mM
EDTA (pH 8.0)).  To this cell suspension, 40 ml 10% SDS and 450 µl of phenol
(equilibrated with AE buffer) was added and the mixture were incubated at 65˚C for 4
minutes.  The solution was frozen in dry-ice ethanol bath for ~30 seconds and then
centrifuged for 6 minutes.  The aqueous phase was extracted with phenol/chloroform
(equilibrated with AE buffer) twice. 40 µl (1/10 volume) of 3 M NaOAc [pH 5.3], and
1 ml (2.5 volume) of ethanol were added to the aqueous phase to precipitate the RNA.
The RNA was pelleted by centrifugation for 10 minutes, washed once with 1 ml of
cold 70% ethanol, and resuspended in diethylpyrocarbonate (DEPC)-treated H2O.
RNA concentration was determined by measuring OD260 and calculated using the
formula 1OD260=40 mg/ml.
Northern blotting
 RNA was separated on a 1.5% agarose/formaldehyde gel (0.66M
formaldehyde, 1XMOPS) in 1xMOPS buffer (0.04M morpholinopropanesulfonic acid
[MOPS], 0.01 M sodium acetate, 1 mM EDTA, pH 7.2).  The gel was soaked in
DEPC-treated H2O with shaking twice for 10 minutes each at room temperature to
remove the formaldehyde.  It was then soaked in 10XSSC with shaking for 10 minutes
at room temperature.  The RNA was transferred by capillary action to a
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Genescreenplus membrane (DuPont NEN) in 10XSSC overnight.  The membrane was
baked at 80˚C for 2 hours and prehybridized in 50% formamide, 5XSSC,
5XDenhardt's solution, 1% SDS and 100 mg/ml denatured sheared salmon DNA at
50˚C for 4 hours.
Two types of probes were used, either antisense RNA or antisense DNA
oligonucleotide.  To make the antisense RNA probe, a template with a T7 promoter
was made through PCR.  Template for the Ppo.L1925 ribozyme probe was made with
PrRS80  and PrRS79 using pJLI3α as a template.  Template for Tth.L1925 ribozyme
probe was made with PrRS82  and PrRS49 using pRSTth-α as a template.  Template
for α fragment of β-galactosidase ribozyme probe was made with PrRS61 and PrRS81
using pRSTth-α as a template.  17S rRNA probe was made using PrRS111 and
PrRS109 using yeast total genomic DNA as a template.
Synthesis of the antisense RNA probe was done with the MAXIscript in vitro
transcription kit (Ambion Catalog number 1308-1326).  Templates for the RNA probe
were made by adding a T7 promoter at the 5’ end of the complementary sequence of
the desired probe through PCR, The full length Tth-α RNA probe template was made
using primers PrRS83 and PrRS85 using pRSTth-α as a template.  The α template was
made using primers PrRS83 and PrRS62 using pRSTth-α as a template.  The
transcription mix consisted of, 5 ml of purified PCR product (purified with High Pure
PCR Purification Kit, as above), 1 ml each of 10 mM ATP, CTP, and GTP, 40 µCi of
labeled [α32P]-UTP, 2 ml of 100 ml unlabeled UTP, 3 ml of nuclease free water, and 2
ml of T7 enzyme solution.  The reaction was incubated at 37˚C for 1 hour.  The
reaction was passed through a Sephadex G-25 spin-column (Roche Diagnostics,
catalog number 1814397) to remove excess label.
After purification, antisense RNA probes were added to the prehybridization
solution.  The membrane was hybridized for 16-24 hours at 50˚C and then
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consecutively washed with 2XSSC/0.1% SDS for 15 minutes at room temperature,
0.5XSSC/0.1% SDS for 30 minutes at 60˚C, 1XSSC/0.1% SDS and 0.1XSSC/0.01%
SDS each for 15 minutes each at room temperature.
For the DNA oligonucleotide probe, the probe was end-labeled.  The end-
labeling reaction consisted of 3 ml of the appropriate oligonucleotide (at 10 mM), 2 ml
of 10x PNK buffer (New England Biolabs), 20 µCi [g32P]-ATP, 1 µl PNK (10 U), and
13 µl DEPC-treated water.  The reaction was incubated at 37˚C for 60 minutes, after
which the PNK was heat-inactivated by incubating at 65˚C for 20 minutes.  The
reaction was passed through a Sephadex G-25 spin-column (Roche Diagnostics,
catalog number NC9839095) to remove excess label.  PrRS86 was used to probe the 5'
end of α sequence.   PrRS87 was used to probe the 3' end of Tth.L1925 sequence.
The probe was then added to the prehybridization solution.  The membrane
was hybridized for 16-24 hours at room temperature and then consecutively washed
with 2XSSC/0.1% SDS for 15 minutes at room temperature and 0.5XSSC/0.1% SDS
for 15 minutes at room temperature.
RNA size standards for the northern blots were also made with the MAXIscript
in vitro transcription kit from Ambion (catalog number 1308-1326).  PCR products
were used as templates for transcription in a similar manner to the anti-sense RNA
probes.
To strip oligo probes from northern blots, they were incubated with stripping
solution (1% SDS, 0.1XSSC, 40 mM Tris, pH 7.5 mixed 50/50 (v/v) with formamide)
twice at 50˚C for 60 minutes.  To confirm that the probe had been removed from the
blot, they were used to expose a phosophoimager plate overnight to check for removal
of the probe.  The blots were then re-probed as above.
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Primer extension
Primer extension reactions were performed using the EndoFree RT kit
(Ambion Catalog number 1740).  Primer PrRS60 was used to prime the reaction.  The
corresponding sequence reaction was performed using the dsDNA cycle sequencing
system (GibcoBRL Catalog number 18196), again using primer PrRS60.  Both
reactions were analyzed on an 8% polyacrylamide sequencing gel (Sequagel-8,
National Diagnostics Catalog number EC-838).  Gels were pre-run for 30 minuets at
65 W, max voltage, and run at 65 W, max voltage for 2 hours.  After running, they
were placed on filter paper and dried before exposing them to a phosphorimager plate,
which was developed on a Storm phosphorimager (GE Healthcare).
Reverse transcription
Reverse transcription to detect circular intron RNA was performed using the
RETROscript kit (Ambion, Catalog number AM1710).  The RT reaction was
performed using either PrRS71, which binds in the α region of both Tth-α and Ppo-α
introns, or PrRS157 (for Tth.L1925-based introns) and PrRS158 (for Ppo.L1925-based
introns), which bind in the P2 region.  PCR amplification was performed using the RT
primer and either PrRS103 (for Tth.L1925-based introns) or PrRS72 (for Ppo.L1925-
based introns).
β-galactosidase assay
Assay for β-galactosidase activity was performed as described in (Ausubel,
Brent et al. 1990).  Yeast cultures were grown in appropriate medium to an OD600 of
1.0 to 1.5.  Cells were collected by centrifugation and resuspended in an equal volume
of Z buffer (60 mM Na2HPO4, 40 mM NaH2PO4, 10 mM KCl, 1 mM MgSO4, 50 mM
β-mercaptoethanol, pH 7.0).  Aliquots of the cell-suspension were then transferred to
another tube.  Assays of low expressing cultures (~5-20 U) were assayed in 1 ml and
0.5 ml aliquots, while higher expressing cultures were assayed in 0.1 ml and 0.5 ml
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aliquots.  Z buffer was then added to bring the cell suspension to a final volume of 1
ml.  Twenty ml of 0.1% SDS and forty ml of chloroform were added to the cell
suspension and the suspension incubated at 30°C for 15 minutes.  Two hundred ml of
4 mg/ml o-nitropphenyl-β-D-galactoside (ONPG) in 0.1 M KPO4, pH7.0 buffer was
added to start the reaction.  At various time points, the reaction was stopped by adding
0.5 ml of 1 M Na2CO3.  The reactions were then spun at 3000 rpm for 5 minutes, and
then OD420 and OD550 of the supernatant were determined.  β-gal activity units were
calculated using the following equation: U = 1000x(OD420-
(1.75xOD550))/(TxVxOD600) where T = time of reaction in minutes, V = volume of
cell suspension aliquot in ml, OD600 = cell density at the start of the assay.
Yeast protein extraction
Yeast protein extracts were made as in (Amberg, Burke et al. 2006). Yeast
cells were grown in 6 ml of an appropriate medium to an OD600 of 1-3. Cells were
collected and resuspended in 100 µl of H2O, to which was added 100 µl of 0.2 M
NaOH.  The mixture was incubated at room temperature for 5 minutes.  The yeast
cells were pelleted by centrifugation for 3 minutes and the supernatant was removed.
The pellet was resuspended in 50 µl 1x PAGE sample buffer (10% (by volume)
glycerol, 62.5 mM Tris-HCL, pH 6.8, 2% SDS, 0.01 mg/ml bromophenol blue, 5% β-
mercaptoethanol (BME)) and incubated in a boiling water bath for 3 minutes.  Cell
debris was pelleted and the supernatant was removed and transferred to a new tube.
Protein concentration was determined using the NI Protein Assay Kit (G-Biosciences,
Catalog number 786-005).
Western blotting
Yeast total protein extracts were run on 15% polyacrylamide gels on Might
Small II eletrophoresis apparatus (Heofer, Catalog number SE250-10A-.75). Transfers
were performed at 75 volts for 50 minutes in 1x transfer buffer (0.192 M glycine,
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0.025 M Tris base, 20% methanol) onto an Immobilon-P membrane (Millipore).  Blots
were blocked in 1x TBST (150 mM NaCl, 20 mM Tris pH 8, 0.05% Tween 20) with
10% W/V with dry milk for at least 8 hours (usually over night) at 4˚C.  Primary
antibody (Monoclonal anti-HA antibody produced in mouse, Catalog number H 3663)
was added to the blocking solution and incubated on a shaker for one hour at 4˚C.
Blots washed five times for 10 minutes with 1x TBST with 1% W/V dry milk.  The
membrane was then immersed in 1x TBST with 1% W/V dry milk.  The secondary
antibody (Anti-mouse IgG from rabbit (whole molecule) conjugated to alkaline
phosphatase) was added to this solution and incubated on a shaker for one hour at 4˚C.
blots were washed five times for 10 minutes with 1x TBST with 1% W/V dry milk.
Blots were removed from the wash and developed with 0.5 ml of ECF (GE
Healthcare, Catalog number RPN5785) and visualized with a Storm phosphorimager
(GE Healthcare).  The HA-tagged standard used as a control for blots was a total E.
coli lysate of cells overexpressing HA-tagged GST (Pierce catalog number 23613).
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Chapter III
Chimeric Tetrahymena Introns Integrated in the rDNA of Yeast Express ORFs
Inserted in the P1 Loop
Introduction
The group I self-splicing introns from Physarum, Ppo.L1925, and
Tetrahymena, Tth.L1925, are very closely related.  This might not be initially obvious,
as Ppo.L1925 is nearly twice the size of Tth.L1925, but these introns share 70%
sequence identity in their ribozyme regions and are inserted at homologous sites in the
large ribosomal subunit (LSU) genes of their respective host organisms. The larger
size of Ppo.L1925 is due to additional sequence encoding a homing endonuclease gene
(HEG), I-PpoI, which Tth.L1925 lacks.  It is likely that these two introns are
descended from a common ancestor and that Ppo.L1925 acquired, or Tth.L1925 lost, a
HEG after they diverged.
There is ample evidence that homing endonuclease genes (HEGs) can be
gained or lost by group I introns.  HEGs can transfer into group I introns through
homing. There are two factors that influence whether the HEG will be able to
successfully colonize the new host intron by homing (Figure 3.1).  First, the HEG
must not prevent the intron from splicing.  At best, the disruption of intron splicing
activity would render the intron’s host gene non-functional (in the case of an
unessential host gene); at worst, it would lead to the death of the host cell (in the case
of an essential host gene).  Second, the newly acquired HEG must be expressed.  The
advantage conferred upon the intron by the HEG, the ability to home into intron-
lacking alleles, requires the protein the HEG encodes.  If a HEG is not expressed, it
confers no advantage to the intron; it would not be selected for, and would lose its
ability to act as an endonuclease as mutations accumulate.  Additionally, any future
mutations that prevent the homing endonuclease protein from functioning would have
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Figure 3.1:  A flowchart detailing an intron’s successful acquisition of a HEG.
Red boxes indicate outcomes where the HEG is lost, while the green box indicates
an outcome where the HEG ORF is retained by the intron.
An intron acquires a HEG ORF 
Does the HEG 
prevent intron 
splicing?
The HEG is lost.
Is the intron 
in an essential 
gene?
Is the HEG
 expressed?
The intron is able to splice and
 the HEG is not selected against.
NO
The intron is able enter into 
intron lacking alleles and
 the HEG is selected for.
The host organism dies.
The intron-containing gene
 becomes non-functional.
The HEG is lost through
 genetic drift.
The HEG is selected 
against and lost.
The HEG confers no 
advantage upon it’s host intron.
YES YES
YES
The HEG is selected 
for and retained.
NO NO
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a similar effect, and would lead to loss of HEG from the intron.
When functioning in the rDNA of yeast, Ppo.L1925 was shown to be able to
express I-Ppo or two ORFs of similar size, the β-galactosidase α fragment and the
yeast SOM1gene.  Ppo.L1925 introns containing larger ORFs were unable to be
integrated in yeast, so it is likely that beyond a certain size, ORFs disrupt accurate or
efficient splicing (Lin and Vogt 2000).
The close relationship between Tth.L1925 and Ppo.L1925 suggest that the
Tth.L1925 ribozyme could accommodate an inserted ORF and retain the ability to
splice quickly and accurately.  Indeed, the Tth.L1925 ribozyme is far more active than
that of Ppo.L1925 (Zhang, Ramsay et al. 1995), so Tth.L1925 might be able to tolerate
the large ORFs that Ppo.L1925 could not.  Additionally, the model for intron
acquisition of HEGs suggests that it takes few, if any, mutations to allow expression of
an ORF once it is inserted in an intron.  Thus, it seemed plausible that ORFs inserted
into Tt.L1925 introns would not disrupt intron splicing and would be translated from
the intron RNA.  The experiments in this chapter were designed as an initial test of
this hypothesis.
Results
Chimeric ORF-containing Tth.L1925 introns can trans-integrate into the yeast genome
The system I used to study these introns is to integrate the intron into all ~120
copies of ribosomal large subunit (LSU) of the budding yeast Saccharomyces
cerevisiae.  This system has several advantages over other in vivo systems, such as
expressing the intron and surrounding RNA from a plasmid.  In yeast, the ribosomal
RNA genes (rDNA) are sequestered in the nucleolus, and nucleolus-specific factors,
which may be important for intron splicing or expression of an intron-encoded ORF,
might interact inefficiently, or not at all, with an intron transcribed from a plasmid.
Additionally, since the intron is integrated into all ~120 copies of rDNA, it should be
81
easier to observe the protein products of weakly expressed intron-encoded ORFs than
it would be from the ~20 copies of a yeast expression plasmid.  The one major
disadvantage of this system is that it requires the intron to be able to self-splice.
Integration of a non-splicing intron would prevent the formation of ribosomal RNA
and thus prevent the yeast cell from growing.
Introns are introduced into the yeast rDNA through the process of trans-
integration (Figure 1.6).  The intron of interest, flanked by yeast rDNA sequences, is
constructed in a yeast shuttle vector.  This shuttle vector is co-transformed with
pCPIPpo, a plasmid which encodes the homing endonuclease I-PpoI under Gal 1,10
promoter control, into the desired yeast strain.  Inducing expression from the plasmid
causes a reaction similar to homing; the endonuclease cleaves the yeast chromosomal
DNA at the intron insertion sites.  The rDNA exon sequence flanking the intron allows
the intron-containing plasmid to act as template for double strand break repair
(DSBR).  Since the intron sequence interrupts the homing endonuclease target site, cut
rDNA copies that use the intron-containing as sequence as a template for DSBR are
resistant to cleavage by the homing endonuclease, while cut rDNA copies that use
intron-lacking rDNA copies as a template for DSBR will be re-cleaved by the homing
endonuclease.  This results in the intron sequence being copied into all the rDNA
copies of the yeast cell.  However, there is a second way for the rDNA to become
immune to cleavage by the homing endonuclease.  Sometimes, during the repair of an
rDNA repeat using a intron-lacking template, mutations that make the repaired allele
immune to homing endonuclease cleavage are introduced to the repaired allele.  If one
of these mutations occurs, the mutant rDNA can be used as a template for DSBR,
instead of the intron, and thus could spread rapidly to all the rDNA copies.  Potential
trans-integrants can be screened for the presence of the intron or for the homing
endonuclease resistance mutation through PCR amplification over the intron insertion
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site.  Since the intron-donor plasmid contains some rDNA sequence, primers
complementary to regions outside of the donor plasmid rDNA sequence are used to
avoid amplifying sequences from any residual intron-donor plasmid.  Normally,
potential trans-integrants contain only intron-integrated rDNA copies or only
endonuclease-resistant rDNA copies, but not mixtures of the two.  In rare cases, a
mixture of intron-inserted and endonuclease-resistant rDNA has been found.  This
phenotype has only been seen with introns that splice poorly, and presumably, the
endonuclease-resistant rDNA copies are necessary to provide enough rRNA for yeast
cell to continue growing.
The Tth-ClaI intron served as a starting point and a useful tool for my
experiments.  This intron is based on Tth.L1925, but four nucleotides in the P1 loop
were mutated by Jue Lin to encode a ClaI restriction site (Figure 3.2A, B).  The site of
the ClaI site is homologous to the site of the I-PpoI ORF in Ppo.L1925 (Figure 3.2 C,
D).  Using this ClaI site, I could then insert ORFs into the P1 loop to create chimeric
Tth.L1925 introns.  Tth-ClaI can be trans-integrated into yeast (Figure 3.4), which
indicates that the four-nucleotide change does not disrupt splicing.
I chose four ORFs to insert into the ClaI site of Tth-ClaI:  the α fragment of β-
galactosidase, Neo, HIS3, and I-PpoI (Figure 3.3).  The β-galactosidase α fragment is
a small ORF, ~300 base pairs in length, and can replace the I-PpoI ORF in Ppo.L1925
without disrupting splicing.  The bacterial Neo and yeast HIS3 are two larger ORFs,
both between 700-800 base pairs in length.  Since chimeric Physarum introns
encoding Neo and HIS3 are unable to integrate into the yeast genome, these ORFs
presumably disrupt splicing in that context.  Lastly, I-PpoI is the HEG from
Ppo.L1925.  Successful I-Ppo expression from Tth.L1925 would demonstrate that a
homing endonuclease can be introduced into an intron sequence and be immediately
expressed.
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Figure 3.2:  The P1 stem loops of Tth.L1925, Tth-ClaI, a chimeric Tth.L1925
intron based on Tth-ClaI, and Ppo.L1925.  A. Tth.L1925. B.  Tth-ClaI.  Purple
nucleotides indicate the wild-type Tth.L1925 sequence in the region mutated to
make Tth-ClaI.  Red nucleotides indicate mutations necessary to add the ClaI site
to the P1 loop.  Green nucleotides are part of the ClaI site but are unchanged from
the wild type Tth.L1925 sequence.  The 5’ exon sequence is in lowercase.
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Figure 3.2 (Continued) . The P1 stem loops of:  C.  A chimeric Tth.L1925 intron
based on Tth-ClaI.  D.  Ppo.L1925.  Blue nucleotides indicate the two ClaI sites in
the chimeric Tth-ClaI intron. The 5’ exon sequence is in lowercase.
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Figure 3.4:  Trans-integration of chimeric Tth.L1925 introns.  Agarose gel
electrophoresis of PCR products from yeast DNA extracts.  Lane 1 1Kb Ladder
(New England Biolabs).  INVSc2-the PCR product of non-intron integrated yeast
strain InvSCII.  Tth-ClaI:  PCR product from total genomic DNA of INVSc2 yeast
with integrated Tth-ClaI.  Tth-a: PCR product from NOY505GalWT yeast with
integrated Tth-α.  Tth-Neo:  PRC product from INVSc2 yeast with integrated Tth-
Neo.
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Tth.L1925 is able to accommodate and express a small inserted ORF
 The first ORF I inserted into Tth-ClaI was the α-fragment of β-galactosidase.
Since this ORF had already been shown not to interfere with splicing of, and to be
expressed from, the α-containing Physarum intron, Ppo-α, I assumed it would have
the highest probability of being expressed from Tth.L1925.  I cloned the β-
galactosidase α ORF into the ClaI site of Tth-ClaI to create the intron Tth-α.  Because
it was thought that the nucleotides near the 5’ and 3’ ends of the ORF could be
important in splicing, Ppo-α had been designed to conserve the first and last fifteen
nucleotides of I-Ppo I sequence.  The α ORF was inserted into a ClaI site engineered
between the 5’ and 3’ 15-nucleotides, resulting in an α protein with seven additional
amino acids at its N and C termini (five I-Ppo I amino acids and two from the 6
nucleotide ClaI site).  In order to make Tth-α as directly comparable to Ppo-α as
possible, I designed the intron to encode a similar ORF.  The Tth-α ORF keeps the
first and last five amino acid residues of the I-Ppo I sequence.  Since I was cloning the
α ORF into the external ClaI site of Tth-ClaI, I mutated the internal α ClaI sites in
Ppo-α ORF to prevent ClaI cleavage and to conserve the two amino acids encoded.
The β-galactosidase α fragment is a small piece of the larger β-galactosidase
protein.  The α fragment has no activity of its own, but when expressed in trans with
the remainder of the β-galactosidase protein, the Ω fragment, the two proteins
associate.  The resulting α-Ω complex has full β-galactosidase activity.  This
phenomenon, known as α-complementation, was demonstrated in yeast for the first
time during analysis of Ppo-α (Lin and Vogt 2000).  The yeast strain NOY505GalΩT
is a useful tool for measuring the amount of α protein being produced by an integrated
intron, as this strain has the Ω-fragment gene integrated into the trp1 locus under Gal
1,10 promoter control (Figure 3.5A). NOY505GalΩT is also the same yeast strain that
was used to analyze expression from Ppo-α (Lin and Vogt 2000).  In this system, the
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α-fragment expressed from the intron complements with the Ω-fragment expressed
from the chromosomal locus (Figure 3.5B).
Tth-α is able to splice efficiently, as the majority of potential trans-integrants
screened contained integrated introns (Figure 3.4). The α ORF is expressed from the
integrated intron, as these yeast cells exhibited a light bluish color on media
containing X-gal (data not shown).  ONPG assays on liquid cultures indicated that the
β-galactosidase activity of Tth-α was 10 U, slightly less than the 15 U of Ppo-α
(Figure 3.5D).  Assuming that the specific activity for α complementing β-
galactosidase is comparable to that of the whole molecule, (300,000 U/mg (Steers,
Cuatrecasas et al. 1971)), I estimate that α protein is 0.05% of yeast total protein. It is
unlikely that the amount of α protein is being underestimated, for the following
reason.  Crude extracts from NOY505GalΩT transformed with a multi-copy plasmid
expressing the α-fragment, which presumably produces α in excess of the Ω fragment
produced from a single copy gene, exhibited roughly 500 Units of β-galactosidase
activity.  This is roughly 25% of the activity seen from the intact β-galactosidase
protein expressed from the same plasmid (Lin and Vogt 2000), which greatly exceeds
the activity seen from Tth-α, suggesting that the Ω fragment is in excess of the α
fragment in the Tth-α-integrated yeast.
Tth.L1925 is able to accommodate and express large inserted ORFs
It is clear that Tth.L1925 can accept a small ORF, but is it able to accept and
express larger ORFs?  To address this question, I chose to insert two ORFs, Neo and
HIS3, both of which had been shown earlier to disrupt splicing of Ppo.L1925 (Lin and
Vogt 2000).  Both of these reporter genes give a qualitative phenotype: Neo confers
resistance to G418 and HIS3 allows growth on -His media.  I decided to add an
hemagglutinin (HA) epitope tag to the end of the HIS3 ORF to allow for a quantitative
measurement of the amount of HIS3 protein being produced, through western blotting
89
α-fragment expressed
from intron (RNA Pol I
transcribed)
Ω-fragment expressed from
Gal 1,10 promoter (RNA
Pol II transcribed)
β-galactosidase activity
A
B
Figure 3.5:  Tth-α.  A.  The NOY505GalΩT system.  The α fragment is encoded
in introns integrated in the ~120 copies of rDNA, while the Ω fragment is
expressed from a single copy under Gal 1,10 promoter control.  B.  The α fragment
expressed from the introns complements with the Ω fragment expressed from the
single locus to produce β-galactosidase activity.
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0.4Plasmid pRSTth-α
10Integrated Tth-α
15Integrated Ppo-α
0.2Integrated Tth-ClaI
0.4No intron
Tth-α β-gal α5’ Tth.L1925 3’ ribozyme
ClaI ClaI
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β-gal α5’ Ppo.L1925 3’ ribozymeIPpo IPpo UTR
ClaI ClaI
Ppo-α
X X
C
D
Figure 3.5 (Continued):  C.  The Ppo-α and Tth-α introns.  The 15 5’ and 3’ I-Ppo
nucleotides are indicated in purple.  The mutated ClaI sites in Tth-α are indicated
by the X’s.  D.  β-galactosidase activity of introns integrated into yeast strain
NOY505GalΩT.  Plasmid pRSTth-α indicates NOY505GalΩT transformed with
the plasmid used for trans-integrating Tth-α.
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of yeast protein extracts.  The HA tag is a nine-amino acid sequences (YPYDVPDYA)
from the human influenza virus hemagglutinin protein that is commonly used as an
epitope tag (Field, Nikawa et al. 1988). I inserted two copies of the HA sequence
interrupted by a single glycine residue in order to increase the number of binding sites
for anti-HA antibodies (Figure 3.7B).  Because of the possibility that the sequence
encoding the HA tag itself might disrupt intron splicing or somehow inhibit
translation, I decided to only add the HA tag to the HIS3 ORF and excluded it from
the Neo ORF.  Additionally, to determine if the five upstream and downstream I-PpoI
amino acids used in Tth-α are required for splicing or translation, I chose to omit them
from the Neo and His3-HA ORFs.
I cloned these two ORFs into the ClaI site of Tth-ClaI to create introns Tth-
Neo (Figure 3.6) and Tth-His3HA (Figure 3.7) and trans-integrated them into S.
cerevisiae.  PCR analysis of isolated colonies potentially carrying Tth-Neo (Figure
3.4) and Tth-His3HA (data not shown) introns showed that some of them contain
integrated introns.  Thus, the Tth.L1925 ribozyme is able to splice with large inserted
ORFs that disrupt splicing when inserted in its cousin intron Ppo.L1925.  Also, the
HA tag sequence added to His3 ORF, and the lack of the sequence encoding the 5’ and
3’ I-PpoI amino acids from both ORFs, did not appear to significantly disrupt splicing.
If the Neo protein is being expressed from Tth-Neo, yeast cells with integrated
Tth-Neo should be resistant to G418.  Yeast with integrated Tth-Neo grew on media
containing G418, while the Tth-Neo-lacking parent strain did not (Figure 3.6),
indicating that Neo expression from Tth-Neo is indeed occurring.
Due to the added HA-tag, expression of the His3HA can be tracked both
qualitatively, by plating the yeast on –His selective media, and quantitatively, through
western blotting of protein extracts and comparison with a known standard.  Yeast
with integrated Tth-His3HA introns were able to grow on –His media, indicating that
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Figure 3.6:  Tth-Neo.  A. Schematic representation of the Tth-Neo intron. B.
Yeast with no integrated intron or with integrated Tth-Neo are plated on YEPD
(left) and YEPD + 0.5 mg/ml G418.
Tth-Neo Neo5’ 3’ ribozyme
ClaIClaI
No intron Integrated Tth-Neo
YEPD
No intron Integrated Tth-Neo
YEPD + G418(0.5 mg/ml)
A
B
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Figure 3.7:  Tth-His3HA.  A.  Schematic representation of the Tth-His3HA intron.
B.  Sequence of the double HA tag added to the 3’ end of the His3 ORF.  C.
Western blot of yeast extracts probed with an anti-HA antibody.  Lane 1, 50 µg of
total Noy505GalΩT protein.  Lane 2-5, 50 µg, 25 µg, 6.25 µg, and 2.5 µg of
Noy505GalWT with integrated Tth-His3HA total protein.  Lanes 6-8, 0.25 µg, 0.05
µg, and 0.0125 µg of total lysate of E. coli over expressing a HA tagged standard.
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the His3HA protein was being produced by the cells.  The protein could be visualized
by western blot (Figure 3.7).
To estimate the amount of His3-HA produced, I used the total lysate of an E.
coli strain which was overexpressing a singly-tagged HA standard.  To estimate the
percentage of the lysate that the HA-tagged standard comprised, I analyzed Coomasie
stained polyacrylamide gels using Adobie Photoshop and determined that the standard
made up approximately 15% of the lysate.  I then compared the intensity of the
standard band in western blots to that of the His3HA using the ImageQuant.  From this
comparison, I estimate that the His3HA protein comprises ~0.01% of the yeast total
protein, an amount similar to that of β-galactosidase a fragment produced by Tth-α.
Insertion of the I-PpoI ORF disrupts splicing of chimeric-Tth.L1925 introns
The fourth ORF I examined was the I-PpoI HEG.  Inserting this ORF into the
Tth-ClaI intron is interesting from an evolutionary perspective, as it is likely that the
HEG that was either lost or gained by an ancestral Tth.L1925 and Ppo.L1925 intron
after their divergence from a common ancestral intron.  The 489 nucleotide I-PpoI
ORF is larger than the 255 α ORF it and in its native context, obviously does not
disrupt the splicing of Ppo.L1925.
To make the chimeric intron Tth-IPpoHA, I decided to add the double HA-tag
to the 3’ end of the I-PpoI ORF, before insertion into Tth-ClaI (Figure 3.8). The
amount of I-PpoI protein produced in principle could be quantitated through an
endonuclease activity assay, where substrate DNA containing the 15 nucleotide I-PpoI
cleavage site is incubated with a protein extract, or by western blotting. Crystal
structures of I-PpoI show that the C-terminus, to which the HA tag is appended, is on
the surface of the protein and is involved in making dimerization contacts, and is not
involved in DNA binding or catalytic sites, so it seemed likely that the C-terminus
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I-PpoI5’ 3’ ribozyme2xHA
ClaI ClaI
I-PpoI5’ 3’ ribozymeUTRPpo.L1925
Tth-IPpoHA
Figure 3.8:  Tth-IPpoHA.  A.  Schematic representation of the Ppo.L1925 and
Tth-IPpoHA introns.  The HA sequence used in Tth-IPpoHA is identical to that
used in Tth-His3HA (Figure 3.7).
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would be able to accommodate the extra HA-tag amino acids (Flick, Jurica et al.
1998).
My attempts to trans-integrate Tth-IPpoHA were unsuccessful.  All of the 12
potential Tth-IPpoHA integrants screened from two independent trans-integration
reactions contained I-PpoI resistant rDNA but no integrated introns (data not shown).
This suggests that the Tth-IPpoHA intron is unable to splice efficiently in S.
cerevisiae.  It is unclear how the ORF is disrupting splicing, although is unlikely that
this disruption was caused by ORF length, as introns with the longer His3-HA and
Neo ORFs were able to splice.
In summary, three out of the four tested chimeric Tth.L1925 introns, Tth-α,
Tth-Neo, and Tth-His3HA were able to splice, despite the inserted ORF.  This result is
in contrast to previous observations that Neo and His3 prevented splicing in chimeric
Ppo.L1925 introns.  The I-PpoI ORF prevented splicing in the context of Tth-IPpoHA
Tth-α Tth-Neo, and Tth-His3HA produced functional proteins, with the latter two
being at comparable levels, ~0.01% of total yeast protein.  Protein production
obviously was very inefficient, much lower per gene copy number than from a RNA
Pol II-transcribed gene.
Discussion
In order to be successful in its parasitic lifestyle, a group I intron must be able
to remove itself from the primary transcript of its host gene.  The ability of an intron to
splice is affected by both the catalytic activity of the ribozyme and the rate that the
freshly-synthesized ribozyme RNA folds into the active conformation.  The intron-
folding rate is affected by surrounding exon sequences, the presence of inserted
sequences, and the presence of splicing factors (protein factors that promote, or act as
a scaffold for, intron folding) (Woodson and Cech 1991; Rocheleau and Woodson
1995; Koduvayur and Woodson 2004).  Misfolded intron RNAs do not appear to get a
97
second chance to fold correctly and are instead sequestered and degraded in yeast
(Jackson, Koduvayur et al. 2006).  Because of this degradation of misfolded RNA, a
slowly-folding intron that forms a highly active ribozyme may appear to be inactive in
vivo.
In order to be accepted into an intron sequence, an inserted ORF cannot
interfere too severely with either the folding pathway of the ribozyme RNA or the
splicing reaction of the ribozyme.  The inserted ORF sequence would disrupt splicing
by blocking important catalytic ribozyme sites, such as the exogenous G binding site.
It could also promote mistargeting of the 5’ or 3’ splice sites, which would result in
excision of exon sequence or inclusion of some intron sequence in the spliced exon
RNA, disrupting structures formed by exon RNA and resulting in frame-shift
mutations in protein coding RNAs.  ORF sequences could disrupt folding by pairing
with ribozyme sequences before they can form their proper pairing, or the ORF could
be so long as to prevent ribozyme elements interrupted by the ORF from pairing
before the unfolded pre-rRNA is degraded.
Tth.L1925 is able to accommodate the small β-galactosidase α ORF as well as
the larger Neo and His3HA ORFs and retain the ability to function in vivo (Figure
3.9).  The smaller α ORF can be inserted in both Tth.L1925 and Ppo.L1925 introns
without disrupting splicing.  The larger Neo and His3HA ORFs disrupt the splicing of
Ppo.L1925 but not that of Tth.L1925.  I interpret this difference to be due to the
robustness of the Tth.L1925 ribozyme, which would allow Tth.L1925, even if splicing
were slowed by and ORF, to splice at a fast enough rate to produce functional rRNA.
These results support the idea that a HEG ORF could enter into an intron sequence
without disrupting intron function, preventing selection against the newly ORF-
containing intron.
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 The one tested chimeric Tth.L1925 intron that is unable to trans-integrate into
the yeast genome is Tth-IPpoHA, implying that the inserted ORF disrupts folding or
splicing, or that the protein or RNA is otherwise toxic to the yeast.  It is possible that I
randomly selected twelve I-PpoI resistant mutants out of a larger pool of yeast that
contained both I-Ppo resistant mutants and integrated introns.  However, this
possibility seems unlikely, as the majority of potential integrants of other chimeric
Tth.L1925 introns screened contained integrated introns while a minority contained
resistant mutants.
In Ppo.L1925, the I-PpoI ORF is followed by a 53-nucleotide sequence dubbed
the 3’ untranslated region (3’UTR), which is not part of the Ppo.L1925 ribozyme
structure and is not present in Tth.L1925.  Deleting nucleotides 41-50 of the 3’ UTR
prevents any trans-integration of Ppo.L1925 and full trans-integrating of Ppo-α, so
this UTR sequence is important for splicing (Lin and Vogt 2000).  Interestingly, the
actual sequence of nucleotides 41-50 does not seem to affect splicing, as introns with a
wide variety of different sequences in this region are able to trans-integrate.  It could
be that the 3’UTR sequence is required for the splicing of an I-PpoI-containing intron,
perhaps acting as a spacer and preventing the I-PpoI sequence from interacting with
ribozyme sequence.  Doubt is cast on this possibility, though, by the fact that the
3’UTR sequence is required for splicing of Ppo.L1925-based introns that do not
contain the I-PpoI sequence.  For example, the 3’UTR is required for Ppo-α splicing,
but is not required for the splicing of Tth-α.
Another possibility is that Tth-IPpoHA is actually able to trans-integrate and
splice and the I-Ppo I-HA protein is somehow toxic to yeast cells. The I-PpoI protein
is toxic when expressed in yeast cells that do not contain I-PpoI resistance mutations
in their rDNA, and, if the I-Ppo I-HA protein is produced high levels, it might cut the
host cell DNA at a rate that the DSBR machinery is unable fully correct. However,
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this possibility is rendered unlikely, as during the trans-integration process, I-PpoI is
expressed at high levels from the Gal 1,10 promoter from the multi-copy pCPIPpo
plasmid, yet some yeast survive.  In addition, this scenario is incongruent with the
levels of expression seen from Tth-α and Tth-His3HA, both of which are much lower
than that of a Gal 1,10 promoter.
A third possibility is that the HA tag added at the C-terminal end of I-PpoI
interfered with DNA recognition and perhaps reduced the specificity of the I-PpoHA
enzyme.  This could cause the protein to cut the yeast genome at sites other than the I-
PpoI recognition site, which would be highly toxic to the yeast cells.  If this is the
case, it is unlikely that yeast with integrated Tth-IPpoHA would survive.  A crystal
structure of I-PpoI bound to DNA shows, though, that the C-terminus of the I-PpoI
protein is involved in dimerization of I-PpoI proteins and is relatively far away from
the active and DNA binding sites of the protein (Flick, Jurica et al. 1998).  If the HA
tag interfered with I-PpoHA dimerization, it would lower I-PpoI activity and actually
make the protein less toxic.
Expression of chimeric Tth.L1925 encoded ORFs
Based on the results in this chapter, it appears that no significant changes in the
intron sequence is required for expression of most ORFs inserted in the P1 loop of
Tth.L1925.  The three chimeric Tth.L1925 introns that are able to integrate into all of
the rDNA copies of yeast are expressed.
Estimates of the amount of protein produced from Tth-α and Tth-His3HA
indicate that the introns are producing roughly similar amounts of protein, 0.05% and
0.01%, respectively, of total yeast protein.  These levels are consistent with the
amount of protein produced by both Ppo.L1925 and Ppo-α in yeast, where I-PpoI is
0.04% and α is 0.07% of yeast total protein, respectively (Lin and Vogt 1998; Lin and
Vogt 2000).  Protein is expressed from either Tth.L1925 or Ppo.L1925 much less
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efficiently, roughly 1000-fold less per DNA copy, than from a highly active RNA Pol
II promoter such as the Gal 1,10 promoter.  Interestingly, protein expression from
Ppo.L1925 in its native genome of Physarum is even lower, with I-PpoI representing
1.3x10-4% of Physarum total protein (Lin and Vogt 1998).
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Chapter IV
The Role of Intron Sequence Elements in Expression from Chimeric
Tetrahymena Introns.
Introduction
The most obvious difference between the Ppo.L1925 and Tth.L1925 introns is
the large I-PpoI ORF in Ppo.L1925.  In addition, there are also other major sequence
differences between these two introns (Figure 4.1 A).  One of these regions, a 53-
nucleotide sequence called the 3’ untranslated region (3’UTR), lies between the end of
the I-PpoI ORF and the Ppo.L1925 ribozyme and is entirely absent in the Tth.L1925
intron.  The short 5’ end sequences of the introns are also very different, having
identical bases at only 3 of the first 11 nucleotides, compared with the 70% sequence
identity in the core ribozyme.
The role of the 53-nucleotide 3’UTR sequence has been investigated in
Ppo.L1925, using both Ppo.L1925 and the chimeric Ppo-α (Lin and Vogt 1998; Lin
and Vogt 2000).  After the Ppo.L1925 intron is spliced, a processing cleavage
separates the 3’UTR and the upstream ORF from the Ppo.L1925 ribozyme RNA
(Figure 1.13).  Initially, it was hypothesized that the 5’ processed RNA functioned as
the message for I-PpoI translation and that the 3’UTR stabilized the RNA or somehow
promoted translation.  Experiments showed that instead, the full-length intron RNA
apparently serves as I-PpoI message (Lin and Vogt 1998). Thus, it appears that the
functional 3’ untranslated region of the Ppo.L1925-encoded ORF consists of both the
53-nucleotide region and the entire Ppo.L1925 ribozyme.  This means that referring to
the 53-nucleotide sequence as the 3’UTR is a misnomer, even though the term is still
used for this region.
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Figure 4.1:  Features of Tth.L1925 and Ppo.L1925.  A.  Schematic
representation of sequences shared between  Ppo.L1925 (top) and Tth.L1925.  The
Ppo.L1925 ribozyme region is interrupted by the I-PpoI ORF and the 53 nucleotide
3’UTR sequence, while Tth.L1925 has only a ribozyme region.  B.  Summary of
previous experiments examining the role of the 3’UTR in splicing and expression.
Numbers indicate 3’UTR nucleotide positions (from 1 to 53).
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 The function of the 3’UTR is mysterious, but it appears to play a role in both
intron splicing and ORF expression (Figure 4.1 B) (Lin and Vogt 2000).  By
sequentially deleting 10 nucleotide sections of the 3’UTR, Jue Lin found that
nucleotides 1-10, 11-20, 21-30 and 31-40 have no significant effect on splicing, as
inferred from the ability of the chimeric α intron to integrate into yeast rDNA.
Deleting 3’UTR nucleotides 41-50, however, appeared to greatly reduce intron
splicing.  A possible explanation for this finding was suggested by the observation that
nucleotides 46-53 are complementary to, and might be base-pairing with, an eight
nucleotide stretch in the I-PpoI ORF.  However, this hypothesis was disproven, as
changing the I-PpoI sequence so that it is no long complementary to the 3’UTR
sequence had no effect on splicing (Lin and Vogt 2000).  Additionally, experiments
that created pools of introns with random nucleotides at positions 41-47 and 48-53
showed that a wide variety of sequences at these positions did not disrupt splicing.
This result strongly suggests that the sequence of the nucleotides is not important for
splicing.  On the other hand, the sequence of the last six nucleotides (48-53) of the
3’UTR had a strong affect on expression of a Ppo.L1925-encoded ORF.  Changing the
sequence of the last six nucleotides can prevent expression or increase it over ten-fold.
These effects on expression levels were not seen in introns when the sequence of
nucleotides 41-47 was changed (Lin and Vogt 2000).
The Ppo.L1925 5’ end is important in splicing, as binding of this sequence and
the 5’ exon sequence with the intron’s internal guide sequence (IGS) determines the
location of the 5’ splice site.  The effect of the Ppo.L1925 5’ end sequence on
translation, though, has not been investigated.  It is easy to imagine that the 5’ end
sequence could be important for translation, possibly by interacting with translation
factors or by promoting the formation of a translation-competent RNA structure.
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In this chapter, I describe experiments designed to examine the role of
Ppo.L1925 sequences in splicing and expression, by introducing these sequences into
the to chimeric Tth.L1925 intron.  The first sequence I examine is the Ppo.L1925
3’UTR.  In the previous chapter, I found that, unlike Ppo.L1925-based introns,
chimeric Tth.L1925 did not require the 3’UTR sequence to splice properly.  I now
address how the 3’UTR sequence affects expression from chimeric Tth.L1925 introns.
Does adding the 3’UTR reduce expression, and conversely do the mutant, high-
expressing 3’UTR sequences increase expression, in Tth.L1925 as they appear to do in
Ppo.L1925?  The 3’UTR has been implicated as playing a role in the post-splicing
processing of Ppo.L1925.  Does the 3’UTR affect chimeric Tth.L1925 introns in the
same way?
I also examine the Ppo.L1925 5’ end sequence.  How does this sequence affect
translation from a chimeric Tth.L1925 intron?    Does the 5’ end sequence somehow
interact with the 3’UTR sequence?  I address these questions by introducing the
Ppo.L1925 5’ end sequence into chimeric Tth.L1925 introns.
Results
HEUTR sequences cause increased β-galactosidase activity in Ppo-α-HEUTR introns
integrated in yeast
Nucleotides 48-53 of the 3’UTR play an important role in translation from
Ppo.L1925-based intron RNAs through an unknown mechanism.  Previously, Jue Lin
created a pool of Ppo-α introns, Ppo-α ran 1, with random sequences at these six
positions.    The majority of yeast strains containing integrated introns from the Ppo-
α ran1 pool exhibited much higher levels (over ten fold more) of β-galactosidase
activity than those containing the wild type Ppo-α intron.  Thus, it appears that
changing nucleotides 48-53 of the Ppo.L1925 3’UTR can greatly increase expression,
although no consensus for the high expressing 3’UTR (HEUTR) sequences from the
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Ppo-α ran1 pool was apparent, and many of the introns had very different sequences
in this region.
An alternate explanation for the high levels of β-galactosidase activity seen
from the yeast with Ppo-α ran1 introns is that the increases are not caused by changes
in the 3’UTR sequence, but by other mutations in the host yeast genome.   To
differentiate between these two possibilities, I selected six yeast strains containing
individual, high expressing introns from the Ppo-α ran1 pool, which I named Ppo-α-
HEUTR A through F (Figure 4.2).  I amplified the intron and the surrounding rDNA
sequence from these six isolates, cloned these fragments into the yeast shuttle vector
pRS423 and trans-integrated them into yeast strain NOY505GalΩT.  If the high β-
galactosidase activity was due to a mutation in the original host strain, then it should
not be carried over to the new host yeast and the freshly trans-integrated strains should
not exhibit high levels of β-galactosidase activity.  On the other hand, if the increase in
expression level was due to the 3’UTR sequence, the freshly trans-integrated strains
should exhibit the same high β-galactosidase activity as the original strains.  I assayed
the β-galactosidase activity of crude extracts of the intron containing yeast strains and
found that all of the intron-integrated yeast exhibited the high β-galactosidase
activities, with the highest, Ppo-αHEUTR C, exhibiting over 700 U, nearly 50 fold
more than the wild type Ppo-α.  This result confirms that the 3’UTR sequences are
responsible for the increased β-galactosidase activity seen from yeast containing these
introns.
Ppo.L1925 3’UTR sequences do not have a large effect on β-galactosidase activity
from chimeric Tth-α introns
Since the 3’UTR sequence can have such a large effect on expression levels
from Ppo-α, I decided to see what effect it would have on expression from Tth-α.  In
Ppo.L1925, the wild type UTR sequence is thought to have evolved to down regulate
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expression from the intron, as evidenced by the observation that majority of random
UTR nucleotide 48-53 sequences resulted in an intron with increased expression.
However, it is impossible to test what the base level of expression of an integrated
intron would be  without any 3’UTR, since deleting the this sequence prevents
splicing.
Adding the 3’UTR sequence to the Tth-α intron could have several possible
effects.  First, and possibly least interestingly, the UTR sequence could disrupt
splicing, which would prevent the intron from trans-integrating. Second, the 3’UTR
sequence might decrease expression from the chimeric Tth.L1925 intron.  Third, the
3’UTR sequence might promote expression from the chimeric Tth.L1925 intron.
To add the 3’UTR sequence to Tth-α, I used a two-step PCR process to fuse
the 3’UTR sequence to the α ORF. I then cloned this PCR product into the ClaI site of
Tth-ClaI to create the intron Tth-αUTR (Figure 4.3) and trans-integrated the Tth-
αUTR intron into yeast strain NOY505GalΩT.  I found that the majority of potential
trans-integrants contained integrated introns (data not shown), indicating that the
addition of the UTR sequence does not significantly disrupt Tth-αUTR splicing.  The
cells exhibited 5 U of β-galactosidase activity, somewhat lower than the 10 U
produced from the Tth-α intron.  This slight reduction in activity suggests that the
3’UTR sequence from Physarum does not have a major positive or negative effect on
ORF expression in the Tetrahymena intron.
If the wild-type Ppo.L1925 3’UTR sequence does not have a large effect on
Tth-α, how would the HEUTR sequences affect Tth-α?  To address this question, I
chose HEUTR sequences from Ppo-αHEUTR A, Ppo-αHEUTR B, and Ppo-αHEUTR
C (Figure 4.3), to insert into Tth-α, thus creating introns Tth-αHEUTR A, Tth-
αHEUTR B, and Tth-αHEUTR C.  After trans-integrating the HEUTR introns, again I
found that the majority of potential trans-integrants contained integrated introns (data
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not shown), indicating that the HEUTR sequences does not disrupt splicing in the
context of Tth-α. The three HEUTR introns exhibited similar levels of β-galactosidase
activity, about 4 U, which is roughly the same as that of Tth-αUTR.  Thus, the
HEUTRs found previously to greatly increase ORF expression in the Physarum intron
Ppo-α, do not function similarly in the context of Tth-α.
It is possible that the HEUTRs were being translated at a high level, but the
UTR presence destabilized the intron RNA, which would reduce the message for and
therefore, the protein product of, the Tth-αHEUTR introns.  To address this
possibility, I performed a northern blot (Figure 4.4).  Using total RNA from yeast cells
with integrated Tth-α, Tth-αUTR, the three Tth-αHEUTR introns, as well as Ppo-α
and the three Ppo-HEUTR introns.  The probe was an in vitro-made radiolabeled RNA
complementary to Tth-α, which should hybridize with any α, Tth.L1925, and
Ppo.L1925 ribozyme RNA.  However, since the two entire ribozymes share only 70%
sequence identity, the Ppo.L1925 intron was expected to give a weaker signal. No
significant difference between the amount of full-length (i.e. potential message) Tth-α,
Tth-αUTR, or Tth-αHEUTR RNA was evident.  Thus, I conclude that neither the wild
type 3’UTR nor HEUTR sequences significantly change the amount of α-encoding
RNA being translated.
The northern blot also revealed at least two species of Tth-α RNA smaller than
the full-length Tth-α.  For comparison, in yeast, Ppo.L1925 RNA is known to be
processed at two sites, internal processing sites one and two (IPS1 and IPS2).  IPS1
processing occurs both in vivo and in Physarum, but IPS2 processing occurs only in
yeast (Ruoff, Johansen et al. 1992; Lin and Vogt 1998).  These processing sites are
only 15 nucleotides apart and are both located in the P1 stem loop (Figure 4.7 A), with
IPS1 cleavage occurring at the end of the 3’UTR and IPS2 cleavage occurring at the
base of the P1 stem.  In Ppo-α, all of the RNA species produced by cleavages are of
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Figure 4.4 (Continued):  The potential identities of the RNAs composing bands
A, B, and C.  The black arrow represents the anti-sense RNA probe.  Band A
consists of the full-length intron RNA.  Band B consists of asymmetrically-cleaved
RNA.  Band C consists of a symmetrically-cleaved RNA.
β-gal α5’ 3’ ribozymeIPpo IPpo
β-gal α5’ IPpo IPpo
α     3’ ribozymeIPpo
β-gal α5’ IPpo IPpo
3’ ribozyme
or
and/or
Band A
Band B
Band C
B
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similar size, and thus run at the same position on a northern blot (Figure 4.4, Band C).
All of the Tth-α-based introns exhibit a band of similar size, which is indicative of
processing at an IPS1/IPS2-like site.
Because the products of cleavage at IPS1 and IPS 2 are so similar in size, it is
impossible to tell from this northern blot if only one cleavage is occurring in Tth-α
introns or if, like their cousins from Physarum, they are undergoing two cleavages.  I
performed a primer extension reaction to more accurately map the central Tth-α
processing site, using the same radio-labeled primer in a parallel sequencing reaction.
Both reactions were then run on the same denaturing poly-acrylamide sequencing gel.
Primer extension of total RNA extracts from yeast cells with integrated Tth-α, Tth-
αUTR, and Tth-αHEUTR A produced two major bands (Figure 4.5).  These bands
correspond to a G residue in the second ClaI sequence, just 3’ of the α ORF, and a G
at the base of the P1 stem.  Since group I intron processing occurs by a G addition
mechanism (see Figure 1.2) (Ruoff, Johansen et al. 1992; Lin and Vogt 1998), the
primer extension bands should be one nucleotide longer than the sequencing band that
corresponds to the actual cleavage site.  Thus, it appears that Tth-α introns have two
processing sites in the P1 stem region, IPS1 between Tth-α nucleotides 314-315 and
IPS2 between Tth-α nucleotides 329-330.  These two processing sites correspond
closely with IPS1 and IPS2 of Ppo.L1925.
Tth-α also undergoes cleavage at a third site, IPS3  (Figure 4.4, Band B).  The
resulting RNA species runs between the full-length intron and IPS1/IPS2 processed
RNAs.  Since it is larger than the IPS1/IPS2 RNA, it must be the result of an
asymmetric cleavage of the RNA, placing IPS3 either within the α ORF RNA or
within the ribozyme RNA.  A band corresponding to the complementary fragment is
not visible on the blot, and could have run off of the gel.  Alternatively, the smaller
fragment may not be stable.
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Figure 4.5.  Primer extension analysis of the Tth-α P1’ region.  Sequencing and
primer extension analysis of Tth-α, Tth-αUTR, and Tth-αHEUTR A.
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In order to identify the IPS3-derived band, I prepared a second northern blot
using two different probes sequentially.  The first was an end-labeled oligonucleotide
complementary to the 3’ end of the Tth.L1925 intron.  The second was an end-labeled
oligonucleotide complementary to the 5’ end of the α sequence.  After stripping off
the first probe no bands remained visible (data not shown).   As seen in Figure 4.6, the
3’ end probe bound to the full-length and both processed RNAs, while the 5’ end
probe bound only to the full-length intron RNA.  This result implies that the
processing site is within the α sequence and not the ribozyme.  Interestingly, the only
species of intron RNA that contains the α ORF visualized in either of the blots is the
full-length intron.  It is possible that the ribozyme structure protects RNA species that
contain it, while processed pieces lacking the 3’ end are degraded.
In summary, based on these experiments, the Tth-α introns process at three
sites (Figure 4.7, two that are similar to Ppo.L1925 processing sites IPS1 and IPS2,
and a third site, IPS3, that is in the α ORF.  None of the processed RNA fragments
that contain the α ORF appear to be stable, and so I conclude that it is unlikely that
processed RNA species do not contribute to the amount of α being produced in the
cell.  Based on these results, however, it is impossible to rule out the possibility that
undetected processed fragments, or another, low-quantity intron-derived RNA species
is acting as the message for intron-encoded ORF translation.
The 5’ end of Ppo.L1925 increases β-galactosidase activity from Tth-α
Unlike the 3’UTR, the effect of the intron 5’ end sequence on translation has
not been examined.  This sequence, between the 5’ end of the intron and the I-PpoI
start codon, is only twelve nucleotides long.  Eleven of these nucleotides are encoded
by the intron and one is the exogenous G residue added during the first step of
splicing.  Even in this small sequence, Ppo-α and Tth-α show large differences.  The
Ppo-α 5’ end is C-rich, (6 out of 13 residues, while the Tth.L1925 sequence is A rich
117
4.6  Northern blot of Tth-α and Ppo-α intron RNA with 5’ and 3’ end specific
probes.  The top northern blot was probed with an end-labeled oligonucleotide
primer that is complementary to the 3’ region of the Tth.L1925 intron. The bottom
northern blot was probed with an end-labeled oligonucleotide complementary to
the 5’ end of the β-galactosidase α fragment.  Lane 1  0.1 µg of in vitro transcribed
Tth-α RNA.  Lane 2-13:  2.5 mg of Total RNA isolated from a NOY505GalΩT
strain with the listed intron integrated into the rDNA.  Arrow A indicates full-
length intron RNA, Arrow B indicates asymmetrically processed intron RNA, and
Arrow C indicates RNA processed in the P1’ stem.
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Figure 4.7:  A comparison of the internal processing sites of Ppo.L1925 and
Tth-α.  A.  Ppo.L1925 is processed at two points, IPS1 at the end of the 3’UTR and
IPS2 at the base of the P1’ stem.  B.  Tth-α is processed at three points.  IPS1
occurs in the 3’ ClaI site, IPS2 occurs at the base of the P1’ stem and IPS3 occurs
with the alpha ORF.
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 (6 out of 13 residues) (Figure 4.8 A).  The first three nucleotides of both introns are
very important for splicing, as these nucleotides base-pair with the IGS, which
determines the 5’ splice site (Figure 4.8 B) (Doudna, Cormack et al. 1989).  It is
difficult to predict how exchanging the Ppo.L1925 5’ end for the Tth-α 5’ end would
affect translation.  Since Tth.L1925 does not contain an ORF sequence in
Tetrahymena, it presumably has not been under any selective pressure for a 5’ end
sequence that would affect translation. The potential function of the 5’ end in
Ppo.L1925 is also unknown.  It might function to promote translation of the
downstream ORF or to down-regulate the translation of the potentially toxic I-PpoI
protein, or it might have no function in translation
In order to simplify the addition of the Ppo.L1925 5’ end to chimeric
Tth.L1925 introns, I modified the Tth-ClaI intron to make Tth-5’P-ClaI (Figure 4.9).
Tth-5’P-ClaI has the Tth.L1925 5’ end sequence replaced with that of Ppo.L1925.  I
also changed the complementary nucleotides in the P1 stem to preserve the IGS
contacts in order to minimize potential disruption of the splicing reaction.  These
changes, here referred to as 5’P (for the 5’ end of Physarum), appear not to have a
negative effect on intron splicing, as Tth-5’P-ClaI is able to trans-integrated into yeast
(data not shown).
The Tth-5’P-ClaI intron allowed me to effectively add the 5’P sequence to Tth-
α by cloning the α ORF from Tth-α into the ClaI site of Tth-5’P-ClaI site to create
intron Tth-5’P-α.  Like its parent introns, Tth-5’P-α was able to trans-ingrate into
yeast strain NOY505GalΩT, indicating that the Ppo.L1925 5’ end sequence is
compatible with intron splicing.  β-galactosidase assays of yeast crude extracts
showed 80 U of activity, almost a tenfold increase over the 10 U of activity exhibited
by Tth-α (Figure 4.10 A).
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Figure 4.8:  Comparison of the 5’ end sequences of Ppo.L1925 and Tth-α.  A.
An alignment of the Ppo.L1925 and Tth-alpha 5’ ends.  Green bases indicate
positions where there are differences in the nucleotide sequence.  The orange bases
indicate the ORF start codon.  B.  The 5’ end secondary structure.
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Figure 4.9:  The P1 regions of Tth-α and Tth-5’P-α. Tth-5’P-α nucleotides
changed from Tth-alpha are shown in red and nucleotides composing the ClaI sites
are shown in blue.  Intron sequence is in caps while the 5’ exon sequence is in
lower case.
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The 5’P sequence might interact with the 3’UTR . To test this hypothesis, I
cloned the α-3’UTR sequence from Tth-αUTR into the ClaI site of Tth-5’P-ClaI to
make intron Tth-5’P-αUTR (Figure 4.10 B).  Yeast cells with integrated Tth-5’P-
αUTR exhibited only 3 U of β-galactosidase activity.  Thus, the 3’UTR sequence
strongly down regulates expression from Tth-5’P-αUTR.
As documented earlier in this chapter, the Physarum HEUTR sequences
recovered from Jue Lin’s randomization experiment do not increase expression from
Tth-α as they do in Ppo-α.  It is possible that those sequences could function in an
intron with the 5’P sequence. To create the introns to test this, I cloned the α-UTR
fragment from the appropriate Tth-αHEUTR intron into the ClaI site of Tth-5’P-ClaI
to make introns Tth-5’P-αΗΕUTR A, B, and C, respectively (Figure 4.10).  Yeast
cells with these introns integrated exhibited higher of β-galactosidase activity than
those with the corresponding 5’P-lessTth-α-HEUTR intron.  The HEUTR intron with
the highest activity, Tth-5’P-alpha-HEUTR B, exhibited 30 U of activity, nearly
tenfold more than the 5’P-lacking Tth-α-HEUTR B intron.  However, this is still
under half of the activity of the UTR-lacking Tth-5’P-α and these introns did not
exhibit the very high levels of activity seen from the Ppo-αHEUTR introns,
suggesting that the HEUTR sequences do not functionally interact with the 5’ end in
Ppo-α.  Instead, it seems that all the 3’UTR sequences lower expression, both from
Tth-α and from Tth-5’P-α introns.
Does the 5’P sequence increase expression of other chimeric introns besides
Tth-α?  The 5’ end sequence could be interacting with the α ORF to increase
expression, even though there are no obvious regions where base-pairing could occur.
On the other hand, perhaps the 5’ ends sequence is interacting with downstream
ribozyme sequences that a larger inserted ORF would discourage it from finding.  In
order to address this question, I created intron Tth-5’P-His3HA by cloning the
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His3HA fragment of Tth-His3HA into the ClaI site of Tth-5’P-ClaI (Figure 4.11 A).  I
prepared total protein extracts from yeast with integrated Tth-His3HA and Tth-5’P-
His3HA introns and compared them on a western blot (Figure 4.11 B).  The 5’ end
sequence did not cause Tth-5’P-His3HA to produce more His3HA protein; instead the
levels of His3HA were similar.  Because of this result, I chose to continue work with
Tth-alpah5’P to attempt to determine how the 5’ end increases expression from that
intron.
Use of a randomization approach to study the intron 5’ end in expression of chimeric-
Tth.L1925 introns
I decided to utilize a randomization approach, similar to that used previously to
study the 3’ UTR (Lin and Vogt 2000), to obtain a greater understanding of how the 5’
end sequences affects splicing.  In this approach a pool of Tth-5’P-α introns is created
with a random nucleotide sequence at the 5’ end.  This pool is then trans-integrated
into yeast and individual colonies are screened for β-galactosidase activity through
growth on plates containing X-gal.  This initial screen allows an estimation of the
percentage of 5’ end sequences that cause high, low, or no expression.  If the majority
of 5’ end sequences cause Ppo-5’P-α-like expression levels, the majority of yeast
screened should exhibit a dark blue phenotype.  If increased expression requires
sequences similar to the 5’P sequence, the majority of yeast should be light blue or
white, and a dark blue phenotype should be rare.  After the initial screen, individual
dark blue, light blue, and white yeast colonies can be picked, their introns sequenced,
and the β-galactosidase expression levels determined quantitatively.  The sequences
can then be analyzed for any motifs that might be associated with high or low
expression levels.
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Figure 4.11:  Tth-5’P-His3HA.  A.  Schematic representation of the Tth-His3HA
and Tth-5’P-His3HA introns. Red letters in the second and third columns indicate
the nucleotides that are not shared between introns.  B.  Western blot analysis of
whole protein extracts from intron-containing NOY505GalΩT.  Lane 1, no intron,
25 µg total protein, Lanes 2-4, Tth-His3HA 25 µg, 6.25 µg, and 2.5 µg total
protein, respectively, and Lanes 5-7, Tth-5’P-His3HA 25 µg, 6.25 µg, and 2.5 µg
total protein, respectively
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I decided to examine a pool of introns, called Tth-5’P-α-ran, with eight
randomized nucleotides at Ppo-5’P-α positions 4-11 (Figure 4.12).  The sequence
complexity of this pool is 65,536, and hence only a small fraction of the different
sequences could be analyzed. The first three nucleotides of the intron were left
constant as they are involved in the P1 stem and changing them could negatively
impact splicing.
The process used to create this pool is outlined in Figure 4.13.  The
intron pool was made by combining a pool of intron 5’ end fragments with
randomized fragments created through PCR with a plasmid encoding a version of the
Tth-5’P-a intron which had its 5’ end replaced with the kanamycin resistance gene,
Kan.  The randomized PCR fragment was then cloned into the plasmid to replace the
Kan stuffer fragment.  To estimate the number of unique introns encoded by the
plasmid pool, I plated small aliquots of the E. coli transformation on 2YT+Amp plates
and counted the resulting colonies.  From these plates, the size of the plasmid pool was
estimated to be roughly 50,000-100,000 unique transformants, which means that the
pool should contain most of the possible 65,536 sequences.  Additionally, the Kan
stuffer fragment allows the estimation of the amount of uncut or relegated vector in
the plasmid pool, as E. coli containing these plasmids are resistant to Kan, while E.
coli containing one of the Tth- 5’P-α-ran plasmids are not.  By plating small aliquots
of the E. coli transformation on 2YT +Amp +Kan, I estimate that 9% of the plasmids
still contained the Kan stuffer fragment.  This is an acceptable number, as it means the
majority of plasmids in the pool contain Tth-5’P-α-ran introns.  As a last check of the
integrity of the plasmid pool, I had a small aliquot of the pool sequenced.  The
electropherogram indicated roughly equal concentrations of A, C, G, and T at
positions 4-11, implying that there was no large sequence bias in the plasmid pool.
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Figure 4.12:  Randomization of the Tth-5’P-α 5’ end.  Nucleotides in green are
randomized in the Tth-5’Palpha-ran pool.  Nucleotides involved in forming the P1
stem were unchanged to prevent disruption of intron splicing.  The mutation that
disrupts the 3’ ClaI site is shown in orange.  Nucleotides composing the ClaI sites
are shown in blue.  Intron sequence is in caps while the 5’ exon sequence is in
lower case.
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Figure 4.13:  Process for creating a pool of yeast cells with integrated Tth-5’P-
α-ran introns.
Ligation Mixture
Transform into E. coli
Plate on Amp + Kan to determine % of
plasmids containing stuffer
Result:  ~9% of plasmids contained the stuffer
Plate on Amp to determine the size of
randomized plasmid pool
Result:  ~50,000-100,000 total transformants
Plasmid Prep and Transform into NOY505GalΩT
Pick individual colonies and patch
on SG + X-Gal plates
Count number of colonies
that were:
Dark Blue:  238
Light Blue:  248
White:  484
Pick some colonies,
sequence and perform
ONPG assays
Wash yeast of plates and grow 100 ml O/N in liquid
SD media.  Plate overnight  culture on SG media.
Plate on SD to determine  number of
transformed yeast
Result: ~6,000 transformants
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Confident that the plasmid pool contained a good representation of the possible Tth-
5’P-α-ran sequences, I trans-integrated the Tth-5’P-α-ran pool into yeast, for which it
was necessary to modify some of the procedures.  The first step of trans-integration,
co-transformation of the Tth-5’P-α-ran plasmid pool and pCpIPpo, was unchanged.  I
transformed yeast strain NOY505GalΩT and plated potential transformants on SD
–His -Ura media.  Counting the colonies on these plates revealed that there were
~6,000 yeast transformants.  If I were trans-integrating a single intron, at this point I
would have picked a single colony and streaked it on SG –His –Ura media to induce I-
PpoI production.  Since I wanted to trans-integrate all of ~6,000 introns in the
individual colonies, I washed the yeast off of the SD plates, pooled them, incubated
them in liquid SD media over night, and then plated them on SG –His –Ura media.
Each yeast colony growing on the resulting plates should contain one of these ~6,000
introns or an I-PpoI resistance mutation.
To screen the level of β-galactosidase activity of introns from the pool, I
picked ~1000 individual colonies, patched them on SG+X-gal plates and then scored
the patches as either white, light blue, or dark blue.  Of the scored colonies, 238 were
dark blue, 248 were light blue, and 482 were white, implying that a large number of 5’
end sequences achieve Tth-5’P-α levels of expression.
About ~25% of the 5’ end sequences exhibited a high expression phenotype.
In order to link individual sequences to levels of expression, I picked 21 individual
colonies, PCR-amplified and sequenced their introns, and, in addition, conducted β-
galactosidase activity assays on them.  The results of the sequencing and β-
galactosidase assays are shown in Figure 4.14.  Many of the sequences are AT rich,
although no obvious common motif is associated with either high or low expression.
β-galactosidase activity ranges from 250 U, more than double that of Tth-5’P-α, to
137
Figure 4.14:  Tth-5’P-α-ran intron 5’ end sequence and β-galactosidase
activity. Red letters in the second column indicate the wild type Tth-5’P-α
sequence and green letters in the second column indicate nucleotides in the
randomized region.  Red letters in the third column indicate the nucleotides that are
not shared between Tth-α and Tth-5’P-α.
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1 U, which is only slightly above the background activity seen yeast with no integrated
introns.  A few (Tth-5’P-α-ran 2, 12, and 14) have only seven nucleotides instead of
eight in the randomized region.  This may be due to errors in the synthesis of the 3’
oligonucleotide used as a primer to make the introns.  Having one less nucleotide in
the randomized region has no noticeable effect on expression.
To determine if there is a specific folding motif, I analyzed high and low
expressing sequences using two RNA secondary structure prediction programs,
Kinefold (Xayaphoummine, Bucher et al. 2005) and RNAfold from the Vienna
software package (Gruber, Lorenz et al. 2008).  Since the Kinefold program has a 400
nucleotide limit, it could only be used to examine the P1 stem and the α ORF, while
the RNAfold program, which has a 10,000 nucleotide limit, could be used to examine
both the P1 stem and the α ORF and the entire intron sequence.  I examined five high
expressing intron (Tth-5’P-α and Tth-5’P-α ran 1-4) and five low expressing intron
(Tth-α and Tth-5’P-α ran 15-18) sequences.  The analysis focused on three structural
factors that could be influencing levels of translation: if they shared folding motifs, if
the 5’ end of the intron was involved in a structure, and if the α start codon was
involved in a structure.
My examination of the folds predicted by these programs found that no
common structures that correlate with high or low expressing sequences (data not
shown).  Indeed, several of the secondary structures predicted by RNAfold are shared
between high and low expressing introns.  There is also no correlation between
expression levels and base pairing of the intron 5’ end or the α start codon, two factors
that could potentially allow or prevent access to the ribosome.
Since no sequence or structural motif could be linked to either high or low
expression, I decided to examine the state of the intron RNA for clues that would
explain the differences in expression between the introns.  It seemed possible that the
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new 5’ end sequence might play a role in RNA stability, either by prevent processing
or by inhibiting RNA degradation.  I performed a northern blot on total RNA isolated
from eight of the yeast strains containing Tth-5’P-α-ran introns (Figure 4.15).  No
differences were observed between the intron RNAs.  All of the intron RNAs showed
processing at IPS3 and at IPS1 or IPS2 (or both). Since experiments with Ppo.L1925
found that preventing IPS1 processing increased expression only four-fold (Lin and
Vogt 1998), it seems unlikely that a lack of processing at IPS1 or IPS2 is the source of
the high levels of expression seen for some of the Tth-5’P-α-ran introns.  Differences
in the levels of full-length spliced intron RNA also do not appear to be the source of
differences the amount of α-fragment produced.  Figure 4.16 depicts a comparison of
the amount of full-length intron RNA, normalized by the amount of small ribosomal
subunit RNA in each sample.  These strains showed less than a four-fold difference in
this number, with no correlation between the amount of full-length RNA and β-
galactosidase activity.  Thus, levels of full-length RNA and the extent of processing do
not explain the differences in expression among these introns.
As an additional test, I examined if changing the Tth-α 5’ end sequence,
without the 5’P changes, could produce similar increases in β-galactosidase activity.
Again, a randomization strategy was used to create Tth-α-ran, a pool of introns with
randomized Tth.L1925-like 5’ ends. The Tth.L1925 5’ end is smaller than the 5’P
sequence, with only four positions to randomize (Figure 4.17).  Thus, the maximum
number of possible introns in the pool was only 256.  To make the Tth-α-ran pool, I
followed a process similar to the one used to make the Tth-α-5’P pool. I picked 24
individual colonies, performed β-galactosidase assays on them, and sequenced the
introns from eight (Figure 4.18).  All 24 yeast strains exhibited levels of β-
galactosidase activity similar to Tth-α, and none of the introns exhibited the high
levels of expression seen from some of the Tth-5’P-α-ran introns.  This result suggests
141
Figure 4.15:  Northern blot of Tth-5’P-α-ran intron RNA.  The top northern
blot was probed with an in vitro transcribed radiolabeled RNA that is
complementary to the Tth-α sequence.  The bottom blot was probed with an in
vitro transcribed radiolabeled RNA that is complementary to the yeast small
ribosomal subunit sequence to serve as a loading control.   Lane 1:  0.1 µg of in
vitro transcribed Tth-α RNA.  Lane 2-10:  2.5 µg of Total RNA isolated from a
NOY505GalΩT strain with the listed intron integrated into the rDNA.
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Figure 4.16:  Full-length intron RNA levels normalized by comparison with
SSU RNA levels.  RNA levels were taken from figure 4.15.  The β-galactosidase
activity of each intron is noted below their respective column.
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Figure 4.17:  Randomization of the Tth-α 5’ end.  Nucleotides in green are
randomized in the Tth-α-ran pool. The mutation that disrupts the 3’ ClaI site is
shown in orange.  Nucleotides composing the ClaI sites are shown in blue.  Intron
sequence is in caps while the 5’ exon sequence is in lower case.
145
U A G C U A
G
A
A A A u c u c u c
C
U
U U U G G A G G G
A U C G A U U
A
C
C
5 ’
 S
S
A 
A 
A 
A
P1
5’
3 ’
T
th
-α
U A G C U A
A A A u c u c u c
U U U G G A G G G
U U C G A U U
A
C
C
5 ’
 S
S
A 
A 
A 
A
P
1
5’
3 ’
N
N
N
N
O
R
F
O
R
F
T
th
-α
-r
an
146
β-
ga
l α
3’
 r
ib
oz
ym
e 
(T
th
.L
19
25
)
IP
po
IP
po
C
la
I
C
la
I
10
UA
CC
U U
U G
GA
GG
G
AA
AU
AG
C
T
th
- α
5
UA
CC
U U
U G
GA
GG
G
AA
AA
UA
C
T
th
- α
-r
an
 2
17
UA
CC
U U
UG
GA
GG
G
AA
AC
AG
A
T
th
- α
-r
an
 3
19
UA
CC
U U
UG
GA
GG
G
AA
AC
CC
U
T
th
- α
-r
an
 4
13
UA
CC
U U
U G
GA
GG
G
AA
AA
UC
U
T
th
- α
-r
an
 5
11
UA
CC
UU
U G
GA
GG
G
AA
AG
CU
C
T
th
- α
-r
an
 6
7
UA
CC
U U
U G
GA
GG
G
AA
AU
AG
U
T
th
- α
-r
an
 7
4
UA
CC
U U
U G
GA
GG
G
AA
AA
CA
G
T
th
- α
-r
an
 8
16
UA
CC
U U
U G
GA
GG
G
AA
AC
AC
U
T
th
- α
-r
an
 1
In
tr
on
Se
qu
en
ce
 (
5’
 e
nd
)
Se
qu
en
ce
 (
P1
’)
β -
ga
la
ct
os
id
as
e 
ac
tiv
ity
 (
U
)
F
ig
ur
e 
4.
18
: 
 T
th
-α
-r
an
 in
tr
on
 5
’ 
en
d 
se
qu
en
ce
 a
nd
 β
-g
al
ac
to
si
da
se
 a
ct
iv
it
y.
  R
ed
 le
tte
rs
 in
 th
e 
se
co
nd
 c
ol
um
n 
in
di
ca
te
 th
e
w
ild
 ty
pe
 T
th
-α
 s
eq
ue
nc
e 
an
d 
gr
ee
n 
le
tte
rs
 in
 th
e 
se
co
nd
 c
ol
um
n 
in
di
ca
te
 n
uc
le
ot
id
es
 in
 th
e 
ra
nd
om
iz
ed
 r
eg
io
n.
  R
ed
 le
tte
rs
 in
th
e 
th
ir
d 
co
lu
m
n 
in
di
ca
te
 th
e 
nu
cl
eo
tid
es
 th
at
 a
re
 n
ot
 s
ha
re
d 
be
tw
ee
n 
T
th
-α
 a
nd
 T
th
-5
’ P
- α
.
147
β-
ga
la
ct
os
id
as
e 
ac
tiv
ity
 (
U
)
Se
qu
en
ce
 (
P1
’)
Se
qu
en
ce
 (
5’
 e
nd
)
In
tr
on
4
UA
CC
UU
U G
GA
GG
G
N
ot
 s
eq
ue
nc
ed
T
th
- α
-r
an
 2
4
9
UA
CC
U U
UG
GA
GG
G
N
ot
 s
eq
ue
nc
ed
T
th
- α
-r
an
 2
3
13
UA
CC
UU
U G
GA
GG
G
N
ot
 s
eq
ue
nc
ed
T
th
- α
-r
an
 2
2
12
UA
CC
UU
UG
GA
GG
G
N
ot
 s
eq
ue
nc
ed
T
th
- α
-r
an
 2
1
8
UA
CC
U U
UG
GA
GG
G
N
ot
 s
eq
ue
nc
ed
T
th
- α
-r
an
 2
0
11
UA
CC
U U
UG
GA
GG
G
N
ot
 s
eq
ue
nc
ed
T
th
- α
-r
an
 1
9
8
UA
CC
UU
UG
GA
GG
G
N
ot
 s
eq
ue
nc
ed
T
th
- α
-r
an
 1
8
14
UA
CC
U U
UG
GA
GG
G
N
ot
 s
eq
ue
nc
ed
T
th
- α
-r
an
 1
7
14
UA
CC
U U
U G
GA
GG
G
N
ot
 s
eq
ue
nc
ed
T
th
- α
-r
an
 1
6
10
UA
CC
U U
U G
GA
GG
G
N
ot
 s
eq
ue
nc
ed
T
th
- α
-r
an
 1
5
11
UA
CC
U U
U G
GA
GG
G
N
ot
 s
eq
ue
nc
ed
T
th
- α
-r
an
 1
4
10
UA
CC
U U
U G
GA
GG
G
N
ot
 s
eq
ue
nc
ed
T
th
- α
-r
an
 1
3
14
UA
CC
U U
U G
GA
GG
G
N
ot
 s
eq
ue
nc
ed
T
th
- α
-r
an
 1
2
4
UA
CC
U U
U G
GA
GG
G
N
ot
 s
eq
ue
nc
ed
T
th
- α
-r
an
 1
1
8
UA
CC
U U
U G
GA
GG
G
N
ot
 s
eq
ue
nc
ed
T
th
- α
-r
an
 1
0
F
ig
ur
e 
4.
18
 (
C
on
ti
nu
ed
):
  T
th
-α
-r
an
 in
tr
on
s 
10
-2
4 
w
er
e 
no
t s
eq
ue
nc
ed
.  
R
ed
 le
tte
rs
 in
 th
e 
th
ir
d 
co
lu
m
n 
in
di
ca
te
 th
e 
nu
cl
eo
tid
es
th
at
 a
re
 n
ot
 s
ha
re
d 
be
tw
ee
n 
T
th
-α
_a
nd
 T
th
-5
’ P
- α
.
148
that the 5’P sequence is able to modify expression of intron-encoded ORFs in a way
that the native Tth-α 5’ end is not, although how the 5’P sequence modifies translation
remains unknown.
Discussion
Role of the 3’UTR
The results detailed in this chapter, summarized in Figure 4.19, show that
intron sequences can influence expression levels from chimeric Tth.L1925 introns.
The Ppo.L1925 3’UTR sequence has a constant effect on expression from chimeric
Tth.L1925, as every intron made with a UTR sequence expressed at a lower level than
the corresponding UTR-less intron.  Expression from Tth-α is reduced slightly, with
Tth-αUTR producing half the amount of β-galactosidase activity.  The effect of the
3’UTR is more striking when it is added to the highly expressing Tth-5’P-α, which it
reduces nearly twenty fold.  Interestingly, the ability of the 3’UTR sequence to lower
expression appears to be dominant over the ability of the 5’ end to increase expression,
as the Tth-αUTR and Tth-5’P-αUTR introns express at the same level.
The HEUTR sequences, which dramatically increase the expression in Ppo-α
introns, have a similar inhibitory effect on Tth-α expression as the 3’UTR sequence.
All of the three HEUTR sequences tested decrease levels of expression in both Tth-α
and Tth-5’P-α introns.  The fact that adding the 5’P sequence to the Tth-α-HEUTR
introns does not increase expression suggests that, in Ppo-α, the 5’P sequence is not
involved in the HETUR increase in expression or, if the 5’P sequence is involved,
additional Ppo.L1925 sequences are required to increase expression.
Role of the 5’ end
The intron 5’ end sequence appears to have a large influence on levels of
translation from Tth-α.  Adding the Physarum 5’P sequence to Tth-α increases
expression from the intron nearly ten-fold.  This increase does not require the exact
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 5’P sequence, as one quarter of the introns in the Tth-5’P-α-ran pool increased
expression by a similar amount (or more).  It is unclear how the 5’ end sequences are
influencing translation since no consensus sequence that increases expression is
apparent.  Although high expressing introns from the Tth-5’Pα-ran pool tend to be AT
rich, the first four bases of the original Tth-5’Pα sequence is a string of Cs.  Stop
codons in the 5’ end sequence do not diminish activity either.  While the last two
nucleotides of the 5’ end sequence of Tth-5’α-ran 16 and Tth-5’α-ran 17, two of the
weakly expressing introns, form a UAA stop codon when combined with the first
nucleotide beyond the randomized sequence, high-expressing Tth-5’α-ran 1 contains
the same UA sequence at positions 7 and 8.  Two other high expressers, Tth-5’α-ran 2
and Tth-5’α-ran 9, contain UAA stop codons at other positions with no apparent
reduction of translation.  Both Tth-5’α-ran 16 and Tth-5’α-ran 17 contain out of frame
start codons, so perhaps the low β-galactosidase activity from these introns could be
explained by translation starting at these codons.  This model does not explain, the low
β-galactosidase activity of other Tth-5’α-ran introns that lack start codons in the
randomized sequence.
In silico secondary structure prediction of high expressing and low expressing
intron sequence produced similar contradictory results.  There is no predicted
secondary structure motif common to either high or low expressing introns.  Since the
ribosome needs to access the start codon to begin translation, I hypothesized that the
predicted structures of high expressing introns would have α start codons that were
not base paired.  This is not the case, as the all of the predicted structures have at least
one base of the start codon involved in a pair, and several of the high expressing
sequences have all three bases paired.  Structures of low expressing sequences also
have a mixture of partially- and fully-paired start codons.
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The hypothesis that interactions between the 5’ end sequence and the α or
ribozyme sequence allow the ribosome access to the α ORF is also not supported by
the predicted structures.  Individual intron 5’ ends are unpaired, interact with other
sequences close to the 5’ end to forming a short stem loop, interact with sequences
near the 3’ end of the α ORF to extending the P1’ stem, or interact with sequences at
the 3’ end of the intron.  There is no correlation between any of the 5’ end interactions
and expression level of the intron.
It is also difficult to explain why all of the introns from the Tth-α-ran pool had
levels of expression similar to Tth-α, while introns from the Tth-5’P-α-ran pool had
varied levels of expression.  Neither of the two obvious differences between the
introns in these two pools, the slightly longer length of the Tth-5’P-α-ran 5’ end and
the differences in the P1 stem downstream of the ORF (Figure 4.9), provides an
explanation for differences in activity.  There is no correlation with 5’ end length and
expression levels, as individual introns from the Tth-5’P-α-ran pool, all of which have
a longer 5’ end than the Tth-α-ran pool introns, have both lower and higher expression
levels than the Tth-α-ran introns.  The same is true for the downstream P1 sequences
possessed by all Tth-5’P-α-ran introns and lacked by the Tth-α-ran introns.
In contrast to its effect on Tth-5’Pα, adding the Ppo.L1925 5’ end sequence
had little effect on Tth-His3HA. The 5’ end might need to interact with sequences in
the α ORF, or the I-PpoI sequences at the 5’ and 3’ ends of the ORF, to increase
expression.  The length of the His3HA ORF could also prevent interactions between
the 5’ end and sequences in the ribozyme.  Lastly, sequences in His3HA could interact
with that the 5’ end thereby preventing it from increasing translation.  For example,
His3HA nucleotides 64-84, 5’-UUUAAAGGGTG-3’, could interact with the 5’ end
sequence of 5’-CACCCCCUUAA-3’.
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Neither the 3’UTR nor 5’ end sequence influenced processing of chimeric Tth-
α introns.  All of the Tth-α introns, including those that have no 3’UTR sequence,
processed at the same three sites, IPS1, IPS2, and IPS3.  Two of these sites, IPS1 and
IPS2, match the processing sites of the same name in Ppo.L1925.  The fact Tth.L1925
introns lacking the 3’UTR sequences still processed at these sites implies that the
3’UTR may not be involved in processing in Ppo.L1925, even though the 3’ end of the
3’UTR is defined by processing.
In summary, intron sequences do play a large role in the levels of expression
from chimeric Tth.L1925 introns.  Adding the Ppo.L1925 3’UTR sequence to Tth-α
or Tth-5’P-α lowered expression levels from both introns.  None of the HEUTR
sequences increased expression in the Tth-α, or Tth-5’P-α contexts as they do in Ppo-
α.  Instead, the HEUTR sequences also lowered expression levels from those introns.
I found that the 5’ end sequence, on the other hand, could greatly increase expression
from Tth-α.  Addition of the 5’P sequence to Tth-α increased α expression almost ten
fold and the screen of Tth-5’P-α introns with randomized 5’ end sequences showed
that one quarter of 5’P-like 5’ ends exhibited this high level of expression.
Randomization of the Tth-α 5’ end, without the 5’P sequence, showed that none of the
possible Tth.L1925-like 5’ end sequences could increase expression in a similar way.
It is unclear how these sequences are modifying expression, although they could be
promoting the formation of a highly-translated intron species or interactions with yeast
factors that promote translation.
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Chapter V
Investigation of the Mechanism of Translation of Chimeric Tetrahymena Intron-
Encoded ORFs
Introduction
Changing the sequence 5’ and 3’ of an intron-encoded ORF can increase or
decrease the expression of a Ppo.L1925- or Tth.L1925-encoded ORF.  The mechanism
by which these sequences act, however, is unclear.  High-expressing intron sequences
do not appear to affect protein levels by changing the rate of splicing, by changing the
position of processing sites, by altering the levels of full-length intron RNA, or by
stabilizing the intron RNA molecule.  Alternative models explaining the effect of these
sequences include promoting interaction of the intron RNA with cellular translation
machinery or promoting the formation of an intron structure necessary for translation.
One model for translation of intron-encoded ORFs is that they use internal
ribosome entry sites (IRES), which promote translation in a cap-independent manner.
This model is attractive for intron RNA translation as spliced introns are also cap-less.
At least two well-characterized IRES elements have been documented in yeast, the
URE2 IRES and the invasive growth IRES.  The URE2 IRES forms a 25 nucleotide
long stem topped with a 24-nucleotide loop (Reineke, Komar et al. 2008).  Since this
74-nucleotide sequence is much longer than the intron 5’ end, it is unlikely that the
intron sequence is mimicking the URE2 IRES.  The invasive growth IRES, on the
other hand, could be mimicked by the intron 5’ end sequences, as both elements are
characterized by short (~12 nucleotide) unstructured poly-A stretches directly
upstream of the respective ORF start codon (Figure 5.1 A) (Gilbert, Zhou et al. 2007),
and many of the high-expressing introns from the Tth-5’P-α-ran pool had A-rich 5’
end sequences.
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It is also possible that the full-length intron RNA must undergo a post-splicing
reaction in order to serve as a viable message (Figure 5.1 B).  Cleavage at internal
processing sites does not appear to promote translation, but the role of full-length
intron circles has not been examined (Lin and Vogt 1998). These RNA circles might
mimic the circular complexes that mRNAs form through interactions between the cap
binding complex and poly-A binding proteins. The high expressing introns could be
forming intron circles at higher levels or at different junctions to increase translation
levels.
Results
Translation levels of Tth.L1925-encoded ORFs are constant throughout the yeast cell
cycle.
Before investigating specific models, I examined if expression from Tth-α and
Ppo-α changed during growth.  Several instances have been described in which the
population of intron RNAs changes depending on the growth state of the cell.  For
example, Dir.S951-1, an intron naturally found in the slime mold Didymium iridis,
produces an additional RNA species in encysted cells that is not found in amoeboid or
flagellate cells (Figure 5.2) (Vader, Johansen et al. 2002).  In Didymium, the freshly-
transcribed, unprocessed rRNA (the pre-rRNA) encodes both the small ribosomal
subunit RNA (SSU) and the large ribosomal subunit rRNA (LSU).  In growing
Didymium cells, which can be amoebae or flagellates, Dir.S951-1 catalyzes its
removal from the pre-RNA and then proceeds to go through a series of processing
steps.  In encysted Didymium, however, Dir.S951-1 processes internally before
splicing itself out of the pre-rRNA; this results in the accumulation of a 7.5 kb RNA
that includes the 3’ half of Dir.S951-1, the SSU rRNA, the LSU rRNA, and a spacer
rRNA that lies between the SSU and LSU.  The biological role of this 7.5 kb RNA is
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Figure 5.2:  Splicing pathways of Dir.S956-1 vary depending on cellular
growth stage.  A.  The Didymium pre-rRNA.  B.  In Didymium amoeba,
flagellates, and cysts, GIR2 splices the Dir.S956-1 intron RNA out of the
surrounding RNA, and the intron RNA is processed by GIR1, which is responsible
for the 5’ cleavage, and cellular factors, which are responsible for the 3’ cleavage.
C.  In encysted Didymium, there is an alternate processing pathway.  GIR1 cleaves
5’ of the intron-encoded ORF and the two spliceosomal introns are removed from
the LSU to create a 7.5 kb RNA.
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 unclear, but since it does contain the homing endonuclease ORF, it could act as a
source of homing endonuclease for the encysted cell.
I decided to examine if expression of intron-encoded ORFs is influenced by
the growth stage of their host yeast cell. I grew 200 ml cultures of NOY505GalΩT
yeast with no intron, Tth-α, Ppo-α, and Ppo-α-HEUTR A, and then periodically
performed β-galactosidase assays (Figure 5.3).  All of the yeast strains had
comparable doubling times and β-galactosidase levels were consistent throughout all
stages of growth.  These results rule out the possibility that growth-stage specific
factors are affecting the translation of the intron-encoded ORF.
The YMR181c IRES sequence does not increase expression of Tth.L1925-encoded
ORFs.
S. cerevisiae cells have two growth forms, a vegetative form and an invasive
(or filamentous) form (Gimeno, Ljungdahl et al. 1992).  The vegetative form is
characterized by round cells, while the invasive form is characterized by elongated
cells that clump together in liquid culture and penetrate the surface of agar plates.  The
carbon source available to the yeast determines which of these forms the cells take;
yeast grows vegetatively on glucose-containing media and invasively on media with
other carbon sources, such as galactose (Palecek, Parikh et al. 2002).  Yeast cells that
have been grown on glucose and then switched to glucose-lacking media respond by
undergoing a number of sudden changes.  Translation stops immediately (within 1
minute) through a 5’ decapping enzyme-dependent process, which likely involves the
decapping of the majority of mRNA, and the cells then transition to invasive growth,
which requires the cells to undergo a number of structural changes (Ashe, De Long et
al. 2000; Cullen and Sprague 2000).  An inherent contradiction exists between these
two responses, as translation is required to produce the factors necessary for the switch
to invasive growth.  Yeast  has solved this conflict through the invasive growth IRES
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Figure 5.3:  The β-galactosidase activity of intron-containing yeast strains
through out growth.  A.  Growth curve of Noy505GalWT, Noy505GalWT/Tth-α,
Noy505GalWT/Ppo-α, and Noy505GalWT/Ppo-αHEUTR A.  Cells were grown in
YEPG media shaking at 30˚C.  Aliquots were taken at time points 1-7 and tested
for b-galactosidase activity (shown in B).
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sequence.  This sequence, found upstream of the genes required for invasive growth,
allows for translation of these genes during the starvation-induced translation
shutdown (Gilbert, Zhou et al. 2007).  These IRES sequences have been shown to
operate in a poly-A binding protein (PABP)-dependent manner and likely initiate
translation by recruiting PABP, which in turn recruits initiation factors or the 60S
ribosomal subunit independently of the 5’ cap binding protein.
One possible model for expression of intron-encoded ORFs is that that capless
intron RNA acts like an invasive growth gene that has an IRES.  Higher expressing
introns could have sequences better at mimicking the invasive growth IRES than
lower expressing introns.  To address this possibility, I made a chimeric Tth-α intron
containing the invasive growth IRES from YMR181c, an invasive growth gene that is
translated from the second message of a bicistronic mRNA (He, Li et al. 2003; Suzuki,
Hori et al. 2003).  The YMR181c IRES sequence contains an unstructured poly-A
tract, AACAAAAAAAAA, directly 5’ of the start codon.  This sequence has been
shown to act as an IRES both in vitro and in vivo , and deleting this sequence or
replacing it with its reverse complement, UUUUUUUUUGUU, abrogates IRES
activity (Gilbert, Zhou et al. 2007).  If the high-expressing introns are mimicking the
invasive growth IRES sequences, a Tth-α intron containing the IRES sequence should
express at a higher level than an intron without it.
To determine if the IRES sequence has an effect on expression from Tth-α, I
constructed three introns: Tth-αHA, Tth-IRES-αHA and Tth-RCIRES-alpahHA
(Figure 5.4).  Tth-αHA has an unmodified (Tth-α-like) 5’ end, Tth-IRES-αHA has the
YMR181c IRES sequence directly 5’ of the α start codon, and Tth-RCIRES-αHA has
the reverse complement of the YMR181c IRES sequence.  Since it could be useful to
track expression of the intron-encoded ORF without relying on expression of the Ω
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fragment, I added a double HA tag to the C-terminus of the α sequence.  The Tth-
αHA intron serves as a control to ensure that the HA tag sequence does not influence
expression or splicing.  Unfortunately, attempts to visualize the αHA product through
western blot were unsuccessful, possibly due to the small size of the α fragment (data
not shown). However, after trans-integrating these introns into NOY505GalΩT, I
found the β-galactosidase activity of Tth-αHA to be 7 U.  This level is similar to that
of Tth-α, which suggests that the HA tag sequence does not interfere with splicing,
translation, or α-complementation.
Since yeast cells with galactose as the only carbon source grow invasively, the
IRES sequences should be active in yeast growing in the media necessary to induce Ω
fragment expression from NOY505GalΩT.  If the Tth-α introns mimic invasive
growth IRESs, Tth-IRES-α should exhibit higher β-galactosidase activity than Tth-
RCIRES-α in invasively growing yeast.  However, I found that in fact both Tth-IRES-
αHA and Tth-RCIRES-αHA exhibit similar levels of β-galactosidase activity, 16 U
and 20 U, respectively.  This activity is slightly higher than Tth-αHA but is not at the
extreme levels seen for the Tth-5’P-α-ran or Ppo-α-ran introns.  The similarity
between the levels of β-galactosidase activity of these two introns suggests that Tth-α
intron RNAs are not translated by mimicking invasive growth IRES sequences.
Chimeric Tth.L1925 introns form several species of RNA circle
A second model for translation of intron-encoded ORFs involves the
circularization of the intron RNA.  During translation initiation of an mRNA, the poly-
A binding proteins associate with the cap-binding complex, causing the mRNA to
form a circle-like structure (Imataka, Gradi et al. 1998; Kessler and Sachs 1998).  It
could be that circular intron RNA is translated by somehow mimicking the pre-
initiation mRNA.  Intron 5’ end and 3’UTR sequences could affect translation both by
influencing the rate of circle formation or the junction at which the circles form.  This
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model also allows for 3’UTR sequences to influence translation by recruiting initiation
factors, since in a circular RNA the 3’UTR would be upstream (as well as
downstream) of the intron-encoded ORF.
Group I introns form two major species of RNA, full-length and internal guide
sequence (IGS) circles (Zaug, Grabowski et al. 1983; Been and Cech 1986; Been and
Cech 1987).  Full-length circles are the result of an attack of the intron 3’ end between
the exogenous 5’ G and the first nucleotide in the intron sequence resulting in a circle
that contains the entirety of the intron sequence (Been and Cech 1986; Inoue, Sullivan
et al. 1986; Nielsen, Fiskaa et al. 2003).  This circle can re-linearize through a repeat
of the first step of splicing; the intron ribozyme binds an exogenous G, which attacks
at the circle junction between the 5’ and 3’ ends of the intron.  Since the full intron
sequence is preserved in full-length introns circles, a single spliced intron RNA could
go through multiple circularization and un-circularization events.  The second type of
intron circle, an IGS circle, is the result of an attack of the intron 3’ end in, or near, the
IGS (Zaug, Grabowski et al. 1983; Been and Cech 1986; Been and Cech 1987).
Tth.L1925 has been shown to form full-length circles in vitro, but not in vivo,
as well as two distinct IGS circles both in vitro and in vivo (Figure 5.5) (Been and
Cech 1986; Been and Cech 1987; Nielsen, Fiskaa et al. 2003).  The major Tth.L1925
IGS circularization product results from of an attack between nucleotides 14 and 15,
while a minor product results from an attack between nucleotides 19 and 20.  The
circle species formed by Ppo.L1925 have not been as thoroughly studied as those of
Tth.L1925, but Ppo.L1925 is known to produce full-length circles in vitro (Nielsen,
Fiskaa et al. 2003).  It is logical to expect that chimeric Tth.L1925 introns will form
circles in vivo, although it is unclear if they form Tth.L1925-like IGS circles or
Ppo.L1925-like full-length circles.
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Figure 5.5:  Circularization sites of Tth.L1925 and Ppo.L1925.  The exogenous
G added during the first step of splicing is shown in green.  Circularization at A and
D produce full-length circles, while circularization at B and C produces IGS circles.
Tth.L1925 has been found to form circles at A only in vitro, while it forms circles
at B and C both in vitro and in vivo.  Circularization at B is the major species
formed, while circularization at C is a minor product.  Ppo.L1925 has been found to
form circles at D only in vitro.  The species formed by Ppo.L1925 in vivo have not
been examined.
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In order to determine if the chimeric Tth.L1925 introns circularize in yeast,
and if there is a relationship between the circle species and intron-encoded ORF
expression levels, I used reverse transcriptase-PCR (RT-PCR) to amplify RNA
sequences containing circle junctions (Figure 5.6).  I used two primers, one that binds
to the 5’ end of the intron (or the α sequence) and faces upstream and one that binds to
the 3’ end of the intron that faces downstream.  Because of this primer arrangement,
the only sequence amplified would be the result of intron circularization.
The initial primer set consisted of a primer that binds in the α sequence, 101
nucleotides from the 5’ end of Tth-α, and one that binds 72 nucleotides from the 3’
end of the ribozyme.  I performed reverse transcription reactions on total yeast RNA
isolated from NOY505GalΩT integrated with Ppo-α, Ppo-α-HEUTR A, Tth-α, Tth-
5’P-α, and seven of the Tth-5’P-α-ran introns (Tth-5’P-α-ran 2, 4, 5, 10, 15, 16, and
17). If the intron RNAs formed full-length circles, the amplified product would be
~200 bp in length, and  if the introns formed smaller circles, the amplified product
would be correspondingly smaller.  All amplifications from intron-integrated yeast
RNA tested produced at least one band of the expected size (Figure 5.7), and several
produced two.   I infer that these bands  result from amplification of the reverse-
transcribed intron RNA, as RNA isolated from the intron-less parent strain,
NOY505GalΩT (Figure 5.7 B, lanes 2 and 5), and PCR amplifications run from mock
reverse transcriptions reactions did not produce bands (data not shown).
To determine the location of the circle junction, I sequenced a selection of the
amplified PCR products.  All of the sequences appeared to be amplified from a
mixture of junctions.  The most common junctions of these introns are listed in Figure
5.8.  Ppo-α and Ppo-α-HEUTR A circularize at the same position, between intron
nucleotides 5 and 6. Tth-α makes full-length circles, while the Tth-α-5’P circle
junction is at the –8 position.  High expressing Tth-α-ran 3 formed full-length circles,
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Figure 5.6:  Detecting circular intron RNA.  A.  Primer binding sites on the
target intron RNA.  The 5’ half of the RNA is depicted in purple, the 3’ half is
depicted in green.  B.  Reverse-transcription and PRC over circular intron junction.
1. Reverse transcription starts at Primer 1 and transcribes over the 5’ RNA, circle
junction, and the 3’ RNA.   2-3.  PCR amplifies over the circle junctions.  C.
Reverse transcription and PCR of linear RNA will produce no product. 1. Reverse
transcription starts at Primer 1 and transcribes over the 5’ RNA, ending at the 5’
end of the 5’ end RNA.   2-3.  PCR is unable to amplify the reverse transcription
product, as there is no binding site for primer 2.
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Figure 5.7:  RT-PCR to detect circular RNA junctions near the intron 5’ end.
A.  Primer binding sites for the reverse transcription-PCR.  Primer 1 binds 101
nucleotides from the 5’ end of a and primer 2 binds 72 nucleotides from the 3’
ribozyme end.  B. and C.  Agarose gel electrophoresis of reverse transcriptase-PCR
reactions of total RNA from NOY505GalWT with the indicated intron integrated.
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Figure 5.8:  Circle junction and β-galactosidase activity of selected intron
circles from figure 5.7.
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while low expressing Tth-α-ran 15 circularized at the –15 position.  Both high
expressing Tth-α-ran 4 and low expressing Tth-α-ran 16 circularized at the same
junction, -36.  Since the –36 junction is beyond the β-galactosidase α start codon, and
there is no in-frame start codon in the Tth.L1925 3’ end, it is highly unlikely that these
circles act as the message for the α protein.
Through examination of the raw data from the DNA sequencing reactions of
the Tth-α circle, I discovered a minor circularization junction is at –92, which is the
binding site of primer PrRS71.  In order to guard against the possibility that primer
binding during the reverse transcription reaction is somehow influencing circle
formation, I performed another RT-PCR reaction using a primer that binds in the P2
stem, downstream of the α ORF (PrRS157 for Tth.L1925, PrRS158 for Ppo.L1925,
along with either PrRS72 or PrRS71, respectively, for the subsequent amplification).
Amplification of full-length circles from this primer should result in products ~500
nucleotides in length.  Bands of this size were seen for both Ppo-α and Ppo-α-HEUR
A (Figure 5.9 B).  All Tth.L1925-based introns tested produced a much smaller
product, ~200 bp in length.  Sequencing of these bands showed that the junction at
position 289 of the α ORF (the α ORF is 297 nucleotides long) (Figure 5.10).
Formation of these circles cannot contribute to production of the β-galactosidase α
protein, as the circular RNA contains almost none of the β-galactosidase α sequence
and the 5’ liberated sequence is almost certainly quickly degraded.
Since there is no apparent relationship between circle junctions formed and the
amount of β-galactosidase activity produced by each intron-containing yeast strain
(Figure 5.10), I concluded that that circle formation is unlikely to be involved in
expression of the intron-encoded ORFs.
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Figure 5.9: RT-PCR to detect circular RNA junctions near the P1’ stem.  A.
Primer binding sites for the reverse transcription-PCR.  Primer 1 binds 407
nucleotides from the 5’ end of α and primer 2 binds 72 nucleotides from the 3’
ribozyme end.  B. and C.  Agarose gel electrophoresis of reverse transcriptase-PCR
reactions of total RNA from NOY505GalΩT with the indicated intron integrated.
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Figure 5.10:  Circle junction and β-galactosidase activity of selected intron
circles from figure 5.9.  Numbers in parenthesis indicate a position in the α ORF.
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Discussion
Capless, Pol I-derived RNA has been shown to be inefficiently translated in
yeast, presumably by ribosomes aberrantly initiating translation on an abundant RNA
at a low rate (Lo, Huang et al. 1998).  Translation of intron-encoded ORFs may be
more complicated than this model suggests, since intron sequences can greatly change
the amount of protein being translated without changing the level of spliced intron
RNA.  In this chapter, I investigated two possible models to explain how intron
sequences could modulate intron-encoded ORF expression in yeast.  According to one
model, the 5’ part of the intron RNA acts like an invasive growth IRES, and according
to the other intron circularization creates the messenger RNA for the intron-encoded
ORF.
Invasive growth IRES element does not increase expression from chimeric Tth-α
The invasive growth IRES sequence allows yeast cells to switch from
vegetative growth to invasive growth while at the same time conserving energy by
stopping all other translation.  The genes responsible for invasive growth escape
starvation-induced translation repression because their messages possess an A-rich
IRES sequence.  Since many of the highly expressing Tth-5’Pα-ran introns also had
A-rich 5’ end sequences, it seemed possible that the introns were using this
mechanism to initiate translation as well.  However, the results did not support this
model, as adding the YMR181c IRES sequence to the intron did not allow the intron-
encoded ORF to be translated through this pathway.
Why is the ORF not translated from an IRES-containing intron RNA through
the invasive growth IRES system?  One difference between the intron RNA and
invasive growth gene RNA is the length of sequence 5’ of their ORFs.  Many of the
invasive growth IRES elements have long stretches of upstream sequence, and some,
such as YMR181c, even have entire ORFs upstream.  The small, shared A-rich
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sequence is required for translation, as deletion of these sequences abrogates IRES
function, but it is possible that a length of additional upstream sequence, which is
lacked by the intron, is necessary for binding of other factors to facilitate IRES-
mediated.
Chemical probing of the poly-A tract in the IRES element has revealed that the
region is unstructured (Gilbert, Zhou et al. 2007).  It is possible that the intron
structure prevents PABP binding to the intron RNA.  The P1 stem is only 10
nucleotides upstream of the poly-A tract, and the ClaI sequence directly 5’ of the poly-
A tract and 3’ of the α ORF are likely to be involved in base pairing as well.
According to this argument, the intron 5’ end is far more structured than the IRES
element RNA, which could prevent translation initiation.
Alternatively, the invasive growth IRES elements may only be active during
the switch from vegetative to invasive growth and are not functional after the switch
has been made.  This possibility would explain why the YMR181c IRES did not
increase expression from Tth-IRES-αHA, as the intron-integrated yeast cells assayed
would have already finished their conversion to invasive growth.
There is no relationship between intron circle formation and expression of Ppo.l1925
or Tth.L1925-encoded ORFs.
Experiments deleting one of the IPS sites show that the full-length RNA is
important for translation (Lin and Vogt 1998).  The ribozyme region stabilizes the
ORF and, the ribozyme could play a role in expression.  It is possible that the message
is a relatively rare species that requires the ribozyme for formation.  Changes in the 5’
end and 3’UTR sequence could be influencing formation of this hypothetical species
and, thus influencing translation levels.  One of the more appealing candidates is
circular intron RNA, since this model would explain how sequences downstream of
the ORF, such as the 3’UTR, influence translation of the ORF.  After circularization,
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the “downstream” sequences could recruit factors that would end up “upstream” of the
ORF as well.  Additionally, sequences near the 5’ end of the intron and 3’ end of the
intron could influence the rate of circle formation and junction formed, which would
also influence expression of the intron.
Both Ppo-α- and Tth-α-based introns form circular RNA species in vivo.
Many of them form circles near the intron 5’ end, although only two of the Tth-α
introns, Tth-α and Tth-α-ran 3, appear to form full-length circles.   Interestingly, all of
the Tth-α-based introns form a circle between α nucleotides 288 and 289, while these
similar circles were not seen in the Ppo-α-based introns.  These circles may be related
to the IGS circles formed by an ORF-less Tth.L1925 which, similarly, are not found in
Ppo.L1925.
While all the introns tested form circular RNAs, it does not appear that circular
intron RNAs are involved in the translation of the intron-encoded ORF.  First, there is
no obvious correlation between the circle junction and the amount of protein being
translated from the intron RNA.  Indeed, several of the high and low expressing
introns shared the same junction.  Secondly, many of the circle junctions are inside the
α ORF sequence, removing the α start codon.  There are no start codons in the 3’
Tth.L1925 sequence that could act in place of the deleted start in intron circles, so it is
impossible for these circles to be translated. Additionally, all of the Tth-α based
introns form a circle that removes nearly all of the α sequence.
In conclusion, while intron sequences have an effect on the level of translation
of an intron-encoded ORF, the mechanism by which they operate remains mysterious.
In chapter IV, I found that there was no significant difference in RNA levels and
processing between all of the Tth-α introns.  In this chapter I found that it is unlikely
that the intron RNAs are interacting with the invasive growth IRES pathway, since
adding a known IRES sequence to an intron does not increase translation from the
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intron in relation to adding the reverse complement of the selfsame IRES sequence.
The formation of circular intron RNA also does not seem to play a role in translation
of intron-encoded ORFS.  While Tth-α and Ppo-α introns do form circular RNAs in
yeast there is not a relationship between levels of expression of the intron-encoded
ORF and the type of circle junction formed.  Many of the highest expressing introns
formed circles that disrupted the intron-encoded ORF.
The results of this chapter indicate that intron sequence must be changing
expression levels through another mechanism.  I will discuss a few of the possible
mechanisms in the next chapter.
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Chapter VI
Perspectives on Future Research
In this work, I have shown that a normally ORF-less group I intron,
Tth.L1925, will express ORFs that are added to it and that the sequence of that intron
can greatly influence the level of expression of the inserted ORF.  However, the
mechanism by which these introns are translated, and by which intron sequences
influence translation, remains elusive.  Based on my results, intron sequence does not
influencing translation by altering the level of full-length intron RNA available for
translation, by changing the amount of intron RNA processed at IPS1, IPS2, or IPS3,
by interacting with the invasive growth IRES system, or by causing the intron RNA to
form a highly-expressed circle.  A number of questions exist that, if answered, could
help illuminate how intron-encoded ORFs are translated.
Does the ribozyme have a role in expression of the intron-encoded ORF?  The
ribozyme structure certainly seems to stabilize the spliced intron RNA, as the intron
RNAs that accumulate in the cell contain the ribozyme region (see Figures 4.4 and
4.15).  This stabilizing effect, along with the large number of intron copies (~120) and
the high activity of RNA Polymerase I, explains the large levels of intron RNA in the
cell.  Intron-derived RNA species in yeast amount to ~2% of the total RNA , an
amount that is comparable to the sum total of all the mRNA in yeast (Warner 1971;
Lin and Vogt 1998).  Stabilization of the major intron RNA species, however, does not
explain differences in expression, as all chimeric Tth.L1925 introns I have examined
exhibit similar amounts of full-length and IPS-processed RNA, regardless of the
expression level.
The activity of the ribozyme is required to splice the full-length intron RNA
out of the pre-rRNA, but does it play a role in translation post-splicing?  The
enzymatic activity of the ribozyme could be required for translation of the intron-
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encoded ORF.  Although post-splicing processing and intron circularization do not
appear to be involved in translation, a rare processed RNA could serve as the message
for the intron-encoded protein.  Such a hypothetical RNA species might be impossible
to detect by northern blotting, however.  Signal from the abundant full-length and IPS-
processed RNA could drown out any signal.
The potential role of the reverse-splicing reaction in translation of intron-encoded
ORFs has not been addressed.  Since an RNA requires very little sequence identity to
be a potential target for reverse-splicing, which requires base pairing with the some of
the six nucleotides of the intron IGS (Roman and Woodson 1995; Roman, Rubin et al.
1999), it is likely that reverse splicing is occurring at some low rate in the yeast cells.
Although the most abundant target RNA is the actual intron insertion site of the
ribosomal large subunit RNA, it is likely that the intron is also able to reverse splice
into other RNA species, including mRNA.  By reverse splicing into an mRNA, the
intron would gain both a cap and poly-A tail and, if it reverse-splices ahead of, or in
frame with, the “native” start codon of the mRNA, the intron-encoded ORF could be
translated just like a “normal” mRNA (Figure 6.1).
The reverse splicing model of translation is not ruled out by any of the
experimental data.  RNA species derived from reverse splicing do not appear on
northern blots, but this could be because of their relative rarity compared to the
overwhelming amount of full-length and processed intron RNA.  It is possible that the
“high-expression” sequences 5’ and 3’ of the intron-encoded ORF could increase
translation, both by promoting the reverse splicing reaction and by allowing the intron
to reverse splice at new sites.
If the intron is reverse splicing into mRNAs, it is likely that some of the sites
are downstream of, and in frame with, an existing start codon.  Proteins translated
from these mRNA would be fusions, containing the N-terminal amino acids of the
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Figure 6.1:  Hypothetical translation of intron encoded-ORFs through reverse
splicing.  A.  1.  The intron (green) reverse splices at a site upstream of the
mRNA’s start codon.  2.  The mRNA is translated and, since the start codon of the
intron-encoded ORF(blue)  is the first one encountered by the ribosome, the intron-
encoded ORF is translated.  B.  1.  The intron reverse splices at a site downstream
of, but in frame with, the ORF on the mRNA (red).  2.  The mRNA is translated
and produces a protein that is a fusion of the N-terminus of the mRNA-encoded
protein and the entire intron-encoded protein.
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mRNA-encoded protein fused to the entirety of the intron-encoded protein (Figure
6.1B).  If this is happening with more than one mRNA, fusion proteins of varying
lengths would be produced.  Only a single protein species is seen in the western blot of
protein from Tth-His3HA and Tth-5’P-His3HA (Figure 3.7 and 4.11).  This result
does not necessarily rule out the reverse-splicing model, though.  Proteins
corresponding to the full-length intron-encoded ORF can be translated from reverse-
splicing at many sites, while each larger chimeric protein would be the result of
reverse splicing at a single site (Figure 6.2).  It is quite possible that the western
blotting signal from chimeric protein(s) is drowned out by the signal of the full-length
protein, explaining the single bands seen in Figure 3.7 and 4.11.
Models for translation of intron-encoded ORFs that do not require the
enzymatic activity of the ribozyme are nebulous.  Intron RNA could be forming a
structure that interacts with cellular translation machinery.  Sequences 5’ and 3’ of the
ORF could promote the formation of this structure or discourage the formation of a
competing, translationally inactive, structure.  It is unclear what these structures might
be or the particulars of the proteins the intron RNA would be interacting with,
although perhaps chemical probing of high and low expressing intron RNAs would
illuminate structural differences linked to expression.
An alternate model is that the intron RNA is interacting directly with the
ribosomal RNA (Figure 6.3).  The intron insertion site, which binds to the intron IGS,
hangs over the active site of the ribosome (Figure 6.4).  The first four of the six
nucleotides bound by the IGS are unstructured in the 2000 LSU crystal structure and
may be available to base-pair with the intron sequence (Ban, Nissen et al. 2000;
Nissen, Hansen et al. 2000).  Interaction of the intron RNA with these nucleotides
could promote translation, perhaps by allowing a ribosome-associated intron RNA to
displace the mRNA in a translation initiation complex.  Intron sequences could alter
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Figure 6.2:  The full length intron-encoded protein could be the product of
reverse splicing at many sites, while each fusion protein is the result of reverse
splicing at a unique site.  A.  Each fusion protein produced through reverse
splicing downstream of a start codon is unique.  B. Introns that reverse splice
upstream of a start codon all produce the full-length intron encoded protein.
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+ Interaction with the LSU RNA
Translation
Intron sequence could affect translation through:
•Changing the strength of interactions
between the intron RNA and LSU rRNA.
Figure 6.3:  Model for intron-encoded ORF expression through interactions
with the large ribosomal subunit RNA.
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Figure 6.4:  Space-filling model of the large ribosomal subunit.  The circled
region indicates the position of the intron insertion site.  An inhibitor bound in the
active site is indicated in red. The RNA bases are in grey and sugar-phosphate
backbone in orange.  Ribosomal proteins are in blue.  Adapted from Nissen,
Hansen et al., 2000.
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expression levels by forming structures that promote or discourage ribosome-IGS
binding.
Understanding how these introns-encoded ORFs are translated could be useful
both to understand evolution and as a tool to produce RNA and express proteins in
vivo.  Since the cell contains so much intron RNA, if adjustments could be made in
intron sequence to increase intron-based translation efficiency to that of Pol II mRNA,
it could become a way to produce very large amounts of protein.  There are major
limitations of the system, however.  Any ORF to be expressed could not disrupt intron
splicing, a quality that has proven to be difficult to predict.  Additionally, since Pol I
translation is not inducible, the intron-encoded ORF would be constitutively
expressed, which could cause difficulties in the case of proteins that are toxic at high
levels.  Perhaps modeling an intron after intron Dir.S956-2, which has an ORF
oriented anti-sense to the intron sequence that is driven by an independent RNA Pol II
promoter, would be a more useful tool (Figure 6.5).  This arrangement would not be
able to take advantage of the high activity of RNA Pol I, but would allow ~120 copies
of the ORF of interest to be stably integrated, under the control of an inducible
promoter, into the genome of the host cell.
A simpler use for these introns is as a vehicle to make large amounts of a small
RNA irrespective of translation, for example, an RNA aptamer, which is an RNA
sequences that forms a structure which binds to a specific molecule, in vivo.  As with
inserted ORFs, aptamer sequences would have to be tested to make sure they do not
disrupt splicing, and, additionally, the intron sequences could bind to the aptamer and
disrupt its interactions with the target molecule.  Intron processing near the IGS could
relieve intron-based disruption of the aptamer function, as the resulting 5’ processed
piece would include only minimal intron sequence.
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Figure 6.5:  A Dir.S956-2-like model could be useful for increasing translation
from chimeric Tth.L1925 introns.  A.  A schematic representation of a theoretical
chimeric Tth.L1925.  Note that the ORF (light blue) is oriented in the antisense
direction in relation to Dir.S956-2.  B.  Expression of the intron-encoded ORF from
a Dir.S956-2-like chimeric Tth.L1925.  1.  The ORF DNA (thin lines) is
transcribed by RNA Polymerase II into RNA (thick lines), driven by an inducible
promoter (black arrow).  This transcription is independent of the transcription of
the SSU and intron.  2.  An optional spliceosomal intron is removed by the
spliceosomal complex, and a 5’ cap and poly-A tail is added to the I-DirII RNA.  3.
The processed RNA is translated into the protein of interest (blue circle).
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In conclusion, we do not understand many things about protein expression
from nuclear group I introns.  However, several tantalizing avenues for research have
presented themselves.  There are numerous reasons to pursue these avenues, as they
could provide insight into novel pathways that lead from a DNA sequence to an
expressed protein, provide greater understanding of the evolutionary history of mobile
genetic elements, and provide a useful new tool to produce RNA and protein in vivo.
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